Refine
Year of publication
Document Type
- Journal article (7624) (remove)
Language
- English (7624) (remove)
Keywords
- Toxikologie (110)
- Medizin (94)
- inflammation (86)
- Biochemie (81)
- Anorganische Chemie (66)
- cancer (66)
- gene expression (62)
- Organische Chemie (59)
- Infektionsbiologie (57)
- apoptosis (54)
- expression (53)
- COVID-19 (51)
- Biologie (50)
- Psychologie (49)
- machine learning (49)
- Hadron-Hadron scattering (experiments) (47)
- Physiologische Chemie (46)
- depression (46)
- breast cancer (45)
- children (44)
- multiple myeloma (44)
- therapy (40)
- Neurobiologie (39)
- infection (37)
- virtual reality (37)
- anxiety (36)
- ischemic stroke (35)
- mice (35)
- stroke (35)
- T cells (34)
- Virologie (34)
- boron (34)
- cytokines (33)
- remote sensing (32)
- biomarker (31)
- brain (31)
- melanoma (31)
- SARS-CoV-2 (30)
- metabolism (30)
- multiple sclerosis (30)
- oxidative stress (30)
- prostate cancer (30)
- Germany (29)
- heart failure (29)
- magnetic resonance imaging (29)
- biodiversity (28)
- gene (28)
- DNA damage (27)
- evolution (27)
- Chirurgie (26)
- PET (26)
- climate change (26)
- deep learning (26)
- genetics (26)
- in vitro (26)
- macrophages (26)
- phosphorylation (26)
- High energy physics (25)
- Parton Distributions (25)
- protein (25)
- B cells (24)
- DNA methylation (24)
- MRI (24)
- diagnosis (24)
- medicine (24)
- survival (24)
- Escherichia coli (23)
- Fabry disease (23)
- identification (23)
- immunotherapy (23)
- mortality (23)
- Candida albicans (22)
- Parkinson’s disease (22)
- autophagy (22)
- disease (22)
- positron emission tomography (22)
- Immunologie (21)
- blood (21)
- chronic kidney disease (21)
- neuroinflammation (21)
- obesity (21)
- physics (21)
- radiotherapy (21)
- tissue engineering (21)
- 3D printing (20)
- ADHD (20)
- ATLAS detector (20)
- Parkinson's disease (20)
- activation (20)
- mouse (20)
- physical activity (20)
- platelets (20)
- prognosis (20)
- quality of life (20)
- surgery (20)
- Chemie (19)
- DNA (19)
- behavior (19)
- classification (19)
- dendritic cells (19)
- endothelial cells (19)
- immunohistochemistry (19)
- management (19)
- mouse model (19)
- mouse models (19)
- regulatory T cells (19)
- RNA (18)
- binding (18)
- differentiation (18)
- epidemiology (18)
- fluorescence (18)
- pain (18)
- psychology (18)
- stem cells (18)
- theranostics (18)
- time series (18)
- CXCR4 (17)
- EEG (17)
- Expression (17)
- HIV (17)
- aging (17)
- antibodies (17)
- biology (17)
- colorectal cancer (17)
- deep brain stimulation (17)
- metastasis (17)
- mitochondria (17)
- perception (17)
- toxicity (17)
- transcriptome (17)
- validation (17)
- Staphylococcus aureus (16)
- artificial intelligence (16)
- attention (16)
- biomarkers (16)
- blood pressure (16)
- blood-brain barrier (16)
- cells (16)
- cytotoxicity (16)
- epithelial cells (16)
- messenger RNA (16)
- model (16)
- myocardial infarction (16)
- prevalence (16)
- resistance (16)
- signal transduction (16)
- topological insulators (16)
- Decay (15)
- Positronen-Emissions-Tomografie (15)
- chemotherapy (15)
- cytoskeleton (15)
- escherichia coli (15)
- hadron-hadron scattering (15)
- human (15)
- imaging (15)
- mental health (15)
- mutation (15)
- neurons (15)
- osteoporosis (15)
- proteins (15)
- proton-proton collision (15)
- schizophrenia (15)
- Cytologie (14)
- Drosophila melanogaster (14)
- Extension (14)
- Higgs boson (14)
- P300 (14)
- Sentinel-2 (14)
- adrenocortical carcinoma (14)
- angiogenesis (14)
- bone (14)
- cell death (14)
- foraging (14)
- guidelines (14)
- heart (14)
- immune response (14)
- in vivo (14)
- in-vivo (14)
- learning (14)
- luminescence (14)
- mechanisms (14)
- neuropathic pain (14)
- neuroprotection (14)
- prediction (14)
- rat (14)
- risk factors (14)
- sepsis (14)
- virulence (14)
- vision (14)
- Apis mellifera (13)
- LHC (13)
- Medicine (13)
- Neisseria meningitidis (13)
- Physics (13)
- association (13)
- bacteria (13)
- bees (13)
- case report (13)
- cell staining (13)
- chemistry (13)
- crystal structure (13)
- echocardiography (13)
- epigenetics (13)
- extracellular matrix (13)
- flow cytometry (13)
- honey bees (13)
- land use (13)
- metaanalysis (13)
- microRNA (13)
- molecular docking (13)
- monocytes (13)
- ovarian cancer (13)
- recurrence (13)
- stress (13)
- transcription (13)
- transcription factors (13)
- treatment (13)
- tumor (13)
- Activation (12)
- Aspergillus fumigatus (12)
- Drosophila (12)
- MODIS (12)
- Merkel cell carcinoma (12)
- PET/CT (12)
- blood–brain barrier (12)
- circadian clock (12)
- dopamine (12)
- electronic properties and materials (12)
- event-related potentials (12)
- gene regulation (12)
- genome (12)
- humans (12)
- in-vitro (12)
- inorganic chemistry (12)
- lymphocytes (12)
- mRNA (12)
- metabolomics (12)
- migration (12)
- neurodegeneration (12)
- neurology (12)
- nutrition (12)
- proliferation (12)
- structure elucidation (12)
- ++ (11)
- Aspergillus (11)
- BDNF (11)
- DNA repair (11)
- PRRT (11)
- Squark (11)
- Tanzania (11)
- additive manufacturing (11)
- atherosclerosis (11)
- cancer treatment (11)
- conservation (11)
- diet (11)
- emotion (11)
- exercise (11)
- fMRI (11)
- fibrosis (11)
- follow-up (11)
- fracture (11)
- fungi (11)
- glioblastoma (11)
- glioblastoma multiforme (11)
- growth (11)
- hippocampus (11)
- honeybee (11)
- inhibition (11)
- lung cancer (11)
- lymphoma (11)
- mass spectrometry (11)
- measles virus (11)
- membrane proteins (11)
- memory (11)
- miRNA (11)
- microbiome (11)
- molecular biology (11)
- nervous system (11)
- optogenetics (11)
- osteoarthritis (11)
- proteomics (11)
- randomized controlled trial (11)
- reliability (11)
- self-assembly (11)
- simulation (11)
- tight junctions (11)
- total knee arthroplasty (11)
- transplantation (11)
- traumatic brain injury (11)
- tumor microenvironment (11)
- vitamin D (11)
- Alzheimer’s disease (10)
- PSMA (10)
- Trypanosoma brucei (10)
- adolescents (10)
- animal model (10)
- antimicrobial resistance (10)
- atrial fibrillation (10)
- bipolar disorder (10)
- cardiomyopathy (10)
- complex (10)
- diabetes (10)
- ecosystem services (10)
- emotions (10)
- fear (10)
- fear conditioning (10)
- genome-wide association (10)
- global change (10)
- hypoxia (10)
- insects (10)
- lymph nodes (10)
- melt electrowriting (10)
- metagenomics (10)
- microglia (10)
- mushroom body (10)
- neuroendocrine tumor (10)
- neutrophils (10)
- performance (10)
- polymers (10)
- pregnancy (10)
- psychiatric disorders (10)
- receptor (10)
- relapse (10)
- review (10)
- risk (10)
- safety (10)
- serotonin (10)
- sphingolipids (10)
- Boron (9)
- Cancer (9)
- Depression (9)
- Google Earth Engine (9)
- Krebs <Medizin> (9)
- LASP1 (9)
- RNA-seq (9)
- Schwertkärpfling (9)
- Sentinel-1 (9)
- T-cells (9)
- actin (9)
- active zone (9)
- age (9)
- amygdala (9)
- ants (9)
- asthma (9)
- autoimmunity (9)
- boranes (9)
- central nervous system (9)
- cerebrospinal fluid (9)
- clinical trial (9)
- cortisol (9)
- cytotoxic T cells (9)
- database (9)
- density functional calculations (9)
- diversity (9)
- dosimetry (9)
- dynamics (9)
- ecology (9)
- energy (9)
- enzyme replacement therapy (9)
- fatigue (9)
- forest (9)
- hemodialysis (9)
- human behaviour (9)
- immunology (9)
- ischemia (9)
- mesenchymal stem cells (9)
- mutations (9)
- nanoparticles (9)
- neural networks (9)
- neuroscience (9)
- olfaction (9)
- oncology (9)
- outcome (9)
- pancreatic cancer (9)
- pathogens (9)
- phenotype (9)
- plasticity (9)
- platelet (9)
- pollination (9)
- polymorphism (9)
- prefrontal cortex (9)
- preterm infants (9)
- rats (9)
- reveals (9)
- super-resolution microscopy (9)
- synaptic plasticity (9)
- systematic review (9)
- systematic uncertainty (9)
- temperature (9)
- transcriptomics (9)
- translation (9)
- tumors (9)
- type 2 diabetes (9)
- ubiquitin (9)
- walking (9)
- water oxidation (9)
- Adenosine receptors (8)
- Alps (8)
- Apoptosis (8)
- Beyond Standard Model (8)
- Cross-Section (8)
- EAE (8)
- HNSCC (8)
- Landsat (8)
- MS (8)
- MYC (8)
- Mass (8)
- Mice (8)
- Model (8)
- NK cells (8)
- Parton distributions (8)
- TNF (8)
- Therapy (8)
- West Africa (8)
- X-ray crystallography (8)
- Xiphophorus (8)
- acute kidney injury (8)
- adolescence (8)
- agriculture (8)
- amyotrophic lateral sclerosis (8)
- analysis of variance (8)
- animal models (8)
- antibiotics (8)
- aromaticity (8)
- biofabrication (8)
- body size (8)
- borylation (8)
- calcium (8)
- cardiovascular disease (8)
- cartilage (8)
- cell biology (8)
- cell cycle (8)
- chromatin (8)
- decay (8)
- decision making (8)
- development (8)
- earth observation (8)
- education (8)
- electroencephalography (8)
- emotion regulation (8)
- fluorescence microscopy (8)
- forest management (8)
- gastric cancer (8)
- genomics (8)
- glycine receptor (8)
- head and neck cancer (8)
- heart rate (8)
- high energy physics (8)
- hypertension (8)
- impact (8)
- in vivo imaging (8)
- induced pluripotent stem cells (8)
- jet energy scale (8)
- kidney (8)
- kinematic alignment (8)
- kinetics (8)
- mHealth (8)
- major depression (8)
- mechanism (8)
- microscopy (8)
- molecular imaging (8)
- navigation (8)
- next generation sequencing (8)
- nitric oxide (8)
- oncolytic virus (8)
- organoids (8)
- pathway (8)
- periodontitis (8)
- photocatalysis (8)
- platelet activation (8)
- pollen (8)
- polycyclic aromatic hydrocarbons (8)
- prevention (8)
- progression (8)
- quality assurance (8)
- radioligand therapy (8)
- reactive oxygen species (8)
- reconstruction (8)
- regulation (8)
- rehabilitation (8)
- replication (8)
- rheumatoid arthritis (8)
- serum (8)
- signaling (8)
- subthalamic nucleus (8)
- technology (8)
- thrombosis (8)
- tinnitus (8)
- transmission (8)
- ALS (7)
- ATLAS (7)
- Arabidopsis thaliana (7)
- Gehirn (7)
- NDVI (7)
- NFATc1 (7)
- Neisseria gonorrhoeae (7)
- Pain (7)
- Physik (7)
- SAR (7)
- SPECT (7)
- Supersymmetry (7)
- Survival (7)
- Transcription (7)
- Trypanosoma (7)
- United States (7)
- acute ischemic stroke (7)
- animal behavior (7)
- animal behaviour (7)
- antibacterial activity (7)
- astrocytes (7)
- autoantibodies (7)
- basal ganglia (7)
- bioinformatics (7)
- bioprinting (7)
- biosynthesis (7)
- blood flow (7)
- body mass index (7)
- cell membranes (7)
- central complex (7)
- chemokine receptor (7)
- chronic heart failure (7)
- circadian rhythms (7)
- coherence (7)
- comparative genomics (7)
- dSTORM (7)
- decision-making (7)
- developmental biology (7)
- diabetes mellitus (7)
- diborenes (7)
- domain (7)
- drought (7)
- efficacy (7)
- embodiment (7)
- endurance (7)
- experimental autoimmune encephalomyelitis (7)
- extracellular vesicles (7)
- fibromyalgia syndrome (7)
- fluorescent probes (7)
- genes (7)
- gephyrin (7)
- histology (7)
- hydrogels (7)
- hypophosphatasia (7)
- immersion (7)
- immune evasion (7)
- immunofluorescence (7)
- immunomodulation (7)
- immunoprecipitation (7)
- inhibitor (7)
- innate immunity (7)
- insect (7)
- luciferase (7)
- mechanotransduction (7)
- meiosis (7)
- melt electrospinning writing (7)
- microbiology (7)
- microenvironment (7)
- multicenter (7)
- near-infrared spectroscopy (7)
- optimization (7)
- panic disorder (7)
- peripheral nervous system (7)
- permafrost (7)
- personalized medicine (7)
- platelet aggregation (7)
- population (7)
- psoriasis (7)
- public health (7)
- quantum dots (7)
- radiation (7)
- random forest (7)
- recognition (7)
- responses (7)
- semiconductors (7)
- senescence (7)
- sex differences (7)
- sleep (7)
- social cognition (7)
- software (7)
- species richness (7)
- spectroscopy (7)
- spinal muscular atrophy (7)
- symbiosis (7)
- synthesis (7)
- telomeres (7)
- translational research (7)
- trial (7)
- two-dimensional materials (7)
- water (7)
- wearable (7)
- zebrafish (7)
- Alzheimer's disease (6)
- Chrysomelidae (6)
- Covid-19 (6)
- DNA binding (6)
- ELISPOT (6)
- Earth observation (6)
- Echinococcus (6)
- Ernährung (6)
- Europe (6)
- Evolution (6)
- Gluino Production (6)
- Hadron colliders (6)
- HeLa cells (6)
- Higgs physics (6)
- Inflammation (6)
- Large Hadron Collider (6)
- MASS (6)
- Mechanisms (6)
- Monte-Carlo (6)
- N-heterocyclic carbenes (6)
- NAFLD (6)
- NLO Computations (6)
- PD-L1 (6)
- Prevalence (6)
- RNA sequencing (6)
- Schizophrenie (6)
- South Africa (6)
- TRAIL (6)
- Top physics (6)
- UAV (6)
- absorption (6)
- adhesion (6)
- adults (6)
- aggregation (6)
- algorithm (6)
- antibiotic resistance (6)
- antidepressant (6)
- arabidopsis thaliana (6)
- astrocytoma (6)
- bacterial pathogens (6)
- behavioral conditioning (6)
- bone marrow (6)
- boronate esters (6)
- brain development (6)
- brain-computer interface (6)
- cancer metabolism (6)
- cancer therapy (6)
- carcinoma (6)
- cardiac surgery (6)
- cardiovascular diseases (6)
- catalysis (6)
- cell proliferation (6)
- ceramide (6)
- cerebellum (6)
- change detection (6)
- chemokines (6)
- circular dichroism (6)
- cognitive impairment (6)
- communication (6)
- computed tomography (6)
- copper (6)
- coronary artery disease (6)
- cytokinins (6)
- deadwood (6)
- dementia (6)
- design (6)
- down regulation (6)
- drosophila melanogaster (6)
- drug (6)
- drug delivery (6)
- dystonia (6)
- eHealth (6)
- evaluation (6)
- exposure (6)
- extinction (6)
- eye movements (6)
- eyes (6)
- factor XII (6)
- family (6)
- glaucoma (6)
- glioma (6)
- glucocorticoid receptor (6)
- glycoprotein VI (6)
- homogeneous catalysis (6)
- hyaluronic acid (6)
- hymenoptera (6)
- hyperexpression techniques (6)
- ideomotor theory (6)
- immunity (6)
- immunosuppression (6)
- influenza (6)
- injury (6)
- insulin (6)
- kidneys (6)
- lesions (6)
- leukemia (6)
- liver (6)
- locomotion (6)
- lung (6)
- magnetic properties and materials (6)
- malaria (6)
- mechanical thrombectomy (6)
- membrane potential (6)
- meningococcal disease (6)
- meta-analysis (6)
- metapopulation (6)
- methylation (6)
- molecular dynamics (6)
- monitoring (6)
- motivation (6)
- motor control (6)
- mushroom bodies (6)
- myelin (6)
- neuromuscular junction (6)
- organic chemistry (6)
- outcomes (6)
- p53 (6)
- pathogenesis (6)
- pediatric (6)
- pediatrics (6)
- pharmacokinetics (6)
- phylogenetic trees (6)
- plasmodium falciparum (6)
- precision medicine (6)
- presence (6)
- primary care (6)
- radicals (6)
- receptors (6)
- recombination (6)
- recovery (6)
- regenerative medicine (6)
- repair (6)
- reward (6)
- sRNA (6)
- secondary prevention (6)
- secretion (6)
- segmentation (6)
- sequence alignment (6)
- small interfering RNAs (6)
- smoking (6)
- social interaction (6)
- staphylococcus aureus (6)
- states (6)
- susceptibility (6)
- systems biology (6)
- target (6)
- therapeutic drug monitoring (6)
- thermodynamics (6)
- tool (6)
- transcriptional regulation (6)
- vaccinia virus (6)
- variability (6)
- viral infection (6)
- 53BP1 (5)
- Akt (5)
- B cell (5)
- BRAF (5)
- BRCA1 (5)
- Biology (5)
- Breaking (5)
- Burkina Faso (5)
- CD95 (5)
- CML (5)
- CMV (5)
- CSF (5)
- CT (5)
- Chlamydia trachomatis (5)
- Durchblutung (5)
- Energy (5)
- Enzyme replacement therapy (5)
- Gene-expression (5)
- Genotoxicity (5)
- Heart failure (5)
- Higgs bosons (5)
- IL-10 (5)
- Immunotherapy (5)
- In-vivo (5)
- MRSA (5)
- MSC (5)
- Magnetic resonance imaging (5)
- Metapopulation (5)
- Multiple myeloma (5)
- Multiple sclerosis (5)
- NF-KAPPA-B (5)
- NFκB (5)
- NLO computations (5)
- NLRP3 (5)
- NMR (5)
- NPY (5)
- NRF2 (5)
- PCR (5)
- PD-1 (5)
- Parkinson disease (5)
- Quality of life (5)
- RNA-binding proteins (5)
- Radiotherapy (5)
- Rat (5)
- T cell (5)
- T lymphocytes (5)
- TNF-α (5)
- TNFR2 (5)
- TerraSAR-X (5)
- Top quark (5)
- VEGF (5)
- actinomycetes (5)
- acute myeloid leukemia (5)
- adaptation (5)
- allergy (5)
- allogeneic stem cell transplantation (5)
- altitudinal gradient (5)
- anatomy (5)
- annotation (5)
- antennal lobe (5)
- antibody (5)
- antigen (5)
- antimicrobial stewardship (5)
- antimicrobials (5)
- aorta (5)
- autonomic nervous system (5)
- balance (5)
- bariatric surgery (5)
- biocompatibility (5)
- biological locomotion (5)
- biophysics (5)
- blood brain barrier (5)
- body weight (5)
- bone mineral density (5)
- bone regeneration (5)
- brain tumor (5)
- bronchopulmonary dysplasia (5)
- caloric restriction (5)
- carbenes (5)
- cardiac hypertrophy (5)
- cardiovascular events (5)
- cell cultures (5)
- cell cycle and cell division (5)
- cell differentiation (5)
- cell wall (5)
- ceramides (5)
- cerebral ischemia (5)
- circadian rhythm (5)
- co-culture (5)
- coagulation (5)
- cognition (5)
- cognitive decline (5)
- collagens (5)
- comparison (5)
- competition (5)
- complexes (5)
- condensed matter physics (5)
- coping (5)
- critical illness (5)
- cuticular hydrocarbons (5)
- damage (5)
- density functional theory (5)
- dental education (5)
- detoxification (5)
- diagnostic markers (5)
- diagnostics (5)
- drug design (5)
- drug discovery (5)
- dyes (5)
- ecological momentary assessment (5)
- electron microscopy (5)
- electronic structure (5)
- emission (5)
- endocytosis (5)
- endurance training (5)
- enzyme-linked immunoassays (5)
- enzymes (5)
- experimental design (5)
- eye tracking (5)
- facial expression (5)
- fluorescence imaging (5)
- fluorescence resonance energy transfer (5)
- fluorine (5)
- food-cues (5)
- forensic neuropathology (5)
- fungal infection (5)
- gait (5)
- galactomannan (5)
- gastrointestinal tract (5)
- gender (5)
- gene-expression (5)
- generation (5)
- genotoxicity (5)
- glaucoma surgery (5)
- global warming (5)
- grazing (5)
- guideline adherence (5)
- health-related quality of life (5)
- hearing loss (5)
- heterochromatin (5)
- heterocycles (5)
- human-computer interaction (5)
- immune cells (5)
- implementation (5)
- incidence (5)
- inflammasome (5)
- inflammatory bowel disease (5)
- iron (5)
- larvae (5)
- leaf-cutting ants (5)
- lipids (5)
- localization (5)
- long-term outcome (5)
- mapping (5)
- marine sponges (5)
- masked priming (5)
- mast cells (5)
- matrix metalloproteinases (5)
- membrane (5)
- meningitis (5)
- mental disorders (5)
- metabarcoding (5)
- methionine (5)
- middle cerebral artery occlusion (5)
- migrants (5)
- mineralization (5)
- models (5)
- molecular medicine (5)
- molecular neuroscience (5)
- movement disorders (5)
- movement ecology (5)
- mutualism (5)
- myeloma (5)
- neuroanatomy (5)
- neurogenesis (5)
- neuronal differentiation (5)
- neuropathy (5)
- norepinephrine (5)
- nuclear envelope (5)
- object detection (5)
- octopamine (5)
- oilseed rape (5)
- oncolysis (5)
- optical spectroscopy (5)
- organization (5)
- paraganglioma (5)
- parasitic diseases (5)
- perception and action (5)
- permeability (5)
- phenology (5)
- pheochromocytoma (5)
- physiology (5)
- plant-insect interactions (5)
- plants (5)
- polyomavirus (5)
- preclinical research (5)
- prognostic marker (5)
- protein domains (5)
- protein kinase (5)
- pulmonary hypertension (5)
- quantification (5)
- radial (5)
- recombinant proteins (5)
- recruitment (5)
- refractory (5)
- regression analysis (5)
- replacement (5)
- response inhibition (5)
- salt stress (5)
- scale (5)
- secondary structure (5)
- selection (5)
- sequence (5)
- signaling pathway (5)
- single-crystal X-ray study (5)
- skeletal muscle (5)
- small RNA (5)
- social anxiety (5)
- solar cells (5)
- somatic mutations (5)
- spinal cord (5)
- stem-cell transplantation (5)
- structural biology (5)
- structure (5)
- superconductivity (5)
- supramolecular chemistry (5)
- survey (5)
- sympathetic nervous system (5)
- synaptic vesicles (5)
- system (5)
- taxonomy (5)
- thrombo-inflammation (5)
- tomography (5)
- trabeculectomy (5)
- training (5)
- translocation (5)
- transverse momentum (5)
- tremor (5)
- vaccination (5)
- vaccine (5)
- valence (5)
- vancomycin (5)
- variants (5)
- vestibular schwannoma (5)
- winter wheat (5)
- working memory (5)
- 3D tissue model (4)
- AI (4)
- AdS-CFT Correspondence (4)
- Adenylate cyclase (4)
- Adult (4)
- Alzheimers disease (4)
- Anaphylaxis (4)
- Anura (4)
- Asthma (4)
- Atlas detector (4)
- B-cell lymphoma (4)
- Bordetella pertussis (4)
- Boson (4)
- Botanik (4)
- Brain (4)
- C-MYC (4)
- C-reactive protein (4)
- CNS (4)
- CRISPR/Cas9 (4)
- CT angiography (4)
- Cancer genetics (4)
- Candida auris (4)
- Children (4)
- China (4)
- Cushing’s syndrome (4)
- DNA transcription (4)
- DNA-binding proteins (4)
- Dendritische Zelle (4)
- Diagnosis (4)
- Distributions (4)
- EGFR (4)
- EMG (4)
- ERP (4)
- Earth Observation (4)
- Electroweak interaction (4)
- FDG (4)
- FGFR (4)
- Fn14 (4)
- G proteins (4)
- GABA (4)
- GFAP (4)
- GVHD (4)
- Gene (4)
- Geschichte (4)
- Glioblastoma (4)
- Hierarchy (4)
- Hypothalamus (4)
- IL-2 (4)
- IL-4 (4)
- ITS2 (4)
- Immunobiologie (4)
- InSAR (4)
- IoT (4)
- Krebs (4)
- LPS (4)
- Lepidoptera (4)
- Models (4)
- NASH (4)
- NET (4)
- NGS (4)
- NSCLC (4)
- Neurons (4)
- Neurospora crassa (4)
- Pathway (4)
- Pflanzenfressende Insekten (4)
- Pharmakologie (4)
- Protein (4)
- Quantitative anatomy (4)
- RCT (4)
- RNA interference (4)
- ROS (4)
- RapidEye (4)
- Rituximab (4)
- Roux-en-Y gastric bypass surgery (4)
- SSTR (4)
- Salmonella (4)
- Streptomyces (4)
- Surgery (4)
- TLR4 (4)
- TNF receptor superfamily (4)
- TWEAK (4)
- Th17 (4)
- Transport (4)
- Treatment (4)
- UV/Vis spectroscopy (4)
- Ureaplasma parvum (4)
- Zoologie (4)
- accumulation (4)
- accuracy (4)
- acid sphingomyelinase (4)
- action (4)
- adalimumab (4)
- adenosine (4)
- adipose tissue (4)
- adsorption (4)
- age-related macular degeneration (4)
- ageing (4)
- agency (4)
- aggression (4)
- algorithms (4)
- alignment (4)
- alkaloids (4)
- amyotrophic-lateral-sclerosis (4)
- animals (4)
- anorexia nervosa (4)
- antagonists (4)
- anticoagulation (4)
- antidepressants (4)
- antifungals (4)
- antiretroviral therapy (4)
- antisense RNA (4)
- anxiety disorders (4)
- apis mellifera (4)
- arousal (4)
- arrhythmia (4)
- arthritis (4)
- aspergillosis (4)
- aspergillus fumigatus (4)
- athletes (4)
- atopic dermatitis (4)
- attention-deficit/hyperactivity disorder (ADHD) (4)
- augmented reality (4)
- autoantibody (4)
- automation (4)
- bevacizumab (4)
- binding analysis (4)
- biodiversity conservation (4)
- biofilms (4)
- bioink (4)
- biokinetics (4)
- biological models (4)
- biomass (4)
- biomaterials (4)
- bismuth (4)
- blood plasma (4)
- body composition (4)
- bone-mineral density (4)
- brain computer interface (4)
- burden (4)
- cGMP (4)
- calcium phosphate (4)
- cancer genomics (4)
- cancer immunotherapy (4)
- cancer patients (4)
- cancer stem cells (4)
- capsaicin (4)
- carcinomas (4)
- cardiorespiratory fitness (4)
- cardiovascular genetics (4)
- cardiovascular risk factors (4)
- care (4)
- catecholamines (4)
- cell-cycle arrest (4)
- cervical dystonia (4)
- chirality (4)
- chlamydia (4)
- chondrocytes (4)
- chondrogenic differentiation (4)
- ciliary neurotrophic factor (4)
- cisplatin (4)
- classical conditioning (4)
- climate (4)
- clinical trials (4)
- cochlear implant (4)
- cognitive control (4)
- collagen (4)
- colony-stimulating factor (4)
- consortium (4)
- coronary heart disease (4)
- critical care (4)
- cross-coupling (4)
- crowdsensing (4)
- cystic fibrosis (4)
- cytokine (4)
- cytokinesis (4)
- deficiency (4)
- degradation (4)
- dehydrocoupling (4)
- democracy (4)
- demyelination (4)
- dentate gyrus (4)
- dermatology (4)
- detrended fluctuation analysis (4)
- dexamethasone (4)
- dialysis (4)
- diborynes (4)
- diffusion (4)
- disability (4)
- disease severity (4)
- dispersal (4)
- dyes/pigments (4)
- eating disorders (4)
- economic growth (4)
- ecosystem function (4)
- editorial (4)
- ejection fraction (4)
- elderly (4)
- electrospinning (4)
- empathy (4)
- endoscopy (4)
- endurance exercise (4)
- energy metabolism (4)
- enzyme (4)
- epithelial-mesenchymal transition (4)
- ethanol (4)
- evolutionary genetics (4)
- excitons (4)
- experience (4)
- experimental stroke (4)
- fNIRS (4)
- facial expressions (4)
- fatty acids (4)
- ferroptosis (4)
- fluoroarene (4)
- follow up (4)
- food security (4)
- forensic neurotraumatology (4)
- forest ecology (4)
- fullerenes (4)
- functional characterization (4)
- functional diversity (4)
- functional magnetic resonance imaging (4)
- fungal structure (4)
- genetic loci (4)
- genome annotation (4)
- genotype (4)
- geography (4)
- geomorphology (4)
- giant cell arteritis (4)
- glucocorticoids (4)
- glucose transporter (4)
- glycolysis (4)
- gynecology (4)
- habitats (4)
- head (4)
- healthy volunteers (4)
- hematology (4)
- hematopoietic stem cells (4)
- hepatitis C virus (4)
- homeostasis (4)
- homologous recombination (4)
- honeybees (4)
- hospitalization (4)
- host cells (4)
- host-pathogen interaction (4)
- hybrid materials (4)
- hydroboration (4)
- hydrogen bonding (4)
- hypercortisolism (4)
- hyperekplexia (4)
- image processing (4)
- imaging techniques (4)
- immune checkpoint blockade (4)
- immune system (4)
- immunization (4)
- immunohistochemistry techniques (4)
- impulsivity (4)
- in vitro selection (4)
- individual-based model (4)
- induction (4)
- infectious diseases (4)
- inpatient rehabilitation (4)
- insect brain (4)
- insulin resistance (4)
- integrins (4)
- interaction (4)
- intervention (4)
- invasion (4)
- invasive aspergillosis (4)
- iron oxide nanoparticles (4)
- jet energy resolution (4)
- juvenile idiopathic arthritis (4)
- knee (4)
- knockout (4)
- knockout mice (4)
- land cover (4)
- latency (4)
- learning and memory (4)
- ligands (4)
- lines (4)
- linkage (4)
- lipid bilayer (4)
- liquid crystals (4)
- living cells (4)
- locus coeruleus (4)
- lysosome (4)
- magnesium phosphate cement (4)
- major depressive disorder (4)
- man-computer interface (4)
- medaka (4)
- medical education (4)
- medical research (4)
- megakaryocytes (4)
- melatonin (4)
- meningioma (4)
- methylphenidate (4)
- microRNAs (4)
- microarray (4)
- microglomeruli (4)
- micronuclei (4)
- mindfulness (4)
- minimally invasive surgery (4)
- mitosis (4)
- mobility (4)
- modulation (4)
- molecular modelling (4)
- monoclonal antibodies (4)
- multisensory processing (4)
- mycotoxin (4)
- myelination (4)
- nanostructures (4)
- natural disturbance (4)
- natural products (4)
- neisseria meningitidis (4)
- neural stem cells (4)
- neuroimaging (4)
- neuroimmunology (4)
- neuropeptides (4)
- neuropsychiatric disorders (4)
- neurotrophins (4)
- nickel (4)
- norepinephrine transporter (4)
- nutrients (4)
- oligodendrocytes (4)
- oncogenes (4)
- opioids (4)
- organoid (4)
- osteogenesis (4)
- oxidation (4)
- pathogenicity (4)
- pathways (4)
- patient (4)
- patient blood management (4)
- perioperative management (4)
- periprosthetic infection (4)
- persistence (4)
- personality (4)
- perylene bisimide (4)
- pharmacology (4)
- phase transitions and critical phenomena (4)
- phosphorescence (4)
- photoelectron spectroscopy (4)
- photonic devices (4)
- phylogeny (4)
- phytic acid (4)
- plasma cells (4)
- plasma membrane (4)
- polarization (4)
- polycaprolactone (4)
- polygenic risk score (4)
- polymerase chain reaction (4)
- polyneuropathy (4)
- post-traumatic stress disorder (4)
- predictors (4)
- principal component analysis (4)
- prospective (4)
- protein binding (4)
- protein expression (4)
- protein synthesis (4)
- psychiatry (4)
- quantum dot (4)
- quantum optics (4)
- radar (4)
- radical (4)
- radioiodine therapy (4)
- reaction time (4)
- rectal cancer (4)
- regeneration (4)
- renal function (4)
- resilience (4)
- resolution (4)
- revision (4)
- risk assessment (4)
- risk factor (4)
- saccades (4)
- saproxylic beetles (4)
- sarcopenia (4)
- scaffold (4)
- screening (4)
- seasonality (4)
- semiconductor lasers (4)
- sequence motif analysis (4)
- serotonin transporter (4)
- sex (4)
- sex chromosomes (4)
- shear stress (4)
- silver (4)
- singlet oxygen (4)
- skin (4)
- skin punch biopsy (4)
- small fiber neuropathy (4)
- smartwatch (4)
- social systems (4)
- sodium (4)
- solubility (4)
- somatostatin receptor (4)
- spacer (4)
- sphingomyelinase (4)
- sponges (4)
- stability (4)
- startle reflex (4)
- stem cell transplantation (4)
- streptomyces (4)
- stromal cells (4)
- subarachnoid hemorrhage (4)
- substantia nigra (4)
- sulfur (4)
- supersymmetry (4)
- surface water (4)
- surfactants (4)
- surgical and invasive medical procedures (4)
- surgical oncology (4)
- surveillance (4)
- systemic sclerosis (4)
- systems (4)
- targeted therapy (4)
- teeth (4)
- thrombin (4)
- tight junction (4)
- time series analysis (4)
- titanium (4)
- toe (4)
- tolerance (4)
- top quark mass (4)
- total knee replacement (4)
- transient ischemic attack (4)
- transport (4)
- transposable elements (4)
- triarylborane (4)
- tryptophan (4)
- tumor necrosis factor (4)
- ubiquitination (4)
- uveal melanoma (4)
- viruses (4)
- visual system (4)
- visualization (4)
- vitamin C (4)
- zinc oxide nanoparticles (4)
- γ-H2AX (4)
- 1 (3)
- 18F-FDG (3)
- 18F-FDG PET/CT (3)
- 3D reconstruction (3)
- 5-HT1A (3)
- 5-HT2C (3)
- 5-Methylcytosine (3)
- ACTH (3)
- AIDS (3)
- ARIA (3)
- AVHRR (3)
- Acyrthosiphon pisum (3)
- Alzheimer disease (3)
- Ameisen (3)
- Amphibian oocytes (3)
- Antarctica (3)
- Anxiety (3)
- Autonomous UAV (3)
- B-cells (3)
- B7-H1 (3)
- BCI (3)
- BRAF mutation (3)
- Barth syndrome (3)
- Bevacizumab (3)
- Biomarker (3)
- Biomarkers (3)
- Biomedical engineering (3)
- Bipolar disorder (3)
- Bosons (3)
- C5aR1 (3)
- CD4(+) (3)
- CD40 (3)
- CMR (3)
- COPD (3)
- COVID-19 pandemic (3)
- COVID‐19 (3)
- CRMO (3)
- Caenorhabditis elegans (3)
- Carcinogenesis (3)
- Carcinogenicity (3)
- Central nervous system (3)
- Cerebellar cortex (3)
- Chemotherapy (3)
- Chlamydia (3)
- Coexpression (3)
- Coleoptera (3)
- Cystic fibrosis (3)
- DNA double-strand breaks (3)
- DNA replication (3)
- Deep learning (3)
- Design (3)
- Diabetes mellitus (3)
- EBV (3)
- ERK1/2 (3)
- ESS (3)
- Ecology (3)
- Electron microscopy (3)
- Enterobacteriaceae (3)
- Enzyme induction (3)
- Enzymes (3)
- Epichloë (3)
- Events (3)
- FMRI (3)
- Fabry-associated pain (3)
- Fitness (3)
- Fluorescence (3)
- Formicidae (3)
- GABAA receptors (3)
- GPCR (3)
- GWAS (3)
- Gauge-gravity correspondence (3)
- Gaussian approximation (3)
- Genetik (3)
- Genome (3)
- Gibbs free energy of binding (3)
- Gram-positive bacteria (3)
- HBMEC (3)
- HUWE1 (3)
- Hadron Colliders (3)
- Helicobacter pylori (3)
- Hfq (3)
- Hirschsprung disease (3)
- Hodgkin lymphoma (3)
- Humans (3)
- Hymenoptera (3)
- IGRT (3)
- IgE (3)
- In-vitro (3)
- Insulin (3)
- Kenyon cells (3)
- Käfer (3)
- LC-HRESIMS (3)
- LC/MS (3)
- Langerhans cells (3)
- Legionella pneumophila (3)
- Leishmania (3)
- Lewis acids (3)
- LiDAR (3)
- Listeria monocytogenes (3)
- Lolium perenne (3)
- Lung cancer (3)
- Lymphozyt (3)
- MC simulation (3)
- MDD (3)
- MIZ1 (3)
- MSCs (3)
- MYCN (3)
- Macaranga (3)
- Macrophage (3)
- Mathematik (3)
- Maus (3)
- Measuring Masses (3)
- Meningitis (3)
- Methylation (3)
- Micronuclei (3)
- Mortality (3)
- Muscarinic receptor subtypes (3)
- Muscarinic receptors (3)
- Mycobacterium tuberculosis (3)
- Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) (3)
- N170 (3)
- NMR spectroscopy (3)
- NSG (3)
- NSSI (3)
- Neurodegeneration (3)
- Neuromyelitis optica spectrum disorders (NMOSD) (3)
- Neurotrophic factors (3)
- Nrf2 (3)
- Nude-mice (3)
- Oncology (3)
- Onkogen (3)
- Optic neuritis (3)
- Osteoarthritis (3)
- Outcome survey (3)
- Oxygen (3)
- P-glycoprotein (3)
- PER (3)
- PTEN (3)
- Pair Production (3)
- Parkinsons disease (3)
- Particle data analysis (3)
- Physical activity (3)
- Plants (3)
- PolSAR (3)
- Polymerase chain reaction (3)
- Promoter (3)
- Prostaglandine (3)
- Protein-Tyrosin-Kinasen (3)
- Proton-Proton Collisions (3)
- Psychiatrie (3)
- Purkinje cells (3)
- QCD (3)
- Quadrocopter (3)
- Quadrotor (3)
- RADS (3)
- RNA modification (3)
- RNA polymerase II (3)
- RNA splicing (3)
- RNA structure (3)
- RNA-SEQ (3)
- RNA-Seq (3)
- RNA-sequencing (3)
- RNAseq (3)
- RNS (3)
- Radarsat-2 (3)
- Radiosurgery (3)
- Regulatory T cells (3)
- Relapse (3)
- SGLT1 (3)
- SM background (3)
- SOAT1 (3)
- SWOT (3)
- Saccharomyces cerevisiae (3)
- Salmonella enterica (3)
- Salmonella typhimurium (3)
- Scattering (3)
- Schizophrenia (3)
- Schlaganfall (3)
- Search (3)
- Serotonin (3)
- Skin (3)
- Staphylococcus (3)
- Stem cells (3)
- Strahlentherapie (3)
- Stroke (3)
- Supersymmetric models (3)
- Symmetry (3)
- T cell receptor (3)
- T cell receptors (3)
- T-lymphocytes (3)
- TEM (3)
- TGF-beta (3)
- TNF-alpha (3)
- TNFR1 (3)
- TRAF2 (3)
- TRH (3)
- Tourette syndrome (3)
- Tumor-necrosis-factor (3)
- USP28 (3)
- Ureaplasma urealyticum (3)
- VMAT (3)
- Vaccination (3)
- W boson (3)
- Weak (3)
- Wilms tumor (3)
- Wilms' tumor (3)
- X-ray (3)
- Z boson (3)
- Zebrafish (3)
- ab initio calculations (3)
- abandonment (3)
- abnormalities (3)
- absolute configuration (3)
- accelerometer (3)
- acetylcholine (3)
- acrophobia (3)
- actins (3)
- active galactic nuclei (3)
- acute graft-versus-host disease (3)
- acute respiratory distress syndrome (3)
- adaption (3)
- adaptive immunity (3)
- adenocarcinoma of the lung (3)
- adipose-derived stromal cells (3)
- adrenal insufficiency (3)
- adrenocortical cancer (3)
- adverse events (3)
- aerobic fitness (3)
- african trypanosomes (3)
- age groups (3)
- agroecology (3)
- alcohol (3)
- aldosterone (3)
- alkaline phosphatase (3)
- alpha-synuclein (3)
- alternative splicing (3)
- altitudinal gradients (3)
- amino acid (3)
- amyloidosis (3)
- anaemia (3)
- anastomotic leakage (3)
- anemia (3)
- aneurysm (3)
- angiography (3)
- animal sociality (3)
- ankle (3)
- antagonist (3)
- antibiotic (3)
- anticipation (3)
- anticoagulants (3)
- antigen testing (3)
- antigenic variation (3)
- antimicrobial (3)
- antimicrobial peptides (3)
- applied physics (3)
- approach (3)
- architecture (3)
- arctic (3)
- arrhythmogenic cardiomyopathy (3)
- arthrography (3)
- arthropods (3)
- artificial photosynthesis (3)
- assistive technology (3)
- attention deficit/hyperactivity disorder (3)
- auditory (3)
- auditory pathway (3)
- autism (3)
- autoimmune disease (3)
- auxin (3)
- avatars (3)
- axons (3)
- azobenzenes (3)
- bacillus subtilis (3)
- back pain (3)
- bacterial infection (3)
- bacterial meningitis (3)
- bee (3)
- bee decline (3)
- beta-D-glucan (3)
- binding protein (3)
- bioactivity (3)
- biogenic amines (3)
- biological techniques (3)
- biologics (3)
- biomedical engineering (3)
- biomedical materials (3)
- bioreactor (3)
- biosensors (3)
- birds (3)
- birth cohort (3)
- black holes (3)
- bladder cancer (3)
- bleeding (3)
- blood vessel (3)
- bone cement (3)
- bone disease (3)
- bone morphogenetic proteins (3)
- bone-marrow (3)
- boronate (3)
- brain cancer (3)
- breast-tumors (3)
- bumblebees (3)
- butterflies (3)
- c-Fos (3)
- c-Myc (3)
- cAMP (3)
- calcification (3)
- calcium phosphate cement (3)
- cancer cells (3)
- cancer microenvironment (3)
- canine cancer therapy (3)
- canola (3)
- carbene ligands (3)
- carbohydrates (3)
- cardiac (3)
- cardiac magnetic resonance imaging (3)
- cardiolipin (3)
- cardiomyocytes (3)
- cardiovascular magnetic resonance (3)
- cartilage regeneration (3)
- caspase-3 (3)
- cationic species (3)
- cations (3)
- cell binding (3)
- cell fusion (3)
- cell imaging (3)
- cell migration (3)
- cell signalling (3)
- central-nervous-system (3)
- cerebellar tDCS (3)
- cerebrovascular disorders (3)
- charge transfer (3)
- chlamydia infection (3)
- chlamydia trachomatis (3)
- chondrogenesis (3)
- chromophore (3)
- chronic pain (3)
- chronic stress (3)
- citrus (3)
- click chemistry (3)
- clinical genetics (3)
- clinical practice (3)
- clinical study (3)
- cloning (3)
- closed head injury (3)
- cochlea (3)
- cochlear implantation (3)
- cohort studies (3)
- colonoscopy (3)
- combination therapy (3)
- comet assay (3)
- community (3)
- complications (3)
- computational chemistry (3)
- conditioned response (3)
- consciousness (3)
- conversion (3)
- convolutional neural networks (3)
- copy number variation (3)
- coronavirus (3)
- corticosteroids (3)
- count time series (3)
- criteria (3)
- critically ill (3)
- crosstalk (3)
- cryptochrome (3)
- culture (3)
- cysteine protease (3)
- cytosol (3)
- data acquisition (3)
- deadwood enrichment (3)
- deafness (3)
- death receptors (3)
- decellularization (3)
- defects (3)
- deficient mice (3)
- definition (3)
- degeneration (3)
- density (3)
- derivatives (3)
- desmin (3)
- desmosomes (3)
- diabetic nephropathy (3)
- diagnostic medicine (3)
- diazepam (3)
- diborane (3)
- dilated cardiomyopathy (3)
- dimerization (3)
- disease progression (3)
- disorder (3)
- diversity gradients (3)
- division of labor (3)
- docking (3)
- dogs (3)
- double-blind (3)
- drug adverse reaction (3)
- drug allergy (3)
- drug hypersensitivity (3)
- drug metabolism (3)
- drug repurposing (3)
- drug resistance (3)
- drug therapy (3)
- drugs (3)
- ecological intensification (3)
- electrical and electronic engineering (3)
- electrocardiography (3)
- electrocatalysis (3)
- electrohydrodynamic (3)
- electrohydrodynamics (3)
- electron (3)
- electron tomography (3)
- electrophysiology (3)
- elevated plus-maze (3)
- embodied cognition (3)
- embryos (3)
- emotional regulation (3)
- emphysema (3)
- end-stage renal disease (3)
- endoradiotherapy (3)
- endothelium (3)
- endovascular (3)
- energy transfer (3)
- entropy production (3)
- environment (3)
- environmental health (3)
- epidermis (3)
- essential tremor (3)
- estrogens (3)
- evidence-based medicine (3)
- exciton coupling (3)
- exercise intensity (3)
- exome sequencing (3)
- exosomes (3)
- extracorporeal membrane oxygenation (3)
- face (3)
- face perception (3)
- fatty liver disease (3)
- feeding (3)
- female (3)
- fibrin (3)
- fish (3)
- flowers (3)
- fluorescence spectroscopy (3)
- force (3)
- formicidae (3)
- frailty (3)
- frontotemporal dementia (3)
- fully convolutional neural networks (3)
- functional training (3)
- fungal pathogens (3)
- fungal rhodopsins (3)
- fusion (3)
- gait initiation (3)
- games (3)
- gametogenesis (3)
- gastroenterology (3)
- gefitinib (3)
- gender differences (3)
- gene therapy (3)
- genetic modifiers (3)
- genetic variation (3)
- genome integrity (3)
- genome sequence (3)
- geoarchaeology (3)
- germinal center (3)
- gingivitis (3)
- glial fibrillary acidic protein (3)
- glomerular filtration rate (3)
- glucose (3)
- glutamate (3)
- growth cone (3)
- guard cell (3)
- hands (3)
- healing (3)
- healthcare (3)
- heart rate variability (3)
- heat transfer (3)
- hemoglobin (3)
- hemolysin (3)
- hepatitis B virus (3)
- herbivores (3)
- herpesvirus (3)
- high-intensity interval training (3)
- hip (3)
- histone H2AX (3)
- histones (3)
- historical document analysis (3)
- honey bee (3)
- host-pathogen interactions (3)
- human brain (3)
- human immunodeficiency virus (3)
- human learning (3)
- humanized mice (3)
- humidity (3)
- hydrodynamics (3)
- hydrology (3)
- hypertrophic cardiomyopathy (3)
- hypofractionation (3)
- image segmentation (3)
- imaging the immune system (3)
- immunodeficiency (3)
- immunoreactive neurons (3)
- immunosenescence (3)
- impedance spectroscopy (3)
- in vitro model (3)
- incisional hernia (3)
- indication for surgery (3)
- individual differences (3)
- infections (3)
- inflammatory diseases (3)
- information (3)
- innovation (3)
- instrument (3)
- insulin receptor (3)
- integration (3)
- intelligence (3)
- intensity distribution (3)
- intensive care (3)
- intentional binding (3)
- interactome (3)
- interface (3)
- interferon (3)
- interleukin-6 (3)
- interleukins (3)
- interoception (3)
- interview (3)
- intestinal epithelial barrier (3)
- intestine (3)
- invasive pulmonary aspergillosis (3)
- investigators (3)
- involvement (3)
- ion channels (3)
- ionic liquids (3)
- iron deficiency (3)
- irradiation (3)
- jet energy scale uncertainty (3)
- ketogenic diet (3)
- kidney function (3)
- kinase (3)
- kinematics (3)
- knee arthroplasty (3)
- land-use change (3)
- laparoscopic ventral hernia repair (3)
- learning curve (3)
- leaves (3)
- left ventricular hypertrophy (3)
- leishmania major (3)
- leishmaniasis (3)
- lenalidomide (3)
- length of stenosis (3)
- leukemic cells (3)
- leukocytes (3)
- library screening (3)
- life history (3)
- ligand binding (3)
- light quark jet (3)
- lipidomics (3)
- liraglutide (3)
- lithium (3)
- liver metastasis (3)
- local field potentials (3)
- localization microscopy (3)
- locomotor activity (3)
- loneliness (3)
- low back pain (3)
- lung and intrathoracic tumors (3)
- lung fibrosis (3)
- lung injury (3)
- macrocycles (3)
- macrophage (3)
- main group elements (3)
- major histocompatibility complex (3)
- malignancy (3)
- malignant melanoma (3)
- malignant tumors (3)
- marine natural products (3)
- marine sponge (3)
- mastocytosis (3)
- materials for optics (3)
- mathematical modelling (3)
- mathematics (3)
- measles (3)
- mechanics (3)
- medical rehabilitation (3)
- melanogaster (3)
- melt electrowriting (MEW) (3)
- memory B cells (3)
- memory formation (3)
- mesencephalic locomotor region (3)
- mesenchymal stromal cells (3)
- mesoscopics (3)
- messenger-RNA (3)
- metabolic adaptation (3)
- metabolic modeling (3)
- metals (3)
- methionine restriction (3)
- miRNAs (3)
- microarrays (3)
- microbial rhodopsins (3)
- microbiota (3)
- microtubules (3)
- microvascular endothelial cells (3)
- migraine (3)
- minimally invasive (3)
- mitotane (3)
- mixed methods (3)
- mobile health (3)
- monoclonal antibody (3)
- morbidity (3)
- morphology (3)
- morphometry (3)
- mothers (3)
- motoneurons (3)
- multijet background (3)
- multilocularis (3)
- multiple linear regression (3)
- multiple system atrophy (3)
- multisensory integration (3)
- muscarinic receptor subtypes (3)
- muscle (3)
- muscle strength (3)
- music (3)
- myocarditis (3)
- myofibroblast (3)
- nanophotonics and plasmonics (3)
- natural history (3)
- natural killer cells (3)
- natural variation (3)
- nature conservation (3)
- necroptosis (3)
- necrosis-factor-alpha (3)
- negative affect (3)
- nephroblastoma (3)
- nephrotoxicity (3)
- nerve fibers (3)
- network (3)
- network analysis (3)
- networks (3)
- neural circuits (3)
- neuroblastoma (3)
- neurodevelopment (3)
- neurofascin (3)
- neurofilament light chain (3)
- neurological disorders (3)
- neuromelanin (3)
- neuropathology (3)
- neurotrophic factor (3)
- neurotrophic factors (3)
- neutrophil (3)
- niche (3)
- non-prompt lepton (3)
- non-verbal communication (3)
- nonsmooth optimization (3)
- noradrenaline (3)
- nucleolus (3)
- nucleotide excision repair (3)
- nucleus (3)
- numerical cognition (3)
- obstructive pulmonary disease (3)
- oncolytic viruses (3)
- ontology (3)
- open abdomen (3)
- opioid receptors (3)
- optimal control (3)
- oral anticancer drugs (3)
- organic light emitting diodes (3)
- organic photodiodes (3)
- organic semiconductors (3)
- oscillation (3)
- osteoblasts (3)
- osteogenic differentiation (3)
- outbreak (3)
- outcomes research (3)
- output elasticities (3)
- oxygenation (3)
- paediatric cancer (3)
- parasite (3)
- parasitology (3)
- pasture (3)
- patch-clamp (3)
- pathology (3)
- pathophysiology (3)
- pemphigus (3)
- pemphigus vulgaris (3)
- peptide (3)
- peptide receptor radionuclide therapy (3)
- performance monitoring (3)
- perfusion (3)
- phagocytosis (3)
- pharmacogenetics (3)
- pharmacotherapy (3)
- phenomenology (3)
- phenotypic plasticity (3)
- phosphoantigen (3)
- photodynamic therapy (3)
- photoinduced electron transfer (3)
- photoluminescence (3)
- photoperiodism (3)
- photophysics (3)
- photothrombotic stroke (3)
- phylogenetic analysis (3)
- phylogenetics (3)
- physical fitness (3)
- plasma (3)
- platinum (3)
- pluripotency (3)
- polarized training (3)
- pollinator (3)
- pollution (3)
- poly(2-oxazine) (3)
- polycycles (3)
- polymerization (3)
- polyphenols (3)
- poor prognosis (3)
- population pharmacokinetics (3)
- positron-emission-tomography (3)
- posture (3)
- potassium (3)
- preschool children (3)
- preterm (3)
- preterm birth (3)
- pro-inflammatory cytokines (3)
- process mining (3)
- prognostic value (3)
- prospective study (3)
- prostate-specific membrane antigen (3)
- prostate-specific membrane antigen (PSMA) (3)
- protease inhibitors (3)
- protected areas (3)
- protein kinases (3)
- protein structure (3)
- protein-protein interaction (3)
- psycho-oncology (3)
- psychometrics (3)
- pulmonary embolism (3)
- pulse wave velocity (3)
- punishment (3)
- purification (3)
- quality (3)
- quality control (3)
- quality indicators (3)
- quality of democracy (3)
- quantum mechanics (3)
- quantum physics (3)
- qubits (3)
- questionnaire (3)
- radiation therapy (3)
- radical reactions (3)
- radiology (3)
- radiomics (3)
- radionuclide therapy (3)
- radiosensitivity (3)
- randomized controlled-trial (3)
- real-time (3)
- real-time PCR (3)
- receptor tyrosine kinases (3)
- recommendations (3)
- red blood cells (3)
- regulator genes (3)
- reinforcement learning (3)
- renal cancer (3)
- renal cell carcinoma (3)
- reoperation (3)
- reporter gene (3)
- research (3)
- response regulator (3)
- retinal pigment epithelium (3)
- rhinitis (3)
- rhodesain (3)
- rhodopsin (3)
- ribosomal RNA (3)
- ribosome (3)
- risk stratification (3)
- robustness (3)
- rotator cuff (3)
- ruthenium (3)
- salvage radiotherapy (3)
- sample (3)
- satellite data (3)
- scanning electron microscopy (3)
- schistosomiasis (3)
- school (3)
- scleroderma (3)
- secondary lung tumors (3)
- self-efficacy (3)
- self-organization (3)
- semantic segmentation (3)
- sense of agency (3)
- sensitivity (3)
- sensory cues (3)
- sensory neurons (3)
- sentinel (3)
- sequence databases (3)
- sequestration (3)
- seroprevalence (3)
- serotonin transporter gene (3)
- sexual selection (3)
- shape (3)
- shock (3)
- signal peptides (3)
- single top quark (3)
- single-molecule biophysics (3)
- sleeping sickness (3)
- small RNAs (3)
- social attention (3)
- social media (3)
- specialization (3)
- specificity (3)
- sperm (3)
- spiders (3)
- spillover (3)
- spintronics (3)
- spleen (3)
- startle disease (3)
- statistical data (3)
- stemness (3)
- stenosis (3)
- stereotactic body radiotherapy (3)
- stereotactic irradiation (3)
- stimulation (3)
- stomach (3)
- stomata (3)
- strains (3)
- strategies (3)
- strategy (3)
- substituent (3)
- subtypes (3)
- subunit (3)
- subventricular zone (3)
- sucrose (3)
- sucrose responsiveness (3)
- sudden cardiac death (3)
- super-resolution (3)
- superresolution (3)
- surface (3)
- surgical site infection (3)
- susceptibility loci (3)
- swine (3)
- symptoms (3)
- synapse (3)
- synapses (3)
- synaptic inhibition (3)
- synaptic transmission (3)
- synchrotron radiation (3)
- tMCAO (3)
- teaching (3)
- team sport (3)
- telemedicine (3)
- temozolomide (3)
- temporal binding (3)
- temporal bone (3)
- testosterone (3)
- text comprehension (3)
- theory of mind (3)
- thermogenesis (3)
- thermoregulation (3)
- threat (3)
- three-dimensional imaging (3)
- thromboembolism (3)
- thrombolysis (3)
- thymus (3)
- tissue (3)
- top quark pair (3)
- topography (3)
- topological matter (3)
- total hip arthroplasty (3)
- toxins (3)
- trafficking (3)
- tranexamic acid (3)
- transcranial direct current stimulation (3)
- transcription factor (3)
- transgenic mice (3)
- transient absorption (3)
- transmission electron microscopy (3)
- treatment outcome (3)
- treatment response (3)
- triglycerides (3)
- troponin (3)
- trypanosoma (3)
- tsetse fly (3)
- tumor heterogeneity (3)
- tundra (3)
- tyrosine kinase (3)
- ultimatum game (3)
- ultrasound (3)
- ultrastructure (3)
- unconscious processing (3)
- urbanization (3)
- uremic toxins (3)
- urinary tract infections (3)
- user experience (3)
- user-centered design (3)
- validity (3)
- vasculitis (3)
- velocity (3)
- ventilation (3)
- vesicles (3)
- viral load (3)
- viral replication (3)
- virotherapy (3)
- virtual environments (3)
- virus (3)
- visual orientation (3)
- visual perception (3)
- wall shear stress (3)
- weight gain (3)
- weight loss (3)
- well-being (3)
- whole-exome sequencing (3)
- wild bees (3)
- women (3)
- zinc (3)
- zinc oxide (3)
- "-omics" (2)
- 123I-mIBG (2)
- 123I-metaiodobenzylguanidine (2)
- 177Lu (2)
- 18F-FDS (2)
- 18F-LMI1195 (2)
- 2B (2)
- 3D fluoroscopy (2)
- 3D model generation (2)
- 3D models (2)
- 3D scaffolds (2)
- 4D flow (2)
- 5-Azacytidine (2)
- 5-Fluorouracil (2)
- 5-HT transporter (2)
- 5-HT1A receptor (2)
- 5-HTTLPR (2)
- 5-fluorouracil (2)
- A1 adenosine receptors (2)
- AAA (2)
- ABCG2 (2)
- AKT (2)
- ALCL (2)
- AMADEUS (2)
- AMD (2)
- AML (2)
- AMPK (2)
- ARDS (2)
- ARONJ (2)
- ARPES (2)
- ASC (2)
- ATF4 (2)
- Abwehr (2)
- Achilles (2)
- Acromyrmex fracticornis (2)
- Acute lymphocytic leukaemia (2)
- Acute myeloid leukemia (2)
- Africa (2)
- African Trypanosomes (2)
- Agalsidase beta (2)
- Agent (2)
- Albino rats (2)
- Algorithm (2)
- Allogeneic stem cell transplantation (2)
- Alter Orient (2)
- Ames test (2)
- Amino acids (2)
- Amplification (2)
- Analysis (2)
- Animal models (2)
- Annotation (2)
- Antarctic ice sheet (2)
- Anthropocene (2)
- Anti-k Jet (2)
- Antibody (2)
- Antisense RNA (2)
- Ants (2)
- Arabidopsis (2)
- Araneae (2)
- Association (2)
- Assyriologie (2)
- Atomic and molecular interactions with photons (2)
- Ausbreitung (2)
- Autism spectrum disorders (2)
- Autoantibodies (2)
- Autoimmunity (2)
- Autologous hematopoietic stem cell transplantation (2)
- Autoradiography (2)
- Axon degeneration (2)
- Axonal degeneration (2)
- B cell receptors (2)
- B chromosomes (2)
- B lymphocytes (2)
- BBCH (2)
- BCG (2)
- BCL6 (2)
- BDG (2)
- BGK approximation (2)
- BMP (2)
- BMP-2 (2)
- BN compounds (2)
- BRCA2 (2)
- BRENDA (2)
- BTN3 (2)
- Bacillus (2)
- Bacterial pathogens (2)
- Bavaria (2)
- Bees (2)
- Biene (2)
- Big Five (2)
- Bioinformatik (2)
- Biokinetics (2)
- Blattkäfer (2)
- Blood-brain barrier (2)
- Body weight (2)
- Bone marrow (2)
- Bone marrow transplantation (2)
- Bone morphogenetic protein-2 (2)
- Bone-marrow-transplantation (2)
- Bor (2)
- Brassica napus (2)
- Breast-cancer (2)
- Breast-tumors (2)
- Bruchpilot (2)
- C-X-C motif chemokine receptor 4 (2)
- C. elegans (2)
- C57BL/6 mice (2)
- C5a (2)
- CA19-9 (2)
- CADe (2)
- CAR T cell (2)
- CAR T cells (2)
- CCL4 (2)
- CCR2 (2)
- CD117 (2)
- CD274 (2)
- CD28 (2)
- CD30 (2)
- CD39 (2)
- CD4(+) T-cells (2)
- CD40L (2)
- CD73 (2)
- CD8 (2)
- CD8+ T cells (2)
- CD9 (2)
- CNN (2)
- CNO (2)
- CNS cancer (2)
- CNS disease (2)
- CNS disorders (2)
- CNV (2)
- COMT (2)
- CORDEX Africa (2)
- CRC (2)
- CSVD (2)
- CTLA-4 (2)
- CVID (2)
- CYP2W1 (2)
- Ca\(^{2+}\) signalling (2)
- Caco2 cells (2)
- Calibration (2)
- Cambrian (2)
- Camponotus floridanus (2)
- Campylobacter jejuni (2)
- Cancer treatment (2)
- Candida (2)
- Carcinogen (2)
- Carcinogens (2)
- Cardiovascular disease (2)
- Cardiovascular diseases (2)
- Cardiovascular risk factors (2)
- Cell therapy (2)
- Cells (2)
- Central Asia (2)
- Cerebellum (2)
- Cerebrospinal fluid (2)
- Chagas disease (2)
- Charcot-Marie-Tooth (2)
- Childhood (2)
- Childhood medulloblastoma (2)
- Chili RNA Aptamer (2)
- Chromatin structure (2)
- Chronic heart failure (2)
- Chronic kidney disease (2)
- Circular dichroism (2)
- Cisplatin (2)
- Cl Lowe limit (2)
- Climate change (2)
- Clinical Neuroradiology (2)
- Clinical trial (2)
- Colombia (2)
- Colonization (2)
- Combination (2)
- Computersimulation (2)
- Concealed Information Test (2)
- Conservation (2)
- Consistent partial least squares (2)
- Constraints (2)
- Costa Rica (2)
- Crohn's disease (2)
- Crohn’s disease (2)
- Cross-section (2)
- Cryo-EM (2)
- Cu(111) (2)
- CubeSat (2)
- Cushing’s disease (2)
- Cyanobacteria (2)
- Cys-loop receptor (2)
- Cytokines (2)
- DAPI staining (2)
- DFT (2)
- DHAP (2)
- DIRA (2)
- DLBCL (2)
- DM-domain gene (2)
- DNA Methylation (2)
- DNA antibodies (2)
- DNA barcoding (2)
- DNA helicase (2)
- DNA sequencing (2)
- DNA storage (2)
- DNA-PK (2)
- DNA-repair (2)
- DNA/RNA sensors (2)
- DNS-Schädigung (2)
- DOTATOC (2)
- DSG2 (2)
- DUB (2)
- DYT1 (2)
- Dark-Matter (2)
- Dendritic cells (2)
- Deoxyribozymes (2)
- Deutschland (2)
- Diagnose (2)
- Diagnostic medicine (2)
- Diethylstilbestrol (2)
- Difenidol (2)
- Differential effects of stressors (2)
- Dionaea muscipula (2)
- Disease (2)
- Diseases (2)
- Dopamine (2)
- Dose response (2)
- Dose-response relationship (2)
- Down syndrome (2)
- Drug development (2)
- Drug resistance (2)
- Duchenne muscular dystrophy (2)
- Dyes (2)
- Dynamics (2)
- E. coli serotype 06 (2)
- ECM (2)
- EDA-NOCV (2)
- EF-1A (2)
- EMT (2)
- EPR spectroscopy (2)
- ERK (2)
- EUROASPIRE (2)
- EW (2)
- EZH2 (2)
- Early-onset (2)
- Echinococcosis (2)
- Egypt (2)
- Eiablage (2)
- Eiparasitismus (2)
- Elderly (2)
- Electropermeabilization (2)
- Emotion regulation (2)
- Emotional processing (2)
- Endosymbiont (2)
- Endothelium (2)
- Entanglement (2)
- Environment (2)
- Epidemiology (2)
- Epitope (2)
- Epitranscriptomics (2)
- Estrogen (2)
- European beech (2)
- Evaluation (2)
- Event-related potential (2)
- Event-related potentials (2)
- Exercise capacity (2)
- Exercise testing (2)
- Expansion microscopy (2)
- Extensions of gauge sector (2)
- F-actin (2)
- F8 fimbriae (2)
- FAAH (2)
- FDG PET/CT (2)
- FDG-PET/CT (2)
- FGF-pathway (2)
- FGFR1 (2)
- FIB-4 (2)
- FISH (2)
- FKBP5 (2)
- FSHD (2)
- FTIR spectroscopy (2)
- Fabry (2)
- Fabry genotype (2)
- Fabry nephropathy (2)
- Fabry phenotype (2)
- Factor receptor (2)
- Fagus sylvatica (2)
- FcγR (2)
- Female (2)
- Festkörperphysik (2)
- Fibroblasts (2)
- Fibromyalgia syndrome (2)
- Fish (2)
- Flow cytometry (2)
- Fluorescence spectroscopy (2)
- Fokker–Planck equation (2)
- Foxp3 (2)
- Frosch (2)
- Fusarium (2)
- Fusion proteins (2)
- G protein-coupled receptors (2)
- G-protein (2)
- G-quadruplexes (2)
- GIS (2)
- GLUT2 (2)
- GLUT3 (2)
- GLV-1H68 (2)
- GM-CSF (2)
- GPVI (2)
- Galeruca tanaceti (2)
- Gamma (2)
- Gedächtnisleistung (2)
- Gen (2)
- Gene cloning (2)
- Gene regulation (2)
- Genes (2)
- Genetics research (2)
- Geographie (2)
- Geologie (2)
- German Hepatitis C-Registry (2)
- German people (2)
- Glatiramer acetate (2)
- Gluino production (2)
- Glutathione (2)
- Golgi (2)
- Grad-seq (2)
- Group B Streptococcus (2)
- Growth (2)
- Grundvorstellung (2)
- Guidelines (2)
- Guillain-Barre-Syndrome (2)
- Guinea-pig uterus (2)
- GvHD (2)
- H-1-NMR spectroscopy (2)
- HBV (2)
- HFQ (2)
- HFpEF (2)
- HGF (2)
- HHV-6 (2)
- HIV-1 (2)
- HKT transporter (2)
- HPA axis (2)
- HPP (2)
- HPV (2)
- HSC (2)
- HUVEC (2)
- Habichtskraut (2)
- Habitat fragmentation (2)
- Haemophilus influenzae (2)
- Halcyon (2)
- Hamburg (2)
- Healthy subjects (2)
- Heart (2)
- Hemolysin (2)
- Heterocycles (2)
- Hexahydro-sila-difenidol analogues (2)
- Hieracium (2)
- Higgs (2)
- Hill numbers (2)
- Hippo signaling (2)
- Holothuria spinifera (2)
- Hormone (2)
- Hospitalization (2)
- Host-parasite interaction (2)
- Host-parasite interactions (2)
- Hsp90 (2)
- Human behaviour (2)
- Human brain (2)
- Human papillomavirus (2)
- Hypothetical gauge bosons (2)
- I-tasser (2)
- IAPS (2)
- IFN-γ (2)
- IL-17 (2)
- IL-6 (2)
- ILEX (2)
- IMAT (2)
- IMRT (2)
- IN-VIVO (2)
- IR (2)
- IR spectroscopy (2)
- Identification (2)
- IgG (2)
- Image-guidance (2)
- Imaging techniques (2)
- Imatinib (2)
- Immunbiologie (2)
- Immunosuppression (2)
- Impact (2)
- In vitro (2)
- Induced apoptosis (2)
- Infections (2)
- Infectious disease (2)
- Inhibitor (2)
- Insects (2)
- Insekten (2)
- Interleukin-4 (2)
- Interleukin-6 (2)
- Internet of Things (2)
- Invasion (2)
- Iran (2)
- JES uncertainty (2)
- JNK (2)
- Japankärpfling (2)
- Jena Experiment (2)
- Jets (2)
- Josephson junctions (2)
- J‐aggregates (2)
- KDIGO (2)
- KEAP1 (2)
- KIT (2)
- Kaposi sarcoma (2)
- Kenya (2)
- Ketogenic diet (2)
- Ki67 (2)
- Kidney function (2)
- Kilombero (2)
- Kultur (2)
- L-arginine (2)
- L929 (2)
- LC-MS/MS (2)
- LINC complex (2)
- LMHFV (2)
- LPP (2)
- LST (2)
- Lampbrush chromosomes (2)
- Landsat time series (2)
- Langerhans-Inseln (2)
- Larvae (2)
- Latin America (2)
- Lebendgebärende Zahnkarpfen (2)
- Lewis acidity (2)
- Lichtheimia (2)
- Ligand (2)
- Lipofuscin (2)
- Longitudinally extensive transverse myelitis (LETM) (2)
- Lung-cancer (2)
- MAG3 (2)
- MAPK signaling cascades (2)
- MASK (2)
- MATQ-seq (2)
- MC event generator (2)
- MCC950 (2)
- MCPH1 (2)
- MDSC (2)
- ME/CFS (2)
- MEG (2)
- MIBG (2)
- MLST (2)
- MPFL (2)
- MPI (2)
- MPS1 (2)
- MRI criteria (2)
- Machine learning (2)
- Malaysia (2)
- Malignant hyperthermia (2)
- Malignant melanoma (2)
- Masernvirus (2)
- Matlab (2)
- Mc4r (2)
- Measurement (2)
- Mekong (2)
- Melanom (2)
- Melanoma (2)
- Merkel cell polyomavirus (2)
- Mesenchymal stem cells (2)
- Mesenchymal stem/stromal cells (2)
- Mesenteric circulation (2)
- Met (2)
- Metabolic pathways (2)
- Metabolism (2)
- Metabolomics (2)
- Metastatic breast cancer (2)
- Methotrexate (2)
- Microarray (2)
- Microcirculation (2)
- Microglia (2)
- Microtubules (2)
- Mitochondria (2)
- Molecular biology (2)
- Molecular neuroscience (2)
- Molecules (2)
- Monte Carlo (2)
- Mouse (2)
- Mouse model (2)
- Mouse-brain (2)
- Multiple Myeloma (2)
- Multiple bonds (2)
- Multivariate analysis (2)
- Muscarinic receptor antagonists (2)
- Mushroom bodies (2)
- Mutations (2)
- Mycobacterium (2)
- Myeloma (2)
- N ligands (2)
- N-Myc (2)
- N-formyl peptides (2)
- N-heterocyclic carbene (2)
- NEUROWIND (2)
- NF-Kappa-B (2)
- NF-kappa-B (2)
- NF-κB (2)
- NFAT (2)
- NFkB (2)
- NHC (2)
- NMDAR (2)
- NMOSD (2)
- NOAC (2)
- NONO (2)
- NOTCH (2)
- NRPS (2)
- NVP-BEZ235 (2)
- Nanoparticles (2)
- Nervenzelle (2)
- Netzwerk (2)
- Neuronal ceroid lipofuscinosis (2)
- Neuropathy (2)
- Neurophysiologie (2)
- Neuroprotection (2)
- Neutrino Telescope (2)
- New Zealand (2)
- Nfatc1 (2)
- Niger (2)
- Non-coding RNAs (2)
- Nucleolus (2)
- OCD (2)
- Olea (2)
- Omega-3-Fettsäuren (2)
- Oocytes (2)
- Oomyzus galerucivorus (2)
- Optical spectroscopy (2)
- Orthoptera (2)
- Oxidative stress (2)
- P53 (2)
- PALM (2)
- PAPA (2)
- PARK2 (2)
- PDE (2)
- PI3K (2)
- PIP2 (2)
- PKA (2)
- PML (2)
- PMMA (2)
- PPGL (2)
- PROM (2)
- PSA (2)
- PSMA I&T (2)
- PSMA-RADS (2)
- PTCL (2)
- PTSD (2)
- Paediatric (2)
- Pair production (2)
- Pakistan (2)
- Parasit (2)
- Parkinson (2)
- Parkinsonism (2)
- Pathogens (2)
- Patron Distributions (2)
- Patterns (2)
- Pharmazie (2)
- Phase-II (2)
- Phonologische Bewusstheit (2)
- Phosphorylation (2)
- Photochemistry (2)
- Physiologie (2)
- Placebo (2)
- PlanetScope (2)
- Plasma-membrane (2)
- Plus plus (2)
- Pollen (2)
- Positron emission tomography (2)
- Pp Collision (2)
- Prognose (2)
- Program (2)
- Proliferation (2)
- Prostate Cancer (2)
- Pseudomonas aeruginosa (2)
- Psychiatric disorders (2)
- Pulmonary imaging (2)
- Pädiatrie (2)
- R factor = 0.027 (2)
- RCC (2)
- RFID (2)
- RHO (2)
- RKIP (2)
- RNA extraction (2)
- RNA metabolism (2)
- RNA secondary structure (2)
- RNA synthesis (2)
- RNA-SEQ data (2)
- RNA-dependent RNA polymerase (2)
- RNA-polymerase-II (2)
- RSK (2)
- RT-PCR (2)
- RT-qPCR (2)
- Radiative-corrections (2)
- Radioligand binding (2)
- Radionuclide Therapy (2)
- Raf kinases (2)
- Randomized controlled trial (2)
- Randomized controlled-trial (2)
- Rashba effect (2)
- Rats (2)
- Ratte (2)
- Reaction kinetics and dynamics (2)
- Rectal cancer (2)
- Reduction (2)
- Regression (2)
- Rehabilitation (2)
- Renal cell carcinoma (2)
- Repair (2)
- Reproductive toxicity (2)
- Rezension (2)
- Rhabdomyosarcoma (2)
- Rheumatologie (2)
- Rhizopus (2)
- Rhodobacter sphaeroides (2)
- Risk (2)
- Risk factors (2)
- Ruthenium (2)
- Ruthenium complexes (2)
- Ruxolitinib (2)
- S-ADAPT (2)
- S. aureus (2)
- SAH (2)
- SARS‐CoV‐2 (2)
- SEM (2)
- SEQ (2)
- SF-36 (2)
- SGLT2 inhibitor (2)
- SGLT2 inhibitors (2)
- SHRSP (2)
- SLC2A3 (2)
- SLX4 (2)
- SMAD signaling (2)
- SMN (2)
- SNP (2)
- SOX9 (2)
- SPECT/CT (2)
- STR profile (2)
- SUV (2)
- Salmonella Typhimurium (2)
- Salmonella-containing vacuole (SCV) (2)
- Salmonella/microsome assay (2)
- Salmonellosis (2)
- Scale (2)
- Scarabaeidae (2)
- Schwann cells (2)
- Selective attention (2)
- Sensitivity (2)
- Signal transduction (2)
- Silicones (2)
- Simulation (2)
- Skorpion (2)
- SnRK1 (2)
- Solution-state NMR (2)
- Sonic hedgehog (2)
- Spermatogenesis (2)
- Squalius alburnoides (2)
- Stem cell (2)
- Stereology (2)
- Stereoselectivity (2)
- Stereotactic body radiotherapy (2)
- Stimuli (2)
- Strains (2)
- Streptomyces axinellae (2)
- Stress (2)
- Structural Biology (2)
- Struktur (2)
- Subarachnoid hemorrhage (2)
- Succinylcholine (2)
- Surveillance (2)
- Swine (2)
- Symmetry-breaking (2)
- System (2)
- Systematic review (2)
- Systemic sclerosis (2)
- Systems (2)
- T = 100 K (2)
- T cell activation (2)
- T cell migration (2)
- T cell receptor excision circles (2)
- T-cadherin (2)
- T-cell (2)
- T-cell lymphoma (2)
- TAVI (2)
- TB (2)
- TCR signaling cascade (2)
- TGF-BETA (2)
- TGFβ signaling (2)
- TGN1412 (2)
- TIMELINE (2)
- TKA (2)
- TKI (2)
- TLR2 (2)
- TNAP (2)
- TNF superfamily (2)
- TNFα (2)
- TP53 (2)
- TanDEM-X (2)
- Tell Karrana (2)
- Temozolomide (2)
- Theoretische Ökologie (2)
- Thyroid cancer (2)
- Tian Shan (2)
- Time-course (2)
- Tissue (2)
- Tissue engineering (2)
- Top-Quark (2)
- Tranquillizer (2)
- Transcriptome (2)
- Transgenic mice (2)
- Translational research (2)
- Transporter (2)
- Trees (2)
- Tregs (2)
- Tregs (regulatory T cells) (2)
- TrkB (2)
- Tuberculosis (2)
- Tumor Treating Fields (TTFields) (2)
- Uganda (2)
- Ulcerative colitis (2)
- Uzbekistan (2)
- VACV (2)
- VAL66MET polymorphism (2)
- VSOP (2)
- Vaccine (2)
- Vaccinia virus (2)
- Validation (2)
- Variability (2)
- Variants (2)
- Vasodilatator-stimuliertes Phosphoprotein (2)
- Vesicles (2)
- WH2 domain (2)
- WNT (2)
- WSS (2)
- WZ (2)
- West Gondwana (2)
- Western Cape (2)
- Western Europe (2)
- Western diet (2)
- Wilms tumour (2)
- Wirt (2)
- Wnt (2)
- Wnt signalling (2)
- X-ray computed (2)
- XAI (2)
- XR (2)
- Xenopus oocytes (2)
- Y chromosome (2)
- YAP (2)
- Yoga (2)
- YouTube (2)
- Zambia (2)
- Zelldifferenzierung (2)
- [68Ga]PentixaFor (2)
- ablation (2)
- abscisic acid (2)
- abscisic acid (ABA) (2)
- absorption spectra (2)
- abundance (2)
- acceptance (2)
- acceptance time efficiency (2)
- accretion (2)
- acetylsalicylic acid (2)
- acid ceramidase inhibitor ceranib-2 (2)
- acoustic signals (2)
- acoustic startle (2)
- actin cytoskeleton (2)
- action control (2)
- action effects (2)
- action planning (2)
- action potential (2)
- action potentials (2)
- activity (2)
- activity rhythm (2)
- acupuncture (2)
- acute heart failure (2)
- acute lymphoblastic leukemia (2)
- acute lymphocytic leukaemia (2)
- acute myeloid leukaemia (2)
- adaptive immune system (2)
- addiction (2)
- adenocarcinoma (2)
- adenomas (2)
- adenosine receptors (2)
- adenovirus (2)
- adenylate cyclase toxin (2)
- adhesion molecules (2)
- adipocytes (2)
- adjustment (2)
- adjuvant treatment (2)
- adolescent (2)
- adoptive transfer (2)
- adrenal (2)
- adrenal cancer (2)
- adrenal crisis (2)
- adrenal gland (2)
- adrenal tumours (2)
- adrenocortical tumors (2)
- adult (2)
- adult-onset (2)
- adulthood (2)
- adverse drug reaction (2)
- adverse effects (2)
- adversity (2)
- affect (2)
- affinity (2)
- age-related hearing loss (2)
- aged 80 and over (2)
- agonist (2)
- agonistic antibodies (2)
- agreement (2)
- agrobacterium tumefaciens (2)
- agroecosystems (2)
- airway management (2)
- albumin (2)
- alleles (2)
- allelic replacement (2)
- allergic rhinitis (2)
- alliance (2)
- allogeneic hematopoietic stem cell transplantation (2)
- allometric scaling (2)
- alloreactive T cells (2)
- allostatic load (2)
- alpaca (2)
- alpha (2)
- altruism (2)
- altruistic compensation (2)
- alveolar bone loss (2)
- alveolar echinococcosis (2)
- amino acid restriction (2)
- amino acid sequence (2)
- amino acid transporter (2)
- amino acids (2)
- aminotroponiminates (2)
- ampicillin (2)
- amplicon sequencing (2)
- amyotrophic lateral sclerosis (ALS) (2)
- anaesthesiology (2)
- anaesthetics (2)
- analgesia (2)
- anaphylaxis (2)
- anaplastic large cell lymphoma (2)
- anchoring (2)
- androgen deprivation therapy (2)
- anesthetics (2)
- angle-resolved photoemission spectroscopy (2)
- anhedonia (2)
- animal physiology (2)
- anion channel (2)
- anions (2)
- annulation (2)
- anomaly detection (2)
- ant (2)
- ant brain (2)
- antenna (2)
- anterior cingulate cortex (2)
- anterior insula (2)
- anthocyanins (2)
- anti-k jet (2)
- anti-parasitic (2)
- anti-trypanosomal (2)
- anti-tumor agents (2)
- antibacterial (2)
- antibody fusion proteins (2)
- anticancer activity (2)
- antifungal susceptibility (2)
- antigen presentation (2)
- antigens (2)
- antimicrobial activities (2)
- antimicrobial activity (2)
- antimony (2)
- antioxidant (2)
- antioxidants (2)
- antirheumatic agents (2)
- antisense RNAs (2)
- antiviral treatment (2)
- anxiety-like behavior (2)
- aortic arch (2)
- aphasia (2)
- app (2)
- approach-avoidance (2)
- arabidopsis (2)
- archaea (2)
- areas (2)
- artemisinin (2)
- arteriovenous loop (2)
- ascites (2)
- aspiration (2)
- assay (2)
- assay systems (2)
- assistive devices (2)
- associative learning (2)
- asymmetry (2)
- atmospheric chemistry (2)
- atmospheric circulation (2)
- atomic-force microscopy (2)
- attention capture (2)
- attentional bias (2)
- auditory cortex (2)
- autobiographical memory (2)
- autoimmune (2)
- autoimmune encephalitis (2)
- autoinhibition (2)
- autologous stem cell transplantation (2)
- autologous transplantation (2)
- autonomous (2)
- auxins (2)
- avatar embodiment (2)
- avoidance (2)
- avoidance learning (2)
- awareness (2)
- axonal degeneration (2)
- axonal transport (2)
- azulene (2)
- bZIP (2)
- background knowledge (2)
- bacterial genetics (2)
- bacterial genomics (2)
- bacteriology (2)
- baghdadite (2)
- barbiturates (2)
- bark beetles (2)
- barrier (2)
- base of support (2)
- basic mental models (2)
- bats (2)
- beech forests (2)
- behavioral plasticity (2)
- behavioural ecology (2)
- beta diversity (2)
- beta oscillations (2)
- beta-catenin (2)
- beta-oxidation (2)
- bias correction (2)
- biased signaling (2)
- big five (2)
- bile (2)
- bioassay-guided fractionation (2)
- bioconjugation (2)
- biodosimetry (2)
- bioengineering (2)
- biofeedback (2)
- biofilm (2)
- biofilm formation (2)
- biogenesis (2)
- biological sciences (2)
- bioluminescence imaging (2)
- biomechanics (2)
- biomedicine, general (2)
- biopsy (2)
- biosensor (2)
- biotechnology (2)
- biradicals (2)
- bisphosphonates (2)
- bisulfite pyrosequencing (2)
- blastocysts (2)
- blazars (2)
- blood coagulation (2)
- blood gas analysis (2)
- blood platelets (2)
- blood-brain barrier (BBB) model (2)
- blood-nerve barrier (2)
- blood-stream forms (2)
- blood–labyrinth barrier (2)
- body ownership (2)
- body representation (2)
- body weight modification (2)
- body weight perception (2)
- bonding (2)
- bone formation (2)
- bone fractures (2)
- bone imaging (2)
- bone loss (2)
- bone marrow edema (2)
- bone marrow immune-microenvironment (2)
- bone marrow stromal cells (2)
- bone metastases (2)
- bone metastasis (2)
- bone remodeling (2)
- bone replacement material (2)
- bone tissue engineering (2)
- boronateesters (2)
- boronic acid (2)
- bortezomib (2)
- borylene (2)
- borylenes (2)
- brain disorders (2)
- brain edema (2)
- brain endothelial cells (2)
- brain metastases (2)
- brain pathology (2)
- brain potentials (2)
- brain stem (2)
- brain-computer interface (BCI) (2)
- brain-computer interfaces (2)
- breed predisposition (2)
- bridging (2)
- brucei (2)
- bullous pemphigoid (2)
- butyrophilin (2)
- butyrophilin 3 (2)
- butyrylcholinesterase (2)
- c-MYC (2)
- c-myc (2)
- c-reactive protein (2)
- cAArC (2)
- cEND (2)
- caenorhabditis elegans (2)
- caffeine (2)
- cage compounds (2)
- calcium signaling (2)
- calcium signalling (2)
- calibration (2)
- calipered (2)
- calorie content (2)
- calorimeter (2)
- calprotectin (2)
- cancer detection and diagnosis (2)
- cancer diagnosis (2)
- cancer genetics (2)
- cancer imaging (2)
- cancer risk (2)
- cancer risk factors (2)
- cancers and neoplasms (2)
- candidate gene (2)
- candidemia (2)
- canine (2)
- canine cancer cell lines (2)
- canine soft tissue sarcoma (CSTS) (2)
- capacitance (2)
- capillary electrophoresis (2)
- carabid beetles (2)
- carbon (2)
- carbon dioxide (2)
- carbon nanotubes (2)
- carborane (2)
- carboxylation (2)
- carcinogenesis (2)
- cardiac MRI (2)
- cardiac innervation imaging (2)
- cardiac magnetic resonance (2)
- cardiac metabolism (2)
- cardiac nerve (2)
- cardiac output (2)
- cardiac rehabilitation (2)
- cardinality constraints (2)
- cardiology (2)
- cardiovascular (2)
- cardiovascular arousal (2)
- cardiovascular morbidity (2)
- caregiver burden (2)
- caries (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- carpenter ant (2)
- cartilage repair (2)
- caspase-8 (2)
- catalytic (2)
- cathepsin (2)
- causality (2)
- cell adhesion (2)
- cell binding assay (2)
- cell culture (2)
- cell cycle arrest (2)
- cell division (2)
- cell fate (2)
- cell growth (2)
- cell labeling (2)
- cell metabolism (2)
- cell of origin (2)
- cell surface (2)
- cellular neuroscience (2)
- cellular physiology (2)
- cellular signalling networks (2)
- cement (2)
- ceramics (2)
- cerebEND (2)
- cerebral autoregulation (2)
- cerebral blood flow (2)
- cerebrosides (2)
- chalcogens (2)
- change vector analysis (2)
- channel (2)
- channelrhodopsin (2)
- chaperone (2)
- chaperones (2)
- characterization (2)
- checkpoint inhibitors (2)
- chemical bonding (2)
- chemical communication (2)
- chemical ecology (2)
- chemical mimicry (2)
- chemokine (2)
- chemotaxis (2)
- child (2)
- child development (2)
- childhood (2)
- childhood asthma (2)
- childhood cancer (2)
- childhood maltreatment (2)
- chimeric antigen receptor (2)
- chirality transfer (2)
- chloroquine (2)
- cholestasis (2)
- cholesterol (2)
- cholinergic system (2)
- chromatin structure (2)
- chromosomes (2)
- chronic cerebrovascular disease (2)
- chronic hepatitis C (2)
- chronic kidney-disease (2)
- chronic myelogenous leukemia (2)
- chronic myeloid leukemia (2)
- chronic non-bacterial osteomyelitis (2)
- chronic nonbacterial osteomyelitis (2)
- chronic recurrent multifocal osteomyelitis (2)
- chronic thromboembolic pulmonary hypertension (2)
- chronobiology (2)
- chronophin (2)
- chronotype (2)
- cigarette smoking (2)
- circulation patterns (2)
- circulation type (2)
- cirrhosis (2)
- claudin-1 (2)
- clinical (2)
- clinical diagnosis (2)
- clinical outcome (2)
- clinical-practice (2)
- clothing (2)
- cluster analysis (2)
- coastal erosion (2)
- coated vesicles (2)
- coatings (2)
- cochlear nucleus (2)
- coexistence (2)
- cognitive conflict (2)
- cognitive function (2)
- cognitive neuroscience (2)
- cognitive psychology (2)
- cohort study (2)
- cold stress (2)
- colloids (2)
- colon (2)
- colon cancer (2)
- colonization (2)
- colorectal carcinoma (2)
- combined therapy (2)
- common variants (2)
- communities (2)
- community structure (2)
- comorbidity (2)
- comparability (2)
- comparative genomic hybridization (2)
- complement (2)
- complement system (2)
- complementary alternative medicine (2)
- complementary medicine (2)
- complex regional pain syndrome (2)
- complexity (2)
- complication (2)
- components (2)
- compound eye (2)
- compressive strength (2)
- computational biology and bioinformatics (2)
- computational physics (2)
- computer software (2)
- cone beam CT (2)
- conjugation (2)
- connective tissue (2)
- consensus (2)
- conservation biology (2)
- consolidation (2)
- contact-kinin system (2)
- contactin (2)
- context (2)
- contextual fear conditioning (2)
- contrast (2)
- convection volume (2)
- conversational agents (2)
- convolutional neural network (2)
- cooperation (2)
- coordination polymers (2)
- copeptin (2)
- corannulene (2)
- cord blood (2)
- coronavirus disease 2019 (2)
- correction (2)
- correlates (2)
- correlation (2)
- cortex (2)
- cortical activation (2)
- cortical neurons (2)
- cost-effectiveness (2)
- costs (2)
- coupling strength (2)
- covalent inhibitors (2)
- craving (2)
- creatine kinase (2)
- creatinine (2)
- creativity (2)
- cropping systems (2)
- cross-cultural comparison (2)
- cross-link repair (2)
- cross-sectional studies (2)
- crowdsourcing (2)
- crystal engineering (2)
- crystal-structure (2)
- cultivation (2)
- cultures (2)
- curcumin (2)
- cyanoborate (2)
- cyanoborates (2)
- cybersickness (2)
- cycle (2)
- cyclic (alkyl)(amino)carbenes (2)
- cycling (2)
- cycloaddition (2)
- cyclodextrin (2)
- cyclophanes (2)
- cystic fibrosis patients (2)
- cytochrome P450 3A4 (CYP3A4) (2)
- cytokine production (2)
- cytokine release (2)
- cytokine secretion (2)
- cytosolic pH (2)
- cytotoxic (2)
- cytotoxic activity (2)
- dRNA-Seq (2)
- dabrafenib (2)
- daratumumab (2)
- dark matter (2)
- data analysis (2)
- data fusion (2)
- data mining (2)
- data visualization (2)
- data warehouse (2)
- ddPCR (2)
- death (2)
- death rates (2)
- decline (2)
- decomposition (2)
- deficit hyperactivity disorder (2)
- deformation (2)
- degree of stenosis (2)
- delineation (2)
- demography (2)
- dendritic cell (2)
- dendrobates pumilio (2)
- dental trauma (2)
- dependent protein-kinase (2)
- depth (2)
- dereplication (2)
- derivation (2)
- dermatitis (2)
- desirable difficulties (2)
- desk-based (2)
- desmosome (2)
- developmental dyslexia (2)
- developmental plasticity (2)
- diabetic retinopathy (2)
- dialysis adequacy (2)
- diapause (2)
- diazadiborinines (2)
- diboration (2)
- dictator game (2)
- dieting success (2)
- differential diagnosis (2)
- differential expression (2)
- differentiation potential (2)
- diffuse large B-cell lymphoma (2)
- diffusion tensor imaging (2)
- digital health (2)
- dimensions (2)
- dimethyl fumarate (2)
- diode (2)
- direct anterior approach (2)
- direct gaze (2)
- direct-acting antivirals (2)
- discovery (2)
- discriminant analysis (2)
- discussion report (2)
- disease genetics (2)
- diseases (2)
- diseases of the nervous system (2)
- disembodiment (2)
- disorders (2)
- dispersal ability (2)
- dispersal rate (2)
- distance measurement (2)
- distress (2)
- distributed control (2)
- distribution (2)
- dog (2)
- dopaminergics (2)
- dorsal root ganglion (2)
- dorsolateral prefrontal cortex (2)
- double intentionality (2)
- doxorubicin (2)
- drug–drug interactions (DDIs) (2)
- dual function (2)
- dual polarimetry (2)
- dual-energy CT (2)
- dual-stage crosslinking (2)
- duchenne muscular dystrophy (2)
- dunce (2)
- dynamic covalent chemistry (2)
- dynamic programming (2)
- dysfunction (2)
- dysphagia (2)
- dysplasia (2)
- dyspnea (2)
- early diagnosis (2)
- early intervention (2)
- early recognition (2)
- echinococcus multilocularis (2)
- ecosystem service (2)
- edema (2)
- edge states (2)
- editorial board (2)
- education for sustainable healthcare (2)
- effectiveness (2)
- effects (2)
- efficiency (2)
- elbow joint (2)
- electroactive (2)
- electrochemistry (2)
- electroencephalogram (2)
- electroencephalography (EEG) (2)
- electrolytes (2)
- electromyography (2)
- electronic and spintronic devices (2)
- electronic health records (2)
- electrophilic substitution (2)
- electroporation (2)
- element (2)
- elements (2)
- elevation (2)
- elevation gradient (2)
- elongation (2)
- embryo (2)
- embryonic stem cells (2)
- emissions (2)
- emotion recognition (2)
- emotional experience (2)
- emotional facial expressions (2)
- emotional pictures (2)
- empagliflozin (2)
- emulsions (2)
- enantiomers (2)
- encephalitis (2)
- endocannabinoid (2)
- endochondral ossification (2)
- endoglin (2)
- endoluminal (2)
- endophenotype (2)
- endophyte (2)
- endoplasmic reticulum (2)
- endosomes (2)
- endothelial cell (2)
- endothelin-1 (2)
- endotoxemia (2)
- endovascular therapy (2)
- endovascular treatment (2)
- energy homeostasis (2)
- engineering (2)
- enteric nervous system (2)
- enteric pathogens (2)
- enterica serovar typhimurium (2)
- entomology (2)
- entropy (2)
- envelopment (2)
- environmental exposure (2)
- environmental impact (2)
- environmental justice (2)
- environmental sciences (2)
- environments (2)
- enzyme activation (2)
- enzyme inhibitors (2)
- epidemology (2)
- epidermal growth factor (2)
- epithelium (2)
- epitope mapping (2)
- establishment (2)
- estimation error (2)
- ethics (2)
- etymology (2)
- eudaimonia (2)
- eugenol (2)
- evapotranspiration (2)
- evolutionary biology (2)
- exact matching (2)
- excimer formation (2)
- excitations (2)
- excited states (2)
- exciton (2)
- executive function (2)
- exercise intervention (2)
- exhaustion (2)
- expansion microscopy (2)
- experiment (2)
- experimental models of disease (2)
- expertise (2)
- exposure therapy (2)
- expression signature (2)
- extinction risk (2)
- extracellular domain (2)
- extramedullary disease (2)
- face processing (2)
- facial electromyography (2)
- factor H (2)
- factor XI (2)
- factor-I (2)
- failure (2)
- fake lepton (2)
- familial DCM (2)
- families (2)
- fatty liver (2)
- fear generalization (2)
- fear-potentiated startle (2)
- feasibility (2)
- feature selection (2)
- features (2)
- femur (2)
- fermions (2)
- ferromagnetism (2)
- fertility (2)
- fetal programming (2)
- fibers (2)
- fibrinogen (2)
- fibroblast (2)
- fibroblast activation protein (2)
- fibromyalgia (2)
- field (2)
- films (2)
- fire (2)
- fish model (2)
- fission yeast (2)
- fitness (2)
- fixation (2)
- flagellar pocket (2)
- flagellum (2)
- flood (2)
- flow (2)
- flowering plants (2)
- fluid (2)
- fluorescence correlation spectroscopy (2)
- fluorescent dyes (2)
- fluorescent probe (2)
- fluorescent protein (2)
- fluorescent proteins (2)
- fluorescent-probes (2)
- fluoroscopy (2)
- flupyradifurone (2)
- flux (2)
- flux balance analysis (2)
- foamy virus (2)
- foamy viruses (2)
- focal cerebral-ischemia (2)
- follicular lymphoma (2)
- food allergy (2)
- food consumption (2)
- food safety (2)
- foot (2)
- forecast (2)
- forest degradation (2)
- forest health (2)
- forestry (2)
- forests (2)
- formation control (2)
- fpVCT (2)
- fracture healing (2)
- framework (2)
- free choice (2)
- free energy (2)
- frontal cortex (2)
- fruit set (2)
- functional analysis (2)
- functional traits (2)
- functionalization (2)
- fungal infections (2)
- fused deposition modeling (FDM) (2)
- future directions (2)
- gain (2)
- gait analysis (2)
- gambling (2)
- gametocyte (2)
- gamma (2)
- gamma rays (2)
- gas (2)
- gastric bypass (2)
- gastrointestinal infections (2)
- gels (2)
- gemcitabine (2)
- gene cloning (2)
- gene conversion (2)
- gene expression profiling (2)
- gene mutations (2)
- gene regulation in immune cells (2)
- gene targeting (2)
- gene-environment interaction (2)
- general anaesthesia (2)
- general practice (2)
- general relativity (2)
- generalization (2)
- generalized anxiety disorder (2)
- generalized cerebral edema (2)
- generation effect (2)
- genetic diagnostics (2)
- genetic engineering (2)
- genetic polymorphisms (2)
- genetic susceptibility (2)
- genetic testing (2)
- genetic variants (2)
- genetically modified plants (2)
- genome analysis (2)
- genome assembly (2)
- genome sequencing (2)
- genome wide (2)
- genome-wide association study (2)
- genomic analysis (2)
- genomic databases (2)
- genomic imprinting (2)
- genomic libraries (2)
- genotyping (2)
- geometry (2)
- germline mutation (2)
- gestational diabetes mellitus (2)
- giant ventral hernia (2)
- glaciers (2)
- glial fate modulation (2)
- glioblastoma multiforme (GBM) (2)
- globotriaosylceramide (2)
- glucose metabolism (2)
- glutathione (2)
- glycemic control (2)
- glycine (2)
- glycopeptide antibiotics (2)
- glycoprotein Ib (2)
- glycoprotein receptor Ib (2)
- go/no-go task (2)
- gold nanoparticles (2)
- grading (2)
- graft (2)
- graft versus host disease (2)
- gram-negative bacteria (2)
- granules (2)
- granulocytes (2)
- grassland (2)
- grasslands (2)
- green fluorescent protein (2)
- gridle muscular-dystrophy (2)
- growth factor (2)
- growth factor beta (2)
- growth hormone deficiency (2)
- guanylyl cyclase (2)
- guard cells (2)
- guided bone regeneration (2)
- gut bacteria (2)
- gut barrier (2)
- gynogenesis (2)
- gyroscope (2)
- habits (2)
- haematopoietic stem cells (2)
- haemophilus influenzae (2)
- haemostasis (2)
- halogenation (2)
- hand (2)
- haploinsufficiency (2)
- harmonization (2)
- head and neck squamous cell carcinoma (2)
- head-mounted display (2)
- health (2)
- health care (2)
- health care workers (2)
- health economics (2)
- health monitoring (2)
- health policy (2)
- hearing (2)
- hearing impairment (2)
- hearing preservation (2)
- heart failure with mid-range ejection fraction (2)
- heat shock response (2)
- heat stress (2)
- helicase (2)
- helicene (2)
- helicenes (2)
- helminths (2)
- hematologic malignancies (2)
- hematopoietic (2)
- hematopoietic stem cell transplantation (2)
- heme oxygenase-1 (2)
- hemicraniectomy (2)
- hemodiafiltration (2)
- hepatic stellate cell (2)
- hepatocellular carcinoma (2)
- herbivore (2)
- herbivory (2)
- hereditary breast and ovarian cancer (2)
- hereditary motor and sensory neuropathy (2)
- heritability (2)
- herpes simplex virus (2)
- herpes virus (2)
- heterogeneity (2)
- heterogeneous catalysis (2)
- heterosis (2)
- hiPSC (2)
- hiPSC-CM (2)
- hierarchy (2)
- high contrast (2)
- high performance liquid chromatography (2)
- high risk (2)
- high-intensity training (2)
- high-risk prostate cancer (2)
- high-throughput screening (2)
- hip fracture (2)
- hippocampal neurogenesis (2)
- histamine (2)
- histopathology (2)
- history (2)
- holography and condensed matter physics (AdS/CMT) (2)
- homogenous catalysis (2)
- homologous chromosomes (2)
- homology modeling (2)
- hormones (2)
- hospitalizations (2)
- human adipose-derived stromal cells (2)
- human african trypanosomiasis (2)
- human breast (2)
- human cells (2)
- human cytomegalovirus (HCMV) (2)
- human exposure (2)
- human genetics (2)
- human interleukin-4 (2)
- human macrophages (2)
- human pathogenic fungi (2)
- human rights (2)
- human-centered design (2)
- hybridogenesis (2)
- hybridomas (2)
- hydrocortisone (2)
- hydrogel (2)
- hydrogen (2)
- hyperactivity (2)
- hyperalgesia (2)
- hypercholesterolemia (2)
- hyperoxia (2)
- hypersensitivity (2)
- hyphae (2)
- hypogammaglobulinemia (2)
- hypothalamus (2)
- hypotonic (2)
- iPSC-cardiomyocytes (2)
- idiopathic inflammatory myopathies (2)
- ileocecal resection (2)
- illness (2)
- image analysis (2)
- image-guided radiation therapy (2)
- imidazolate (2)
- immediate early genes (2)
- immersive technologies (2)
- immune cell infiltration (2)
- immune escape (2)
- immune reconstitution (2)
- immune suppression (2)
- immune therapy (2)
- immunoassay (2)
- immunoblotting (2)
- immunoglobulin superfamily (2)
- immunostaining (2)
- immunosurveillance (2)
- implant (2)
- implant positioning (2)
- implantation (2)
- implants (2)
- in silico analysis (2)
- in situ hybridization (2)
- in vitro models (2)
- inactivation (2)
- incentives (2)
- individual‐based model (2)
- inebilizumab (2)
- infarction (2)
- infection control (2)
- inferior vena cava (2)
- inflammatory cytokines (2)
- inflammatory neuropathy (2)
- inflammatory response (2)
- influenza A virus (2)
- informal caregiving (2)
- information extraction (2)
- infrared spectroscopy (2)
- inhibitors (2)
- inhibitory neurotransmission (2)
- injury prevention (2)
- innate immune response (2)
- innate immune system (2)
- inner ear (2)
- insect decline (2)
- insect flight (2)
- insect monitoring (2)
- insect vision (2)
- insecticide (2)
- insecticides (2)
- insights (2)
- insulin signaling (2)
- integral (2)
- integrated stress response (2)
- intellectual disability (2)
- intensity zones (2)
- interaction networks (2)
- interacts (2)
- interband cascade lasers (2)
- interferometry (2)
- interleukin 6 (2)
- interleukin-8 (2)
- internal medicine (2)
- internalization (2)
- internet of things (2)
- interpolation (2)
- interval timing (2)
- interval training (2)
- intestinal barrier (2)
- intracellular bacterial pathogens (2)
- intracellular membranes (2)
- intracellular pathogens (2)
- intracerebral hemorrhage (2)
- intraoperative imaging (2)
- introgressive hybridization (2)
- intuition (2)
- invasive fungal infection (2)
- invasive fungal infections (2)
- inventory (2)
- ion channel (2)
- ion channels in the nervous system (2)
- ipilimumab (2)
- irrigation (2)
- ischaemic stroke (2)
- ischemia-reperfusion injury (2)
- ischemia/reperfusion injury (2)
- ischemic penumbra (2)
- islet transplantation (2)
- islets of Langerhans (2)
- isocenter (2)
- isolation (2)
- isomerization (2)
- isothermal titration calorimetry (2)
- isotonic (2)
- isotopes (2)
- jet channel (2)
- jet reconstruction efficiency (2)
- jet transverse momentum (2)
- jets (2)
- joint aspiration (2)
- joint instability (2)
- judgements (2)
- juvenile hormone (2)
- keratinocytes (2)
- kidney cancer (2)
- kidney disease (2)
- kinase inhibitors (2)
- kinesin (2)
- kinetic model (2)
- knee osteoarthritis (2)
- knee replacement (2)
- laboratory techniques and procedures (2)
- lactate dehydrogenase (2)
- lactation (2)
- land surface (2)
- land surface temperature (2)
- land use intensification (2)
- land-use intensity (2)
- landsat (2)
- landscape heterogeneity (2)
- landscape metrics (2)
- language (2)
- language acquisition (2)
- laparostomy (2)
- large T antigen (2)
- large vessel occlusion (2)
- laser spectroscopy (2)
- late positive potential (2)
- late-onset (2)
- laterality (2)
- left ventricular ejection fraction (2)
- left ventricular mass (2)
- left-ventricular function (2)
- length of stay (2)
- lepidoptera (2)
- lessons learned (2)
- life (2)
- life cycle (2)
- life events (2)
- lifestyle (2)
- ligand (2)
- light pulses (2)
- lineage (2)
- linear regression analysis (2)
- linguistic morphology (2)
- lipid bilayer membrane (2)
- lipid metabolism (2)
- liquid biopsy (2)
- liquid chromatography/mass spectrometry (2)
- literature review (2)
- liver resection (2)
- lncRNAs (2)
- load management (2)
- locked-in state (2)
- locked-in syndrome (2)
- locomotor adaptation (2)
- locust outbreak (2)
- long non-coding RNA (2)
- long-term potentiation (2)
- long-term survivors (2)
- longitudinal studies (2)
- loss (2)
- low-grade glioma (2)
- lower body (2)
- lower extremity (2)
- lung-cancer (2)
- lying (2)
- lymph node dissection (2)
- lymphocyte activation (2)
- lymphocyte differentiation (2)
- lyso-Gb3 (2)
- lysosomal storage disease (2)
- mRNA expression (2)
- mTOR (2)
- macroecology (2)
- macrophage polarization (2)
- magic (2)
- magnesium (2)
- magnetic compass (2)
- magnetic resonance (2)
- main group element halides (2)
- maize (2)
- malignant hyperthermia (2)
- mammalian cells (2)
- mammalian genomics (2)
- maps (2)
- marcophages (2)
- marine bacteria (2)
- marine natural product (2)
- markers (2)
- mass (2)
- mass casualties (2)
- match load (2)
- maternal exposure (2)
- mathematical modeling (2)
- mating success (2)
- matrix metalloproteinase (2)
- matrix protein porin (2)
- maturation (2)
- meadow (2)
- mean-field theory (2)
- measels virus (2)
- measurement (2)
- measures (2)
- mechanisms of disease (2)
- media equation (2)
- mediated apoptosis (2)
- medical genetics (2)
- medical nutrition therapy (2)
- medical students (2)
- medieval manuscripts (2)
- medullary thyroid cancer (2)
- medullary thyroid carcinoma (2)
- medulloblastoma (2)
- megavoltage computed-tomography (2)
- melanomas (2)
- membrane biophysics (2)
- membrane receptor signaling (2)
- membrane skeleton (2)
- membrane vesicles (2)
- men (2)
- men who have sex with men (2)
- mentalizing (2)
- merocyanines (2)
- mesenchymal stem cell (2)
- mesenchymal stromal cell (2)
- metabolic disease (2)
- metabolic flux (2)
- metabolic flux analysis (2)
- metabolic syndrome (2)
- metabolomic profiling (2)
- metacognitive prompting (2)
- metacomprehension (2)
- metallic trace elements (2)
- metamorphic buffer layer (2)
- metaproteomics (2)
- metastasis-directed therapy (2)
- metastatic (2)
- methodological pluralism (2)
- methods (2)
- methylprednisolone (2)
- miR (2)
- miR-182-5p (2)
- miR-21 (2)
- micelles (2)
- microbial ecology (2)
- microbial spectrum (2)
- microcephaly (2)
- microclimate (2)
- microfluidics (2)
- micronutrients (2)
- microparticles (2)
- microswimmer (2)
- microvascular complications (2)
- microvasculature (2)
- midazolam (2)
- mimicry (2)
- mind–body intervention (2)
- mineral metabolism (2)
- mineralogy (2)
- minimal invasive surgery (2)
- mismatch (2)
- mitochondrial DNA (2)
- mixed hearing loss (2)
- mobile apps (2)
- mobile laser scanning (2)
- modeling (2)
- moderate (2)
- modifiers (2)
- modulation spectroscopy (2)
- molecular alterations (2)
- molecular beam epitaxy (2)
- molecular characterization (2)
- molecular cloning (2)
- molecular diagnostics (2)
- molecular epidemiology (2)
- molecular evolution (2)
- molecular mass (2)
- molecular mechanisms (2)
- molecular modeling (2)
- molecular phylogeny (2)
- molecular structure (2)
- molecular subtypes (2)
- monocyte (2)
- mood (2)
- morality (2)
- morphogenesis (2)
- morphogenetic protein (2)
- morris water maze (2)
- mosquito (2)
- motility (2)
- motivated reasoning (2)
- motoneuron (2)
- motor learning (2)
- motor proteins (2)
- mouse-brain (2)
- movement (2)
- movement disorder (2)
- mtDNA (2)
- mucoepidermoid carcinoma (2)
- multi-fluid mixture (2)
- multi-jet background (2)
- multi-sensor (2)
- multidrug resistance (2)
- multidrug-resistant bacteria (2)
- multimodal (2)
- multiparticle collision dynamics (2)
- multiple bonds (2)
- multiple-sclerosis (2)
- multivariate analysis (2)
- multivariate data analysis (2)
- muon channel (2)
- murine model (2)
- muscarinic receptors (2)
- muscle degeneration (2)
- muscle disease (2)
- musculoskeletal system (2)
- mutants (2)
- myasthenia gravis (2)
- mycotoxins (2)
- myeloid (2)
- myocardial sympathetic innervation imaging (2)
- myocardial work (2)
- myocardial-infarction (2)
- myocardium (2)
- myofibrillar myopathy (2)
- myopathy (2)
- nab-paclitaxel (2)
- naloxone (2)
- nano rods (2)
- nanographene (2)
- nanomedicine (2)
- nanotechnology (2)
- naphthylisoquinoline alkaloids (2)
- national park (2)
- national parks (2)
- natriuretic peptide (2)
- natural enemies (2)
- natural language processing (2)
- natural pest control (2)
- necrobiome (2)
- necrotic cell death (2)
- negative pressure (2)
- neisseria gonorrhoeae (2)
- neoadjuvant (2)
- neonate (2)
- neonates (2)
- neovascularization, physiologic (2)
- nervous-system (2)
- nesting habits (2)
- networking (2)
- neume notation (2)
- neural crest (2)
- neural network (2)
- neural stem cell (2)
- neurite outgrowth (2)
- neuroendocrine tumor (NET) (2)
- neuroethology (2)
- neurofilaments (2)
- neuromodulation (2)
- neuronal dendrites (2)
- neuronal network (2)
- neuronal plasticity (2)
- neuropeptide (2)
- neurophysiology (2)
- neuroplasticity (2)
- neuropsychology (2)
- neurosphere (2)
- neurosurgery (2)
- neurotoxicity (2)
- neurotransmitter release (2)
- neutral sphingomyelinase-2 (2)
- neutralino (2)
- neutrino astronomy (2)
- neutrino emission (2)
- neutrino telescope (2)
- next generation sequencing (NGS) (2)
- next-generation sequencing (2)
- nicotine addiction (2)
- nicotinic receptors (2)
- nilotinib (2)
- nivolumab (2)
- non-invasive ventilation (2)
- non-penetrating glaucoma surgery (2)
- non-small cell lung cancer (2)
- noncoding RNA (2)
- noncoding RNAs (2)
- noncovalent interactions (2)
- normal distribution (2)
- nuclear import (2)
- nuclear magnetic resonance (2)
- nuclear magnetic resonance spectroscopy (2)
- nuclear medicine (2)
- nuclear organization (2)
- nucleophilic addition (2)
- nucleosomes (2)
- nucleotide excision-repair (2)
- nucleotide sequence (2)
- nude-mice (2)
- numerical analysis (2)
- nurses (2)
- o-methoxy-sila-hexocyclium (2)
- object-based classification (2)
- object-based image analysis (2)
- occupational medicine/industrial medicine (2)
- oculomotor control (2)
- oestrogen receptor signalling (2)
- office-workers (2)
- olfactory memory (2)
- oligodendrocyte (2)
- oligomers (2)
- oligorecurrence (2)
- olive (2)
- omega-3 fatty acids (2)
- oncogene-induced senescence (2)
- oncolytic virotherapy (2)
- one-electron oxidation (2)
- onset (2)
- open spaces (2)
- opioid peptides (2)
- optic neuritis (2)
- optical (2)
- optical coherence tomography (2)
- optical physics (2)
- optical remote sensing (2)
- optics and photonics (2)
- optimal control theory (2)
- oral mucositis (2)
- organ-on-a-chip (2)
- organic electronics (2)
- organic solar cells (2)
- orientation (2)
- origin (2)
- orthopedic surgery (2)
- oscillations (2)
- osteoclasts (2)
- osteonecrosis of the jaw (2)
- osteopontin (2)
- osteoradionecrosis (2)
- otitis media (2)
- outer membrane protein (2)
- outer membrane proteins (2)
- outer-membrane proteins (2)
- outpatients (2)
- oxaliplatin (2)
- oxidative addition (2)
- oxygen uptake (2)
- oxygen/glucose deprivation (2)
- oxytocin (2)
- pCa (2)
- paediatrics (2)
- pain sensation (2)
- paleogeography (2)
- palladium (2)
- palliative care (2)
- pandemic (2)
- panel sequencing (2)
- parallel evolution (2)
- parasite biology (2)
- parasitic cell cycles (2)
- paraspeckles (2)
- parastomal hernia (2)
- parasympatholytics (2)
- parietal hypoactivation (2)
- parotid gland (2)
- parthenogenesis (2)
- partial agonists (2)
- partial decay width (2)
- particles (2)
- passive transfer (2)
- pathogen (2)
- pathogenic bacteria (2)
- pathway analysis (2)
- patient education (2)
- patient reported outcome measures (2)
- patient safety (2)
- patient survival (2)
- patient-reported outcomes (2)
- patient-specific (2)
- peak oxygen uptake (2)
- pedagogical content knowledge (2)
- pediatric adrenocortical cancer (2)
- pediatric adrenocortical tumor (2)
- pediatric patients (2)
- peer review (2)
- pelvic examination (2)
- pelvic palpation (2)
- pembrolizumab (2)
- pemphigus foliaceus (2)
- penicillin allergy (2)
- penicillin hypersensitivity (2)
- pentacene (2)
- people (2)
- peptide tyrosine tyrosine (PYY) (2)
- peptide vaccination (2)
- peptides (2)
- perfusion culture (2)
- pericytes (2)
- periodization (2)
- perioperative care (2)
- peripartum (2)
- peripheral nerve (2)
- peripheral neuropathy (2)
- periprosthetic joint infection (2)
- peritoneal carcinomatosis (2)
- peroxisomes (2)
- personalised medicine (2)
- personalized treatment (2)
- perspective taking (2)
- perspectives (2)
- perylene bisimides (2)
- phage (2)
- pharmaceutical applications (2)
- pharmacology/toxicology (2)
- pharmacovigilance (2)
- phasic affective modulation (2)
- phenprocoumon (2)
- pheromones (2)
- phosphatidylserine (2)
- phosphodiesterase (2)
- phosphorus (2)
- photoemission (2)
- photoemission spectroscopy (2)
- photolysis (2)
- photon statistics (2)
- photon-counting (2)
- photoreceptor (2)
- photoswitchable organic fluorophores (2)
- photosynthesis (2)
- photothrombosis (2)
- phototransduction (2)
- physical health (2)
- physical performance (2)
- physical properties (2)
- physiologically based pharmacokinetic (PBPK) modeling (2)
- phytochemicals (2)
- phytohormones (2)
- piRNA (2)
- piperacillin/tazobactam (2)
- piperidines (2)
- placebo-controlled trial (2)
- planning (2)
- plant cuticle (2)
- plant defence (2)
- plant defenses (2)
- plant diversity (2)
- plant–insect interactions (2)
- plaque (2)
- plasma proteins (2)
- plasminogen (2)
- plasmonics (2)
- platelet physiology (2)
- platelet receptors (2)
- platyhelminthes (2)
- plausibility (2)
- pleomorphic adenoma (2)
- pneumolysin (2)
- pneumonia (2)
- point of care testing (2)
- pointing gestures (2)
- polaritons (2)
- policy (2)
- pollen tube (2)
- pollination network (2)
- pollinator decline (2)
- poly(2- oxazoline) (2)
- poly(2-ethyl-2-oxazoline) (2)
- polycationic peptides (2)
- polymavirus (2)
- polymer processing (2)
- polymorphisms (2)
- polymyalgia rheumatica (2)
- polyploidy (2)
- pomalidomide (2)
- population genetics (2)
- population-based (2)
- populations (2)
- pore formation (2)
- porin (2)
- positive selection (2)
- positron emission tomography/computed tomography (2)
- posterior parietal cortex (2)
- postmenopausal women (2)
- postnatal development (2)
- postoperative bleeding (2)
- postoperative care (2)
- postoperative nausea and vomiting (2)
- posttranslational modifications (2)
- postural control (2)
- potassium channel (2)
- power training (2)
- pp Collisions (2)
- pp collisions (2)
- pre-messenger RNA (2)
- precision agriculture (2)
- predation risk (2)
- predictive factors (2)
- predictive marker (2)
- predictive markers (2)
- predictive modeling (2)
- predictive performance (2)
- predictive value (2)
- preexisting bias (2)
- prenatal exposure (2)
- preschool (2)
- presynaptic inhibition (2)
- preterm infant (2)
- primary cells (2)
- primary healthcare (2)
- primary prevention (2)
- primary ventral hernia (2)
- primary vertex (2)
- priming (2)
- printability (2)
- printed tooth (2)
- probability (2)
- probes (2)
- proboscis extension response (PER) (2)
- processing fluency (2)
- prodrug (2)
- productivity (2)
- progenitor cells (2)
- progenitors (2)
- prognostic factors (2)
- projection neurons (2)
- promoter (2)
- promoter methylation (2)
- propensity score matching (2)
- propulsion (2)
- prosocial behavior (2)
- prospective studies (2)
- prostate-cancer (2)
- prostatic neoplasms (2)
- prosthesis (2)
- protease (2)
- protease inhibition (2)
- protein aggregation (2)
- protein interactions (2)
- protein phosphorylation (2)
- protein-coupled receptors (2)
- protein-interaction networks (2)
- protein-protein interactions (2)
- proteinuria (2)
- proteomes (2)
- proteomic (2)
- proton-proton collisions (2)
- proton-proton-collision (2)
- proton–proton collisions (2)
- proximal gradient method (2)
- psychoeducation (2)
- psycholinguistics (2)
- psychological variables (2)
- psychopathology (2)
- psychophysics (2)
- psychotherapy (2)
- puberty (2)
- public speaking (2)
- pulmonary artery pressure (2)
- pupae (2)
- pyrene (2)
- pyrolysis (2)
- qPCR (2)
- quality evaluation (2)
- quality of experience (2)
- quality of life (QoL) (2)
- quantitative SPECT/CT (2)
- quantitative analysis (2)
- quantity discrimination (2)
- quantum information (2)
- quantum wells (2)
- quinine (2)
- quinoa (2)
- radiation sensitivity (2)
- radiation-therapy (2)
- radical cystectomy (2)
- radical prostatectomy (2)
- radii (2)
- radiography (2)
- radioiodine (2)
- radiopharmaceuticals (2)
- radiotherapy (RT) (2)
- radiotracer (2)
- rainforest (2)
- raman spectroscopy (2)
- random forest classification (2)
- randomised controlled trial (2)
- randomized trial (2)
- rapid prototyping (2)
- rare (2)
- rare diseases (2)
- rat brain membranes (2)
- rat hepatocytes (2)
- rat model (2)
- re-irradiation (2)
- reaction mechanism (2)
- reaction mechanisms (2)
- reactivation (2)
- reactive electrophilic species (2)
- reactive intermediates (2)
- reading comprehension (2)
- reading disability (2)
- real time PCR (2)
- real world evidence (2)
- receptor beta (2)
- receptor signalling (2)
- receptor tyrosine kinase (2)
- reconstructed human epidermis (2)
- rectum (2)
- red fluorescent protein (2)
- redox (2)
- reflection (2)
- reflex (2)
- refugees (2)
- regenerative capacity (2)
- regional development (2)
- register (2)
- registries (2)
- registry (2)
- regulator (2)
- regulatory RNA (2)
- regulatory T cell (2)
- regurgitation (2)
- relativistic jets (2)
- relaxation (2)
- release (2)
- religion (2)
- remyelination (2)
- renal disease (2)
- renal failure (2)
- renal system (2)
- renewable energy (2)
- renewable fuels (2)
- repair and replication (2)
- reperfusion (2)
- reperfusion injury (2)
- replacement therapy (2)
- replica (2)
- replication crisis (2)
- reporter genes (2)
- reporting and data system (2)
- repositories (2)
- reproductive success (2)
- resin (2)
- resistance training (2)
- resonant tunneling diode (2)
- resource use (2)
- respiratory chain (2)
- respiratory syncytial virus (2)
- restrictive cardiomyopathy (2)
- resveratrol (2)
- retention interval (2)
- retinitis pigmentosa (2)
- retinoblastoma protein (2)
- retinoic acid (2)
- retrospective (2)
- retroviral vectors (2)
- reverse shoulder arthroplasty (2)
- reverse transcriptase (2)
- reverse transcriptase-polymerase chain reaction (2)
- reversible posterior leukoencephalopathy syndrome (2)
- revision arthroplasty (2)
- rheology (2)
- rheumatology (2)
- ribonucleases (2)
- ribosome biogenesis (2)
- riboswitch (2)
- ribozymes (2)
- rice (2)
- ring-expansion reaction (2)
- robotic surgery (2)
- roentgenographic assessment (2)
- rolipram (2)
- room temperature (2)
- root (2)
- root growth (2)
- rotation (2)
- ruthenium bda complexes (2)
- ruthenium complexes (2)
- saccharomyces cerevisiae (2)
- safety behavior (2)
- salicylic acid (2)
- salinity stress (2)
- salivary gland (2)
- salivary gland tumors (2)
- sampling method (2)
- sarcoidosis (2)
- satellite (2)
- satellite remote sensing (2)
- satisfaction with life (2)
- scaffolds (2)
- scalability (2)
- scapula (2)
- sciatic nerve (2)
- scientific guidelines (2)
- sclerostin (2)
- scoping review (2)
- search (2)
- second hit (2)
- secondary metabolites (2)
- secretion systems (2)
- sectoral planning (2)
- sedentary behavior (2)
- sedimentology (2)
- see (2)
- selective attention (2)
- selenium (2)
- self-adaptive systems (2)
- self-aware computing (2)
- self-help (2)
- self-management (2)
- self-renewal (2)
- semantic coherence (2)
- semi-natural habitats (2)
- sensitivity analysis (2)
- sensor (2)
- sensor fusion (2)
- sensory neuropathy (2)
- sensory perception (2)
- sentinel-2 (2)
- septic (2)
- sequence analysis (2)
- serology (2)
- serum concentration (2)
- serum creatinine (2)
- sevoflurane (2)
- sex chromosome evolution (2)
- sex determination (2)
- sex differentiation (2)
- sexual development (2)
- shape fidelity (2)
- shedding (2)
- short-term memory (2)
- shoulder (2)
- shoulder arthroplasty (2)
- shoulder surgery (2)
- sialic acid (2)
- signal cross section (2)
- signal filtering (2)
- signal inhibition (2)
- signal to noise ratio (2)
- signaling pathways (2)
- signalling pathways (2)
- signals (2)
- signature (2)
- signs and symptoms (2)
- silahexocyclium (2)
- simulated signal event (2)
- simultaneous integrated boost (2)
- single photon (2)
- single top event (2)
- single top production (2)
- single top quark production (2)
- single-cell RNA-seq (2)
- single-nucleotide polymorphisms (2)
- single-sided deafness (2)
- sirolimus (2)
- site-specific RNA cleavage (2)
- sizing (2)
- skeletal dysplasia (2)
- skin biopsy (2)
- skinned fiber (2)
- sleep bruxism (2)
- sleep disorders (2)
- small nucleolar RNAs (2)
- small-molecule activation (2)
- smart speaker (2)
- smartphone app (2)
- smooth muscle cells (2)
- social capital (2)
- social context (2)
- social decision-making (2)
- social features (2)
- social influence (2)
- social psychology (2)
- sodium channel (2)
- sodium channels (2)
- sofosbuvir (2)
- soil (2)
- solid tumors (2)
- solid-state NMR (2)
- solid-state emitters (2)
- solitary bee (2)
- solitary bees (2)
- solvent effects (2)
- somatic mosaicism (2)
- somatostatin receptor (SSTR) (2)
- soybean (2)
- spacing effect (2)
- spatial attention (2)
- spatial navigation (2)
- spatial presence (2)
- speciation (2)
- species concept (2)
- species diversity (2)
- spectral karyotyping (2)
- speech perception (2)
- speed (2)
- sperm DNA methylation (2)
- spermatocytes (2)
- spermatogenesis (2)
- spheroids (2)
- sphingolipid (2)
- sphingosine kinase inhibitor SKI-II (2)
- sphingosine-1-phosphate (2)
- spider (2)
- spider phobia (2)
- spin (2)
- spin polarization (2)
- spinal cord injury (2)
- spinal-cord (2)
- spinal-cord-injury (2)
- spine (2)
- spine radiosurgery (2)
- spin–orbit coupling (2)
- spiral ganglion neuron (2)
- splicing (2)
- split-belt treadmill (2)
- spontaneous symmetry breaking (2)
- sporidia (2)
- squaraine dyes (2)
- stage renal-disease (2)
- standardization (2)
- startle (2)
- state (2)
- stem cell niche (2)
- stent (2)
- stereochemistry (2)
- stereotypes (2)
- stiffness (2)
- stimuli (2)
- streptozotocin (2)
- stress resilience (2)
- stress resistance (2)
- stress response (2)
- strong coupling (2)
- strongly correlated materials (2)
- structural basis (2)
- structural synaptic plasticity (2)
- structure prediction (2)
- structure-activity (2)
- structure-activity relationship (2)
- structure-activity relationships (2)
- structured illumination (2)
- structured illumination microscopy (2)
- student training (2)
- study design (2)
- sturgeon (2)
- subcutaneous animal model (2)
- substantia nigra pars compacta (2)
- succession (2)
- suicide prevention (2)
- sulfates (2)
- sun exposure (2)
- supervisors (2)
- support vector machines (2)
- suppressor cells (2)
- supraglacial lakes (2)
- supraparticles (2)
- surfaces, interfaces and thin films (2)
- surgical site infections (2)
- surgical therapy (2)
- surgical treatment (2)
- survival analysis (2)
- survivors (2)
- susceptibility gene (2)
- sustainability (2)
- sustainable agriculture (2)
- sustainable intensification (2)
- sustained inflammation (2)
- swarming (2)
- swimming (2)
- symptom control (2)
- synapse formation (2)
- synapsis (2)
- synaptonemal complex (2)
- syndrome (2)
- synergistic effect (2)
- synovial fluid (2)
- synthetic aperture RADAR (2)
- synthetic aperture radar (2)
- synthetic biology (2)
- synthetic mesh (2)
- synthetic methods (2)
- systematics (2)
- targeted therapies (2)
- targeting (2)
- targets (2)
- task force (2)
- taste (2)
- teacher education (2)
- telecommunication spectral range (2)
- temporal processing (2)
- temporal-lobe epilepsy (2)
- temporoparietal junction (2)
- tendon (2)
- tension (2)
- teriparatide (2)
- terror attack (2)
- testes (2)
- testis (2)
- tetraspanin (2)
- tetromycin (2)
- textile (2)
- the rich (2)
- theory (2)
- therapy response (2)
- thin films (2)
- thinking (2)
- thorax (2)
- thromboinflammation (2)
- thrombopoiesis (2)
- thyroid cancer (2)
- time (2)
- time perception (2)
- time-resolved spectroscopy (2)
- time-series (2)
- timing (2)
- tissue saturation index (2)
- tocilizumab (2)
- tolerability (2)
- toll-like receptors (2)
- tool use (2)
- tooth extraction (2)
- top quark (2)
- top quark decay (2)
- topic modeling (2)
- total joint arthroplasty (2)
- toxicology (2)
- toxin (2)
- trabectome (2)
- trabecular meshwork (2)
- trace elements (2)
- tracking (2)
- trade-offs (2)
- training intensity distribution (2)
- transactivation (2)
- transcription factor MIZ-1 (2)
- transcriptional control (2)
- transcriptional profiling (2)
- transcriptome analysis (2)
- transfection (2)
- transformation (2)
- transformative education (2)
- transforming growth factor-beta 1 (2)
- transient middle cerebral artery occlusion (2)
- transition (2)
- transition metal oxides (2)
- transition radiation (2)
- translation initiation (2)
- translational initiation (2)
- translational regulation (2)
- transportation (2)
- transposition (2)
- trap (2)
- trap nests (2)
- trastuzumab (2)
- treatment guidelines (2)
- treatment options (2)
- treatment resistance (2)
- trees (2)
- trend analysis (2)
- triple in situ hybridization (2)
- triple-negative breast cancer (2)
- tropical forest (2)
- trust (2)
- trypanosoma brucei (2)
- tuberculosis (2)
- tumor cells (2)
- tumor growth (2)
- tumor immunity (2)
- tumor immunology (2)
- tumor necrosis factor (TNF) (2)
- tumor stem cells (2)
- tumor-infiltrating lymphocytes (2)
- tumour immunology (2)
- two-photon absorption (2)
- two-photon excited fluorescence (2)
- two-stage exchange (2)
- type VII secretion system (2)
- tyrosine (2)
- tyrosine kinase inhibitor (2)
- tyrosine kinase inhibitors (2)
- ultrafiltration (2)
- umbilical hernia (2)
- unconventional superconductivity (2)
- unexpressed needs (2)
- unfolded protein response (2)
- universal prevention (2)
- unmanned aerial vehicles (2)
- unpleasant pictures (2)
- up-regulation (2)
- update (2)
- urban (2)
- urine (2)
- urticaria (2)
- user study (2)
- vaccines (2)
- vacuum conditioning (2)
- vacuum-assisted closure (2)
- vandetanib (2)
- vascular access (2)
- vascular permeability (2)
- vascular plants (2)
- vascular surgery (2)
- vascularization (2)
- vasculature (2)
- vasculogenesis (2)
- vasopressin (2)
- vegetative state (2)
- vemurafenib (2)
- venous system (2)
- ventral hernia (2)
- vertebral metastases (2)
- vertigo (2)
- very-long-baseline interferometry (2)
- vibration (2)
- vicinal surfaces (2)
- video analysis (2)
- virology (2)
- virtual agent (2)
- virtual body ownership (2)
- virulence factors (2)
- viscosity (2)
- visible cross section (2)
- vitamin D deficiency (2)
- vitamins (2)
- volatile anesthetics (2)
- volume regulation (2)
- voluntary movement (2)
- von Willebrand factor (2)
- voxel-based morphometry (2)
- vulnerability (2)
- vulnerability curve (2)
- wR factor = 0.068 (2)
- water load test (2)
- water microbiology (2)
- water splitting (2)
- wave functions (2)
- weakly coordinating anions (2)
- wetland (2)
- white blood cells (2)
- whole exome sequencing (2)
- whole genome sequencing (2)
- whole-genome duplication (2)
- wind speed (2)
- wood anatomy (2)
- wood-inhabiting fungi (2)
- work capacity evaluation (2)
- work engagement (2)
- workplace (2)
- wound healing (2)
- xenotransplantation (2)
- xylem loading (2)
- yam (2)
- yellow fluorescent protein (2)
- yoga (2)
- young children (2)
- youth (2)
- zoology (2)
- γδ T cell (2)
- γδ T cells (2)
- π-conjugated systems (2)
- ( L. ivanovii ) (1)
- ( L. selligeri) (1)
- (+)-limonene (1)
- (13)C (1)
- (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride/pharmacology (1)
- (AB)\(_{n}\) segmented copolymers (1)
- (Mouse L-cell) (1)
- (Nucleotide sequence (1)
- (R)- and (S)-hexahydro- / Antimuscarinic properties / Muscarinic receptor subtypes (1)
- (Rat brain membrane) (1)
- (Rat liver) (1)
- (Salmonella) (1)
- (approximate) functional equation (1)
- (cardiac) surgery (1)
- (classical and atypical) Werner syndrome (1)
- (dis-)embeddedness (1)
- (± )-dioncophyllacine A (1)
- + (1)
- 0 antigen (1)
- 1,2-additionreaction (1)
- 1,2-azaborinine (1)
- 1,2-benzisothiazolinone (1)
- 1,25-dihydroxyvitamin D\(_{3}\) (1)
- 1,4-Diborabenzene (1)
- 1,4-naphthoquinone (1)
- 1/N expansion (1)
- 11C-HED (1)
- 11C-Hydroxyephedrine (1)
- 11C-Methionine PET/CT (1)
- 11C-hydroxyephedrine (1)
- 12-oxo-phytodienoic acid (1)
- 123I-Ioflupane (1)
- 131I (1)
- 133Ba (1)
- 14.7K (1)
- 15-Deoxyspergualin (1)
- 1550 nm (1)
- 16S metabarcoding (1)
- 16S ribosomal-RNA (1)
- 177Lu SPECT/CT imaging (1)
- 17ßEstradiol (1)
- 18-F-fluorothymidine uptake (1)
- 18F-DCFPL (1)
- 18F-DCFPyL (1)
- 18F-flurpiridaz (1)
- 18FDG-PET/CT (1)
- 18FFBnTP (1)
- 18S (1)
- 1960s (1)
- 1H-Magnetic resonance spectroscopy (1H-MRS) (1)
- 1p13.3 (1)
- 1p36 deletion syndrome (1)
- 1q21 (1)
- 1st International Workshop (1)
- 1st-line treatment (1)
- 2 Jets (1)
- 2 PM (1)
- 2',7'-dichlorofluorescin (1)
- 2,5-diketopiperazines (1)
- 2- deoxy-2-(18F)fluoro-D-glucose (1)
- 2-APB (1)
- 2-Acetylaminofluorene (1)
- 2-DG (1)
- 2-Dichloroethane (1)
- 2-Dioxetane (1)
- 2-Generation reproduction (1)
- 2-Thiazaphospholidines (1)
- 2-alkylbranched acids (1)
- 2-chloro (1)
- 2-component system (1)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 2-deoxy-2-18F-fluoro-D-sorbitol (1)
- 2-deoxy-D-glucose (1)
- 2-dimensional speckle tracking (1)
- 2-halo (1)
- 2-imino- (1)
- 2-loop level (1)
- 2-photon absorption (1)
- 2-photon microscopy (1)
- 2-pore potassium channel (1)
- 2-step IMRT (1)
- 2015 (1)
- 21q22.2-q22.3 (1)
- 223Ra (1)
- 224Ra (1)
- 22q11.2 deletion syndrome (1)
- 25-hydroxycholesterol 7 alpha-hydroxylase (1)
- 26S RDNA Data (1)
- 26S proteasome (1)
- 28 (1)
- 2D-perfusion angiography (1)
- 2Dimensionale Spektroskopie (1)
- 2ϕ\(_0\) periodicity (1)
- 3 (1)
- 3 D rotational fluoroscopy (1)
- 3-coordinate boron (1)
- 3-coordinate organoboron compounds (1)
- 3-dimensional MRI (1)
- 3-dimensional structure (1)
- 3-dimensional visualization (1)
- 316L stainless-steel (1)
- 360° videos (1)
- 3D (1)
- 3D GIS analysis (1)
- 3D Printing (1)
- 3D X-ray microscopy (1)
- 3D analysis (1)
- 3D breast cancer model (1)
- 3D cell culture (1)
- 3D cell cultures (1)
- 3D collation (1)
- 3D conformal silicone bolus (1)
- 3D culture (1)
- 3D echocardiography (1)
- 3D electrophysiology (1)
- 3D ex vivo models (1)
- 3D image analysis (1)
- 3D in vitro model (1)
- 3D in vitro models (1)
- 3D lung tumor tissue models (1)
- 3D mapping (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D modeling (1)
- 3D neuronal networks (1)
- 3D object recognition (1)
- 3D organoids (1)
- 3D powder printing (1)
- 3D printer (1)
- 3D remote sensing (1)
- 3D tissue models (1)
- 3D tumor model (1)
- 3D viewer (1)
- 3D-conformal radiotherapy (1)
- 3D-printed tooth (1)
- 3D-reconstruction methods (1)
- 3DTK toolkit (1)
- 3R (1)
- 3 T (1)
- 3‐D electrical resistivity imaging (1)
- 3′ UTR (1)
- 4'-hydroxylation (1)
- 4-(p-nitrobenzyl)pyridine (1)
- 4-dimethylamino-4′-cyanodiphenylacetylene (1)
- 4D (1)
- 4D flow MRI (1)
- 4D flow cardiovascular magnetic resonance (1)
- 4D-GIS (1)
- 4D-MRI (1)
- 4H (1)
- 4TH-Corner Problem (1)
- 5-HT (1)
- 5-HT receptors (1)
- 5-HTT (1)
- 5-HTT knockout mice (1)
- 5-HTTLPR polymorphism (1)
- 5-bromodeoxyuridine (1)
- 5-methyl cytosine (1)
- 5-methylcytosine (1)
- 5HTTLPR (1)
- 5IA-SPECT (1)
- 6-benzylaminopurine (1)
- 6-percent hydroxyethyl starch (1)
- 60-nucleotide duplication (1)
- 65-kda isoform (1)
- 68Ga-DOTATATE (1)
- 68Ga-DOTATATE/-TOC (1)
- 68Ga-PSMA ligand PET/CT (1)
- 68Ga-Pentixafor PET/CT (1)
- 6S RNA (1)
- 7 T (1)
- 7000 GeV-cms (1)
- 77-LH-28-1 (1)
- 7T (1)
- 7q11.2 (1)
- 8 TEV (1)
- 8-Hydroxy-deoxyguanosine (1)
- 8-oxoguanine (1)
- 99mTc-DTPA (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- A chromosomes (1)
- A(2B) receptors (1)
- A-D (1)
- A-delta fibers (1)
- A-type lamins (1)
- A. thaliana (1)
- A1 (1)
- A1 Adenosine receptors (1)
- A20 (1)
- A2a-R receptor (1)
- A375 (1)
- A53T (1)
- A549 cell line (1)
- A<sub>2</sub> Adenosine receptor (1)
- AAA+ ATPase p97 (1)
- AAPA (1)
- ABA receptors (1)
- ABL gene (1)
- ABP1 (1)
- AC Stark effect (1)
- ACC (1)
- ACC deaminase (1)
- ACC/AHA classification (1)
- ACE inhibitor (1)
- ACH-2 (1)
- ACID (1)
- ACKR4 (1)
- ACM (1)
- ACP5 (1)
- ACPC (1)
- ACR practice guidelines (1)
- AChE inhibitor (1)
- AD mouse modele (1)
- AD pathogenesis (1)
- AD-AID (1)
- AD5 mutation (1)
- ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS7) (1)
- ADAM10 (1)
- ADAM9 (1)
- ADAMTS (1)
- ADCC (1)
- ADHD patients (1)
- ADME analysis (1)
- ADP-ribosylation toxins (1)
- ADP-ribosyltransferases (1)
- AF-DX 116 (1)
- AFLP (1)
- AG(110) (1)
- AGP (1)
- AGT (1)
- AHRR (1)
- AICDA (1)
- AID-ΔE4a (1)
- AIE (1)
- AIME (1)
- AIModules (1)
- AIRWAYS ICPs (1)
- AKI (1)
- AKT-signaling (1)
- AKT1 (1)
- ALAN (1)
- ALI culture (1)
- ALK-1 (1)
- ALMT (1)
- ALOS (1)
- ALOS-2 (1)
- ALPH (1)
- ALPH1 (1)
- ALPL (1)
- ALS mimic (1)
- ALS treatment (1)
- ALSIN gene (1)
- ALT (1)
- ALiOS (1)
- AMP-activated kinases (1)
- ANOVA (1)
- ANTARES telescope (1)
- AOM/DSS (1)
- AP-1 (1)
- AP1 (1)
- APC (1)
- APERIO (1)
- APERIO Hybrid (1)
- APEX2 (1)
- API (1)
- APOBEC3G (1)
- APRI (1)
- AQP4 (1)
- ARCI (1)
- ARCI EM type III (1)
- ARDS (acute respiratory distress syndrome) (1)
- ARF (1)
- ARF tumor-suppressor induced lymphomagenes (1)
- ART outcome (1)
- ARVC (1)
- AS clavicle plate (1)
- ASAR (1)
- ASCAT (1)
- ASCs (1)
- ASE formula (1)
- AT/RT (1)
- ATF6 (1)
- ATG (1)
- ATG proteins (1)
- ATG12-ATG5 conjugate (1)
- ATG7 (1)
- ATG8 (1)
- ATLAS experiment (1)
- ATM (1)
- ATM gene (1)
- ATMP (1)
- ATP carrier (1)
- ATP generation (1)
- ATP synthase (1)
- ATP-DnaA complex (1)
- ATP-adenosine triphosphate (1)
- ATP-binding cassette transporter (1)
- ATPase activity (1)
- ATPase mutants (1)
- ATRX (1)
- ATTRv amyloidosis (1)
- AUX1 (1)
- AVA (1)
- AVHRR data (1)
- AYAs (1)
- AZD4547 (1)
- AZD6244 (1)
- A\(_{2A}\) adenosine receptor antagonist (1)
- Aaskäfer (1)
- Ab interno trabeculectomy (1)
- Abatacept (1)
- Abelson helper integration-1 (AHI1) (1)
- Ableitung (1)
- Abstandsmessung (1)
- Accelerator modelling and simulations (multi-particle dynamics; single-particle dynamics) (1)
- Accelerometry (1)
- Accidental coincidence (1)
- Accountability (1)
- Accumulative Femtosecond Spectroscopy (1)
- Accurate (1)
- Acene (1)
- Acer platanoides (1)
- Acetabularia (1)
- Acetylated tubulin (1)
- Achilles tendinopathy (1)
- Acids (1)
- Acinetobacter baumannii (1)
- Acipenser baerii (1)
- Acoustics (1)
- Acquisition of literacy (1)
- AcrAB-TolC efflux pump (1)
- Acromesomelic dysplasias (1)
- Acromyrmex ambiguus (1)
- Acromyrmex heyeri (1)
- Actin nucleation (1)
- Actinokineospora (1)
- Actinomycin D (1)
- Action feedback (1)
- Action potentials (1)
- Active disease (1)
- Acute Myocardial Infarction (1)
- Acute lymphoblastic leukemia (1)
- Acute myeloid leukemia (AML) (1)
- Acute osteomyelitis (1)
- Acute tryptophan depletion (1)
- AdS-CFT correspondence (1)
- Adamantiades-Behçet disease (1)
- Adaptation (1)
- Adaptive cell transfer (1)
- Addison's disease (1)
- Addisons disease (1)
- Adenocarcinomas (1)
- Adenosine receptor (1)
- Adenosine receptor antagonists (1)
- Adenosinrezeptor (1)
- Adenovirus (1)
- Adenylate cyclase toxin (1)
- Adherence (1)
- Adherens junction (1)
- Adhesion (1)
- Adhäsion (1)
- Adipokine (1)
- Adipositas (1)
- Adolescence (1)
- Adolescent (1)
- Adolescents (1)
- Adrenocortial carcinomas (1)
- Adrenocortical Carcinoma (1)
- Adult head (1)
- Adult patients (1)
- Adults (1)
- Advanced snowmelt (1)
- Affective processing (1)
- Afferent nerve stimulation (1)
- Afghanistan (1)
- Aflatoxin (1)
- Aflatoxin B1 (1)
- Africa south of the equator (1)
- African agriculture (1)
- African sleeping sickness (1)
- African trypanosome (1)
- African trypanosomes (1)
- African-americans (1)
- Ag(111) (1)
- Ag-DNA (1)
- Agalsidase beta therapy (1)
- Age (1)
- Ageing (1)
- Aggeneys (1)
- Aggression (1)
- Aggressive behaviour (1)
- Aging (1)
- Agoraphobia (1)
- Agricultural intensification (1)
- Agricultural soil science (1)
- Agro-ecology (1)
- Agrobacterium (1)
- Ahmed (1)
- Akt/PKB (1)
- Akutes Nierenversagen (1)
- Albino rat (1)
- Alcohol dependence (1)
- Aldehyde Bioconjugation (1)
- Aldehyde Complexes (1)
- AldoA (1)
- Alemtuzumab (1)
- Alento hydrological observatory (1)
- Alien limb syndrome (1)
- Alkaline phosphatase (1)
- Alkekengi (1)
- Alkohol (1)
- Alkyl(amino)carbene (1)
- Alkylation (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Alkyne (1)
- Allelic loss (1)
- Allergic rhinitis (1)
- Allergie (1)
- Allergy (1)
- Allogeneic transplantation (1)
- Allophrynidae (1)
- Allorhizobium vitis (1)
- Allotransplantation (1)
- Alpelisib (1)
- Alpen (1)
- Alpha galactosidase (1)
- Alpha therapy (1)
- Alpha-Galactosidase (1)
- Alpha-dependent apoptosis (1)
- Alpha-galactosidase (1)
- Alpha-synuclein oligomers (1)
- Alpine habitats (1)
- Altenpflege (1)
- Alternaria (1)
- Alternative test methods (1)
- Aluminium-copper (1)
- Alvis (1)
- Alzheimer's diseas (1)
- Alzheimer-Krankheit (1)
- Alzheimers-disease (1)
- Alzheimer’s dementia (1)
- Alzheimer′s disease (1)
- AmGr1 (1)
- AmGr2 (1)
- AmGr3 (1)
- Amantadine (1)
- Amazon Molly (1)
- Amazonia (1)
- Amazonian forest (1)
- American Thyroid Association (1)
- American foulbrood (1)
- Amino acid composition (1)
- Aminosäuren (1)
- Ampfer (1)
- Amphibia (1)
- Amphibians (1)
- Amplitude (1)
- Amu Darya (1)
- Amygdala (1)
- Amyloid-beta oligomers; (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Amyotrophic-lateral-sclerosis (1)
- Anabolieagent (1)
- Analgesia (1)
- Analytical Quality by Design (1)
- Anaphylactic shock (1)
- Anarchic limb syndrome (1)
- Anas crecca (1)
- Anatomic reattachment (1)
- Anchimeric assistance in solvolysis (1)
- Ancistrocladus ealaensis (1)
- Ancistrocladus likoko (1)
- Andalusian varieties (1)
- Anderson-Fabry Disease (1)
- Aneuploidy (1)
- Angiopoietin-2 (1)
- Angiopoietin-like 4 (1)
- Angiosperms ; Ant-plant interactions ; domatia ; Flora of Malaysia (1)
- Angola (1)
- Angst (1)
- Aniline derivatives (1)
- Animal Tracking (1)
- Animal behavior (1)
- Animal studies (1)
- Ankyrin (1)
- Anomalous magnetic-moment (1)
- Anoplolepis gracilipes (1)
- Anorexia nervosa (1)
- Ant-following birds (1)
- Ant-plant interactions (1)
- Ant-plant interactions ; Herbivory Macaranga ; Mutualism ; Myrmecophytes (1)
- Ant/plant interaction (1)
- Anterior chamber perfusion model (1)
- Anterior inferotemporal cortex (1)
- Anthraquinone glycosides (1)
- Anti-TNF-alpha agents (1)
- Anti-tank rocket (1)
- Anti-tank weapon (1)
- Antibacterial therapy (1)
- Antibacterials (1)
- Antibiotic resistance (1)
- Antibiotics (1)
- Antibodies (1)
- Antibody index (1)
- Anticoagulants (1)
- Antidepressants (1)
- Antigen 4 (1)
- Antioxidants (1)
- Antiparanodal Autoantibodies (1)
- Antisense (1)
- Antisocial behavior (1)
- Antiviral nucleoside analogues (1)
- Anxiety sensitivity (1)
- Anxiety-like behavior (1)
- Anxiolysis (1)
- Any Evil (1)
- Anästhesiologie (1)
- Aorta (1)
- Aortic arch (1)
- ApaH (1)
- ApaH like phosphatase (1)
- Aphthae (1)
- Apicomplexan (1)
- Apidae (1)
- Apis dorsata (1)
- Aplastic anemia (1)
- ApoE\(^{(-/-)}\) (1)
- Apple Watch 7 (1)
- Applied physics (1)
- Aquaporin-4 antibodies (AQP4-Ig, NMO-IgG)G (1)
- Aquaporin-4 antibodies (AQP4-IgG) (1)
- Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) (1)
- Aqueous Solution Photochemistry (1)
- Arabidopsis-thaliana (1)
- Araneidae (1)
- Araneus diadematus (1)
- ArcCHECK (1)
- Archaea (1)
- Archaeology (1)
- Arctic (1)
- Arena experiment (1)
- Argentina (1)
- Arginine (1)
- Argonaute (1)
- Aromatic-hydrocarbon (1)
- Aromaticity (1)
- Arp2/3 complex (1)
- Arrhenius equation (1)
- Arterial Diameters (1)
- Arterial water (1)
- Arterioles (submucosal) (1)
- Arthrography (1)
- Arthroleptis amphibia (1)
- Arthropod (1)
- Arthropods (1)
- Arthur Hailey (1)
- Articular afferent (1)
- Articular-Cartilage (1)
- Artificial Nuclear Pores (1)
- Aryl hydrocarbon rnonooxygenase (1)
- Arylborylene Complexes (1)
- Asc-1 transporter (1)
- Ascaris lumbricoides (1)
- Aseptic loosening (1)
- Asia (1)
- Asian Englishes (1)
- Aspartate Aminotransferases (1)
- Aspergillus fumigalus (1)
- Aspergillus medium (1)
- Aspergillus niger (1)
- Aspergillus sp. (1)
- Assay (1)
- Assemblages (1)
- Association study (1)
- Associative learning (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Astrocytic tumor (1)
- Astrophysical neutrino sources (1)
- Asymmetrie (1)
- Atacama (1)
- Ataxia (1)
- Atharvaveda (1)
- Atherosclerosis (1)
- Atherosclerosis, intracranial arteries (1)
- Atherosclerotic plaque (1)
- Atmospheric muons (1)
- Atomic force microscopy (1)
- Atria (1)
- Atrial fibrillation (1)
- Atrial natriuretic peptide (1)
- Attention (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention-deficit/hyperactivity disorder (1)
- Attentional performance (1)
- Attitude (1)
- Attitude Heading Reference System (AHRS) (1)
- Au/Ge(111) (1)
- Auditory pathway (1)
- Auditory targets (1)
- Augenkrankheit (1)
- Aulonocara (1)
- Aureobasidium (1)
- AurisID (1)
- Australian stingless bees (1)
- Autism (1)
- Auto-antibodies (1)
- Autoimmune diseases (1)
- Autoimmune-Diseases (1)
- Autoinflammation (1)
- Autologous (1)
- Automated analysis (1)
- Automatization (1)
- AuxRE (1)
- Auxin-regulated transcription (1)
- Available soil water capacity (1)
- Aversive events (1)
- Aversive tension (1)
- Aviophobia (1)
- Avirulent Salmonella (1)
- Avoidance behavior (1)
- Axl tyrosine kinase (1)
- Axon growth (1)
- Axon guidance (1)
- Axonal transport (1)
- Azathioprine (1)
- Aziridines (1)
- Aššur (1)
- Aδ- and C-fibers (1)
- B (1)
- B 37 CAG repeat locus (1)
- B cell culture (1)
- B cell deficiency (1)
- B cell malignancies (1)
- B cell maturation (1)
- B cell receptor (1)
- B cell receptor (BCR) (1)
- B neisseria meningitidis (1)
- B physics (1)
- B,N-heterocycles (1)
- B,N-heterocylcles (1)
- B-0 (1)
- B-B bond (1)
- B-B bond activation (1)
- B-MYB (1)
- B-cell (1)
- B-lymphocytes (1)
- B-tagged jet (1)
- B4GALT7 gene (1)
- B7-H1 Antigen (1)
- BAL (1)
- BARF-mutated melanoma (1)
- BB/OKL rats (1)
- BBC3 (1)
- BCL-X-L P53 (1)
- BCOR (1)
- BCORL1 (1)
- BCR-ABL (1)
- BCR‐ABL (1)
- BDNF Val66Met (1)
- BDNF stimulation (1)
- BET Inhibitor (1)
- BETA(2)-adrenergic receptor (1)
- BH3 domains (1)
- BH3-only proteins (1)
- BIRC7 (1)
- BK channel (1)
- BK virus (1)
- BM (1)
- BMI (1)
- BMP antagonist (1)
- BMP signaling (1)
- BMP-2 delivery (1)
- BMP-6 (1)
- BMPR1B (1)
- BN 52021 (1)
- BNIP3 (1)
- BON-1 (1)
- BP180 (1)
- BPD (1)
- BPM (1)
- BPMN (1)
- BRAF mutations (1)
- BRAF(V600E) mutation (1)
- BRCA1 positive (1)
- BRCA1/2 (1)
- BRCA1/2 negative (1)
- BRCA2 positive (1)
- BRD4 (1)
- BRIP1 gene (1)
- BRM (1)
- BRN-3A (1)
- BSA (1)
- BSM Higgs boson (1)
- BSS directive (1)
- BSTA (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- BT_1884 (1)
- BV-2 (1)
- BaPb\(_{1-X}\)Bi\(_{X}\)O\(_{3}\) (1)
- Babylon (1)
- BacT/ALERT (1)
- Bacillus megaterium (1)
- Bacillus subtilis (1)
- Bacillus-Calmette-Guerin (1)
- Bacillus-subtilis (1)
- Background Epithelioid haemangioma (1)
- Bacteria (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial meningitis (1)
- Bacterial symbionts (1)
- Bacteriaophage AR9 (1)
- Baerveldt (1)
- Baja California [(PNN) Mexico] (1)
- Bakterien (1)
- Balints-Syndrome (1)
- Ballistics (1)
- Baltic Sea (1)
- Barbed suture (1)
- Barbed suture material (1)
- Barbiturates (1)
- Barcodes (1)
- Barium-133 (1)
- Barkhof criteria (1)
- Barratt Impulsiveness Scale (1)
- Barrett-Ösophagus (1)
- Barrier (1)
- Bartak (1)
- Barthel-Index (1)
- Base composition (1)
- Basophil activation test (1)
- Batf3 (1)
- Bavarian Forest (1)
- BayPass (1)
- Bayesian approach (1)
- Bayesian inverse problems (1)
- Bayesian methods (1)
- Bcl-2 proteins (1)
- Beauveria bassiana (1)
- Becker naevus (1)
- Becker naevus syndrome (1)
- Bee abundance (1)
- Beer-lambert law (1)
- Behavior (1)
- Behavioural ecology (1)
- Behçet’s disease (1)
- Bembix (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Benzene (1)
- Benzimidazole (1)
- Benzimidazoles (1)
- Benzo(a)pyrene-DNA binding (1)
- Benzyne (1)
- Berberine (1)
- Berchtesgaden (1)
- Berchtesgaden NP (1)
- Berenil (1)
- Berger-Parker (1)
- Bernstein-type inequality (1)
- Berry phase (1)
- Beryllium (1)
- Bessle functions (1)
- Beta(1)-adrenergic receptor (1)
- Beta(2)-adrenergic receptor (1)
- Beta-blocker (1)
- Beta-catenin (1)
- Beta-glucocerebrosidase (1)
- Bethe–Salpeter equation (1)
- Bewegungsfixateur (1)
- Bhabha Scattering (1)
- Bi-Fidelity method (1)
- Bialowieza (1)
- Bias (1)
- Biased gene conversion (1)
- Bicyclo[1.1.0]butylcarbinyl sulfonates (1)
- Bienenverhalten (1)
- Big picture (1)
- Bilma <Region> (1)
- Bindungsaktivierung (1)
- Binge drinking (1)
- BioID (1)
- BioVaSc (1)
- Biochemical-Diagnosis (1)
- Biochemistry (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Biodiversity (1)
- Biogenic (1)
- Biohazard (1)
- Biological identifications (1)
- Bioluminescence (1)
- Bioluminescence imaging (1)
- Biomarke (1)
- Biomechanical Properties (1)
- Bioorganosilicon chemistry (1)
- Bioorthogonal Tag (1)
- Biophysics (1)
- Biopsy (1)
- Bioreaktor (1)
- Biostratigraphy (1)
- Biowissenschaften (1)
- Biradicals (1)
- Biradikale (1)
- Birds (1)
- Bismuth (1)
- Bisphosphonates (1)
- Bistability (1)
- Black Holes in String Theory (1)
- Black Scholes equation (1)
- Black-hole (1)
- Bland–Altman (1)
- Blattschneiderameisen (1)
- Blepharoplastik (1)
- Bloch oscillations (1)
- Blood (1)
- Blood pressure (1)
- Blood stream infection (1)
- Blood-brain-barrier (1)
- Blood–brain barrier (1)
- Bloom setting (1)
- Blue Spot Analysis (1)
- Blut (1)
- Blut-Hirn-Schranke (1)
- Blutdruck (1)
- Bocas-del-Toro (1)
- Bodenwasser (1)
- Body composition (1)
- Body schema (1)
- Body size (1)
- Bombesin ; Bombesin receptor ; Chromosomal localization (1)
- Bombus (1)
- Bombus Spp. Hymenoptera (1)
- Bombus terrestris (1)
- Bone Mineral Density (1)
- Bone chips (1)
- Bone disease (1)
- Bone graft (1)
- Bone health (1)
- Bone marrow cells (1)
- Bone marrow transplantantation (1)
- Bone regeneration (1)
- Bone tissue engineering (1)
- Bone tumor (1)
- Boolean function (1)
- Boolean tree (1)
- Bootstrap (1)
- Boranes (1)
- Bordeiella pertussis (1)
- Borylation (1)
- Borylene (1)
- Bose gas (1)
- Bose-Einstein Correlations (1)
- Bose-Einstein condensation (1)
- Bose-Fermi (1)
- Bottom-up (1)
- Bound-states (1)
- Bovis (1)
- Bowen’s disease, periungual (1)
- Braak (1)
- Bradyrhizobium (1)
- Bragg-reflection waveguide (1)
- Brahma (1)
- Brain Computer Interface (1)
- Brain atrophy (1)
- Brain cancer (1)
- Brain diseases (1)
- Brain edema (1)
- Brain endothelial cells (1)
- Brain ischemia (1)
- Brain mappins (1)
- Brain stem (1)
- Brain μ-opioid receptors (1)
- Brain-Computer Interface (BCI) (1)
- Brain-computer interface (1)
- Brain-derived neurotrophic factor (1)
- Brainstem encephalitis (1)
- Brain–computer interfaces (BCI) (1)
- Branching fractions (1)
- Brassicaceae (1)
- Brassicogethes spp. (1)
- Brazil (1)
- BrdU replication banding pattern (1)
- BrdU-Hoechst (1)
- BrdU/dT replication banding (1)
- Breast cancer (1)
- Breast cancer cells (1)
- Breath tests (1)
- Breathing (1)
- Breeding system (1)
- Breg (1)
- Broca (1)
- Brockett (1)
- Broken Hill (1)
- Brombeere (1)
- Bromodeoxyuridine labeling (1)
- Bronchopulmonary dysplasia (1)
- Brownian ratchet (1)
- Brownsche Bewegung (1)
- Brucei (1)
- Brugia Malayi (1)
- Brushite (1)
- Bruton Tyrosine Kinase (1)
- Bruton's tyrosine kinase inhibitor CC-292 (1)
- Bryophyta (1)
- Buche (1)
- Bull-Headed Demon (1)
- Bullous pemphigoid (1)
- Bumblebee (1)
- Bunnell (1)
- Buntbarsche (1)
- Burkholderia pseudomallei Mip (1)
- Burkitt lymphoma (1)
- Burkitt lymphoma (BL) (1)
- Burma (1)
- Burmese Days (1)
- Business Process Models (1)
- Butadien (1)
- By-Light Scattering (1)
- B‐cell lymphoma (1)
- B−H activation (1)
- C virus (1)
- C(-1019)G polymorphism (1)
- C-11-methionine pet (1)
- C-13 NMR (1)
- C-13-metabolic flux analysis (1)
- C-6-H (1)
- C-60 fullerene (1)
- C-C coupling (1)
- C-H activation (1)
- C-IAP1 (1)
- C-MYC PUMA (1)
- C-Myc (1)
- C-Terminus (1)
- C-elegans (1)
- C-tactile fibers (1)
- C-terminal HSP90 inhibitors (1)
- C-terminal domain (1)
- C.376A>G (p.S126G) (1)
- C1-inhibitor (1)
- C1q/TNF related protein (CTRP) (1)
- C2-toxin (1)
- C3 (1)
- C3a (1)
- C3aR (1)
- C57BL/KALWRIJ mouse (1)
- C5aR2 (1)
- C6 (1)
- C60 fullerene (1)
- C9orf72 (1)
- CA2+ channels (1)
- CA3 (1)
- CA3 pyrimidal cells (1)
- CA4 (1)
- CAD (1)
- CAD detection (1)
- CAGSSS (1)
- CAM (1)
- CAPA (1)
- CAPS (1)
- CAR T (1)
- CAR T-cell (1)
- CAR-T cells (1)
- CAR-T-cell (1)
- CARAT (1)
- CASP (1)
- CASPASE-3 (1)
- CB1 receptor antagonists (1)
- CBF (1)
- CBT (1)
- CCAP (1)
- CCD (1)
- CCD, charge-coupled device (1)
- CCDC79 (1)
- CCHamide1 (1)
- CCI (1)
- CCL2 (MCP-1) (1)
- CCL3 (1)
- CCL5 (1)
- CCN1 (1)
- CCN2 (1)
- CCR4 (1)
- CCR7 (1)
- CCS (1)
- CCl\(_4\) (1)
- CD coreceptors (1)
- CD/metabolism (1)
- CD10 (1)
- CD105 (1)
- CD105 antigen (1)
- CD11b+ myeloid cells (1)
- CD133 (1)
- CD147 (1)
- CD19 (1)
- CD20 (1)
- CD23 (1)
- CD27 (1)
- CD28 costimulation (1)
- CD28 superagonists (1)
- CD2AP (1)
- CD3/19 depletion (1)
- CD319 (1)
- CD34 antigen (1)
- CD34 selection (1)
- CD38 (1)
- CD4 (1)
- CD4 T cells (1)
- CD4(+)CD25(+) (1)
- CD4+ T cells (1)
- CD4+ T-cells (1)
- CD4+T cells (1)
- CD40 ligand (1)
- CD44 (1)
- CD46 (1)
- CD4\(^{+}\) T cells (1)
- CD4\(^{+}\) T helper cells (1)
- CD52 (1)
- CD56 (1)
- CD62L (1)
- CD70 (1)
- CD74 (1)
- CD8 T cell (1)
- CD8(+) (1)
- CD8+T cells (1)
- CD8\(^+\) T cells (1)
- CDC14A (1)
- CDH13 (1)
- CDH13 Expression (1)
- CDH13 mRNA (1)
- CDL (1)
- CDR3 sequences (1)
- CEA (1)
- CEACAM1 (1)
- CEF (1)
- CENP-A (1)
- CERN (1)
- CERN LHC Coll (1)
- CETCH cycle (1)
- CGG repeat (1)
- CHAC1 (1)
- CHIP (1)
- CHRODIS (1)
- CIAP1 (1)
- CIB1 (1)
- CIDP (1)
- CIED malfunction; pacemaker (PM) (1)
- CIN (1)
- CIP2A (1)
- CIR aerial imagery (1)
- CIS+ (1)
- CIT (1)
- CK5 (1)
- CKD (1)
- CLAVATA3 (1)
- CLEC-2 ITAM (1)
- CLIP (1)
- CLIP-seq (1)
- CLL (1)
- CLN3 (1)
- CLRN2 (1)
- CLV3p (1)
- CMSSM Point (1)
- CMV reactivation (1)
- CMV-specific cellular immunity (1)
- CNG channel (1)
- CNS Myelination (1)
- CNS diseases (1)
- CNS imaging (1)
- CNS infection (1)
- CNS injury (1)
- CNS integrity (1)
- CNVs (1)
- CO sensing (1)
- CO2 (1)
- CO2 gas exchange (1)
- CO2-sequestration (1)
- COD movements (1)
- COH29 (1)
- COI (1)
- COMPLEX 1 (1)
- COMT VAL(158)MET polymorphism (1)
- COPD diagnosis (1)
- CORONATINE INSENSITIVE 1 (1)
- COS cell expression (1)
- COU254 (1)
- COVID 19 (1)
- COVID-19 testing (1)
- COVID‐19 vaccination (1)
- COX-2 (1)
- COX2 expression (1)
- CO\(_{2}\) exposure (1)
- CO\(_{2}\) signaling (1)
- CO‐releasing molecules (CORMs) (1)
- CP-690,550 (1)
- CPAF activation (1)
- CPF (1)
- CPFE (1)
- CPG Island (1)
- CPG binding domain (1)
- CRAC (1)
- CRH stimulation test (1)
- CRH1 (1)
- CRISPR (1)
- CRISPR Cas9 (1)
- CRISPR-Cas Systems (1)
- CRISPR-Cas system (1)
- CRISPR-Cas systems (1)
- CRISPR-Cas9 (1)
- CRISPRs (1)
- CRKL (1)
- CRLs (1)
- CRM (1)
- CRPS (1)
- CRY evolution (1)
- CS1 (1)
- CSE4, CENP-A (1)
- CSI (1)
- CT perfusion (1)
- CT, circadian time (1)
- CT-angiography (1)
- CTCAE (1)
- CTGF (1)
- CTLA-4 Antigen (1)
- CTNNB1 (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- CX3CL1 (1)
- CX5461 (1)
- CXCL10 (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- CXCL13 (1)
- CXCL4 (1)
- CXCL5 (1)
- CXCL7 (1)
- CXCL8 (1)
- CXCL8 (IL-8) (1)
- CXCR2 (1)
- CXCR4-targeting (1)
- CXCR4/SDF-1 (1)
- CXCR7 (1)
- CXorf44 (1)
- CYP induction (1)
- CYP inhibition (1)
- CYP11B enzymes (1)
- CYP1B1 (1)
- CYP24A1 (1)
- CYP2B6 (1)
- CYP2C9 (1)
- CYP3A4 (1)
- CYR61 (1)
- C\(_{60}\) fullerene (1)
- Ca cycling (1)
- Ca2+ (1)
- Ca2+ homeostasis (1)
- Ca2+ ion analysis (1)
- Ca2+ leak (1)
- Ca2+ oscillation (1)
- Ca2+ release activated Ca2+ channel (1)
- Ca2+i handling (1)
- CaMKII (1)
- Ca\(^{2+}\) channels (1)
- Ca\(^{2+}\) indicator (1)
- Ca\(^{2+}\)-Imaging (1)
- Ca\(_{v}\)2.2 (1)
- Cabozantinib (1)
- Caco-2 (1)
- Cadherin (CDH13) (1)
- Cadherin-13 (CDH13) (1)
- Caenorhabditis elegans (C. elegans) (1)
- Calcineurin-NFATsignaling (1)
- Calcium (1)
- Calcium Citrate (1)
- Callyspongia siphonella (1)
- Calu-3 (1)
- Canada (1)
- Canaloplasty (1)
- Cancellous bone (1)
- Cancer Cell (1)
- Cancer models (1)
- Cancer prevention (1)
- Cancer risk factors (1)
- Cancer therapeutic resistance (1)
- Candida lusitaniae (1)
- Candida sp. (1)
- Candidate Phylum Poribacteria (1)
- Canis lupus familiaris (1)
- Capicua transcriptional repressor (1)
- Capillaries (1)
- Capsaicin (1)
- Capsaicin receptor (1)
- Caputo fractional derivative (1)
- CarO (1)
- Carabidae (1)
- Carbachol-induced drinking (1)
- Carbene (1)
- Carbon (1)
- Carbon Metabolism (1)
- Carbon Monoxide (1)
- Carbon-11 (1)
- Carcinogen risk Individual susceptibili (1)
- Carcinogenic potency (1)
- Carcinoma (1)
- Carcinoma cells (1)
- Carcinomatosis (1)
- Cardiac autonomic regulation (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cardiac magnetic resonance imaging (1)
- Cardiac myocyte ; Beta-Receptor ; Muscarinic receptor ; cAMP ; G-protein ; Serum (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy defibrillator (1)
- Cardiac ventricles (1)
- CardioMEMS™ HF system (1)
- CardioMEMS™ HF-System (1)
- Cardiology (1)
- Cardiomyopathy (1)
- Cardiovascular (1)
- Cardiovascular Magnetic Resonance (1)
- Cardiovascular biology (1)
- Cardiovascular hospitalizations (1)
- Cardiovascular magnetic-resonance (1)
- Cardiovascular risk prediction (1)
- Cardiovascular system (1)
- Care-Arbeit (1)
- Career choice (1)
- Carleson embedding theorem (1)
- Carotid intima-media thickness (CIMT) (1)
- Carotid segment (1)
- Carotid ultrasound (1)
- Carpinus betulus (1)
- Cartilage (1)
- Cartilage regeneration (1)
- Cas9 (1)
- Case report (1)
- Case-Control Studies (1)
- Caspase (1)
- Caspase 3/7 activity (1)
- Caspase-8 activation (1)
- Cataglyphis (1)
- Cataglyphis-fortis (1)
- Catechine (1)
- Catheter Lock Solution (1)
- Catheter-related Bloodstream Infections (CRBSI) (1)
- Cauchy-Born rule (1)
- Caudate nucleus (1)
- Cav2.2 (1)
- Cavity quantum electrodynamics (1)
- Cayley graph (1)
- Cdc48 (1)
- Cdu1 (1)
- Cecropia telenitida (1)
- Celebrity Autobiography (1)
- Cell (1)
- Cell Index (1)
- Cell Motility (1)
- Cell binding (1)
- Cell death and comet assay (1)
- Cell lung canger (1)
- Cell permeability (1)
- Cell replacement therapy (1)
- Cell reprogramming (1)
- Cell signalling (1)
- Cell stainin (1)
- Cell surface (1)
- Cell surface proteomics (1)
- Cell transformation (1)
- Cell viability, (1)
- Cell-based assays (1)
- Cell-line (1)
- Cellular imaging (1)
- Cellular prion protein (1)
- Central complex (1)
- Central hyperactivity (1)
- Central nervous system infection (1)
- Central venous access (1)
- Central venous-pressure (1)
- Centrolenidae (1)
- Ceramide (1)
- Cerebellar nuclei (1)
- Cerebellitis (1)
- Cerebral Ischemia (1)
- Cerebral blood flow (1)
- Cerebral small vessel disease (1)
- Cerebral vasospasm (1)
- Cerebral-ischemia (1)
- Cerebrolysin (1)
- Cervical cancer (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- ChAT (1)
- ChIP-seq (1)
- ChIP-sequencing (1)
- ChIPseq (1)
- ChT1 (1)
- Chagas diagnosis (1)
- Chagas monitoring (1)
- Chagas real time PCR (1)
- Chains (1)
- Chambers (1)
- Channelrhodopsin-2 (1)
- Characterization and analytical techniques (1)
- Charcot-Marie-Tooth disease (1)
- Charcot-Marie-Tooth neuropathy 1A (1)
- Charcot–Marie–Tooth disease (1)
- Charcot–Marie–Tooth disease type 1A (1)
- Charged Scalar Field (1)
- Charged aerosol detector (CAD) (1)
- Charged-Particles (1)
- Charm quark (1)
- Charmonia (1)
- Checkpoints (1)
- Chemerin (1)
- Chemerin processing (1)
- Chemical carcinogenesis (1)
- Chemical composition (1)
- Chemical modification (1)
- Chemical nature (1)
- Chemicals (1)
- Chemische Ökologie (1)
- Chemistry (1)
- Chemosensory neurons (1)
- Chemotactic receptors (1)
- Chemotaxis (1)
- Cherenkov detectors (1)
- Cherenkov underwater neutrino telescope (1)
- Chernobyl (1)
- Childhood cancer survivors (1)
- Children-at-Risk (1)
- Childrens-cancer (1)
- Chile (1)
- Chimeric Antigen Receptor T cells (1)
- Chinese family (1)
- Chinese politics (1)
- Chinese state media (1)
- Chl (1)
- ChlaDUB1 (1)
- Chlamydia pneumoniae (1)
- Chlamydiales (1)
- Chlamydomonas reinhardtii (1)
- Chlorophyll fluorescence (1)
- Choice Behavior/physiology (1)
- Choline deficiency (1)
- CholinomiRs (1)
- Chondrogenesis (1)
- Chondrosarcoma (1)
- Chorioamnionitis (1)
- Christianity (1)
- Chromatin and Epigenetics (1)
- Chromatin-remodeling complexes (1)
- Chromophore Assembly (1)
- Chromophores (1)
- Chromosomal instability (1)
- Chromosome aberration (1)
- Chromosome distribution (1)
- Chromosomes (1)
- Chronic Kidney-disease (1)
- Chronic disease (1)
- Chronic heart-failure (1)
- Chronic kidney-disease (1)
- Chronic lymphoblastic leukemia (1)
- Chronic myeloid leukaemia (1)
- Chronic myeloid leukemia (1)
- Chronic neuropathic pain (1)
- Chronic obstrusive pulmonary disease (1)
- Chronic respiratory diseases (1)
- Chronic rhino‑sinusitis (1)
- Chronic stress (1)
- Chrysididae (1)
- Cigarette smoking (1)
- Cimex lectularius (1)
- Circadian rhythms and sleep (1)
- Circinella (1)
- Cis-elements (1)
- Cisterna magna (1)
- Citrus (1)
- Class II antigen blockade (1)
- Claudin2 (1)
- Clay mineralogy (1)
- ClearSight\(^®\) (1)
- Clever Hans Phenomenon (1)
- Climate Change (1)
- Climatic water balance (1)
- Clinical Genetics (1)
- Clinical manifestations (1)
- Clinical practice guidelines (1)
- Clinical prediction rule (1)
- Clinical proteomics (1)
- Clinical remission (1)
- Clinical trials (1)
- Clinical-trials (1)
- Clinically silent stroke (1)
- Clonality (1)
- Clostridioides binary toxins (1)
- Cluster-RCT (1)
- Co (1)
- Co-Crystal Structures of Chili RNA (1)
- Co-option (1)
- CoA (1)
- CoPt (1)
- Coagulation factor IX (1)
- Coahuila (1)
- Cobl domain (1)
- Cocalodinae (1)
- Cochlear duct length (1)
- Cochlear planning software (1)
- Coefficient (1)
- Coffin-Lowry syndrome (1)
- Coffin–Lowry syndrome (1)
- Cognitive (1)
- Cognitive Remediation (1)
- Cognitive Therapy (1)
- Cognitive behavior (1)
- Cognitive control (1)
- Cognitive decline (1)
- Cognitive neuroscience (1)
- Cognitive representation (1)
- Cohort study (1)
- Cold (1)
- Cold War (1)
- Coleoptera: Chrysomelidae (1)
- Collaboration (1)
- Collagen (1)
- Collagen membrane (1)
- Collective effects in quantum optics (1)
- Collicions (1)
- Colloids (1)
- Colonial volvocales chlorophyta (1)
- Colony growth (1)
- Color (1)
- Combination therapy (1)
- Combinatorial Background (1)
- Commercial preparations (1)
- Community ecology (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- Comorbidities (1)
- Comorbidity survey replication (1)
- Complex (1)
- Complex medium (1)
- Complexity (1)
- Components (1)
- Compound 3k (1)
- Compressive Properties (1)
- Computational and Systems Biology (1)
- Computed axial tomography (1)
- Computer modelling (1)
- Computer science (1)
- Computer software (1)
- Computertomographie (1)
- Concealed Information Test (CIT) (1)
- Condensed matter (1)
- Conditioning evidence (1)
- Conditioning regimen (1)
- Conduct disorder (1)
- Cone-beam CT (1)
- Cone-beam computed tomography (1)
- Confidence interval (1)
- Confocal microscopy (1)
- Conformal Field Theory (1)
- Confucianism; East Asia; Traditional Values (1)
- Congo Basin (1)
- Conifers (1)
- Conjugate arc therapy (1)
- Conjugated polymers (1)
- Connective tissue (1)
- Conrad Hilton (1)
- Contaminants (1)
- Context (1)
- Contextual fear (1)
- Contrast-enhanced CT (1)
- Cooperative UAV (1)
- Coordinated Regional Climate Downscaling Experiment (CORDEX)-South Asia (1)
- Copal\(^®\) spacem (1)
- Copaxone® (1)
- Copeptin (1)
- Coptic (1)
- Copy number changes (1)
- Copy number variation (1)
- Corannulene (1)
- Coreidae (1)
- Corneal confocal microscopy (1)
- Coronary artery bypass graft (1)
- Coronary artery disease (1)
- Coronavirus Disease 2019 (1)
- Correlates (1)
- Cortex (1)
- Cortical plasticity (1)
- Corticobasal syndrome (1)
- Corticosteroids (1)
- Corynebacterium urealyticum (1)
- Cosmic-rays (1)
- Cotransporter 2 inhibition (1)
- Couch tracking (1)
- Coulomb interaction (1)
- Coumarin (1)
- Couplings (1)
- Covalent DNA binding (1)
- Covalent binding (1)
- Covalent binding index - Diethylstilbestrol (1)
- Coverage (1)
- Covid19 (1)
- Covid‐19 (1)
- Cox proportional regression analysis (1)
- CpG (1)
- CpG island hypermethylation (1)
- Cranial sutures (1)
- Cranial window (1)
- CreERT2 (1)
- Creatine Kinase (1)
- Crematogaster borneensis (1)
- Crespi effect (1)
- Critically-ill patients (1)
- Crohn disease (1)
- Crohns-disease (1)
- Crohn’s Disease (1)
- Crop seed (1)
- Cross-bridges (1)
- Cross-species analyses (1)
- CrossQuery (1)
- Cruzi (1)
- Cryoelectron Microscopy (1)
- Cryoelectron microscopy (1)
- Cryolesion (1)
- Cryptic species (1)
- Crystalloids (1)
- CsrA (1)
- CubeSat GNSS (1)
- Cultural studies (1)
- Cumulative incidence function (1)
- Curculionidae (1)
- Cuscuta (1)
- Cushing (1)
- Cushing syndrome (1)
- Cushing's (1)
- Cushing's disease (1)
- Cushings syndrome (1)
- Cutaneous hyperemia (1)
- Cutaneous leishmaniasis (1)
- Cutaneous lymphoma (1)
- Cutaneous metastatic Crohn’s disease (1)
- Cvi-0 (1)
- Cx3cr1 (1)
- Cx43 (1)
- CyaA (1)
- Cyclic AMP (1)
- Cyclic GMP (1)
- Cyclic electron transport (1)
- Cyclic nucleotides (1)
- Cyclization (1)
- Cycloaddition (1)
- Cyclobutylcarbinyl sulfonates (1)
- Cyclooxygenase-2 (1)
- Cyclophilin A (1)
- Cyclophosphamide (1)
- Cynoglossus semilaevis (1)
- CysLTR1 (1)
- Cysteine: motif (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cystic-fibriosis (1)
- Cytochrome P 450 pathway (1)
- Cytochrome b5 (1)
- Cytokine GM-CSF (1)
- Cytokine receptors (1)
- Cytoskeleton (1)
- Cytosol (1)
- Cytotoxic (1)
- Cytotoxic T lymphocytes (1)
- Côte d’Ivoire (1)
- D insufficiency (1)
- D serum-levels (1)
- D-amino acid oxidase activator (1)
- D-norm (1)
- D2 receptors (1)
- D313Y genotype (1)
- D4Z4 partial deletion (1)
- D665 (1)
- DAMGO (1)
- DARPA (1)
- DAS28 (1)
- DASA-58 (1)
- DASH (1)
- DAT (1)
- DBH (1)
- DBS biomarkers (1)
- DBS programming (1)
- DBT (1)
- DC gate (1)
- DC vaccination (1)
- DCGAN (1)
- DCM genetic background (1)
- DD, constant darkness (1)
- DECAY (1)
- DEL(5Q) (1)
- DEM (1)
- DES (1)
- DETC (1)
- DEUQUA (1)
- DExD/H-Box RNA helicase (1)
- DFNB32 (1)
- DFNB68 (1)
- DFT+U (1)
- DFT-LDA (1)
- DIA-MS (1)
- DIMBOA (1)
- DIRK method (1)
- DInSAR (1)
- DLS and AFM measurements (1)
- DLX5/6 (1)
- DM2 (1)
- DMARD (1)
- DMRT1 (1)
- DNA Binding (1)
- DNA Breaks (1)
- DNA Damage Repair (1)
- DNA adduct . Repair endonuclease (1)
- DNA barcodes (1)
- DNA binching (1)
- DNA catalysis (1)
- DNA complex (1)
- DNA damage repair (1)
- DNA damage response (1)
- DNA double strand breaks (1)
- DNA double-strand break (1)
- DNA electronic transport (1)
- DNA electrophoresis (1)
- DNA fingerprinting (1)
- DNA fragments (1)
- DNA glycosation (1)
- DNA hybridization (1)
- DNA hypermethylation (1)
- DNA immunolocalization (1)
- DNA lang range mapping (1)
- DNA mediated gene transfer (1)
- DNA metabarcoding (1)
- DNA metabolism (1)
- DNA methylation dynamics (1)
- DNA methylferase homolog (1)
- DNA methyltransferase gene (1)
- DNA methyltransferases (1)
- DNA nanotechnology (1)
- DNA origami (1)
- DNA recognition (1)
- DNA recombination (1)
- DNA repair defect (1)
- DNA repair protraction (1)
- DNA repeat expansion (1)
- DNA replication initiation (1)
- DNA sensing (1)
- DNA sequence (1)
- DNA sequences (1)
- DNA structures (1)
- DNA transfection (1)
- DNA traps (1)
- DNA vaccination (1)
- DNA weight (1)
- DNA-Repair (1)
- DNA-based species delimitation (1)
- DNA-binding (1)
- DNA-binding domain (1)
- DNA-binding vesicles (1)
- DNA-damage checkpoint (1)
- DNA-encapsulated silver nanoclusters (1)
- DNA-encoded library synthesis (1)
- DNA-repair genes (1)
- DNA-tagged amines (1)
- DNA/RNA binding (1)
- DNMT3A (1)
- DNMT3B (1)
- DNS-Reparatur (1)
- DOACs (1)
- DOPA-responsive-dystonia (1)
- DOT1 (1)
- DOT1B (1)
- DOTA-EB-TATE (1)
- DPF3a (1)
- DPP III enzyme (1)
- DRD1 (1)
- DRD2 (1)
- DRD4 (1)
- DSA (1)
- DSB damage (1)
- DSB focus substructure (1)
- DSC (1)
- DSC2 (1)
- DSM (1)
- DSM-5 (1)
- DSM-IV (1)
- DSM-IV disorders (1)
- DT40 cells (1)
- DTI (1)
- DUB inhibitor (1)
- DWI (1)
- DYNC1I1 (1)
- DaTscan (1)
- Damage (1)
- Danio-rerio (1)
- Danish hernia database (1)
- Dara-KDT-P(A)CE (1)
- Dark Factor of Personality (1)
- Dark Matter (1)
- Dark matter (1)
- Dark-matter (1)
- Dark-matter production (1)
- Dasycladales chlorophyta (1)
- Data Fusion (1)
- Data acquisition (1)
- Database searching (1)
- Dauer formation (1)
- Davis gun (1)
- De-novo (1)
- DecaWave (1)
- Decay sequence (1)
- Decays (1)
- Deep Inelastic-scattering (1)
- DeepSqueak (1)
- Deficit/hyperactivity disorder (1)
- Defined burkitts lymphoma (1)
- Deflazacort (1)
- Delayed cerebral infarction (1)
- Delayed ischemic neurological deficit (1)
- Delayed snowmelt (1)
- Delbruck Scattering (1)
- Deletion (1)
- Deletion analysis (1)
- Deliberate practice (1)
- Delphi procedure (1)
- Delta Repertoire (1)
- Democracy Matrix (1)
- Democratic People's Republic of Korea (1)
- Demyelinating peripheral neuropathy (1)
- Dendra2 (1)
- Dendritic Cells (1)
- Dendritic cell tumor (1)
- Denoising (1)
- Densities (1)
- Densovirus (1)
- Dentate granule cells (1)
- Dentistry (1)
- Deoxyribozyme (1)
- Dependence (1)
- Depression treatment (1)
- Depressive symptomatology (1)
- Der Granatapfelbaum (1)
- Der p 23 (1)
- Dermatologie (1)
- Desert ant navigation (1)
- Design patterns (1)
- Desmoplakin (1)
- Desmoplastic fibroma (1)
- Deterioration (1)
- Deutsche Forschungsgemeinschaft (1)
- Developmental biology (1)
- Devic syndrome (1)
- Devic’s syndrome (1)
- Dextran sulphate (1)
- Diabetes (1)
- Diabetes history (1)
- Diabetic nephropathies (1)
- Diabetic polyneuropathy (1)
- Diabetic-nephropathy (1)
- Diagnosis prediction (1)
- Diagnostic approach (1)
- Diagnostic radiopharmaceuticals (1)
- Dialogue Board (1)
- Diaphragmatic breathing (1)
- Diarrhea (1)
- Diastocic Dysfunction (1)
- Diborane (1)
- Diboryne (1)
- Dichte (1)
- Dickblattgewächse (1)
- Dickkopf proteins (1)
- Dictyostelium discoideum (1)
- Dictyota (1)
- Dictyotaceae (1)
- Dicyclohexylcarbodiimid (1)
- Diels–Alder reaction (1)
- Dietary process-related contaminants (1)
- Differential Cross-Sections (1)
- Differential GPS (DGPS) (1)
- Differential RNA-sequencing (1)
- Differentiation (1)
- Diffusion tensor imaging (1)
- Digital platforms (1)
- Dihydroboranes (1)
- Diisononyl phthalate (1)
- Diktat (1)
- Dilated Cardiomyopathy with Ataxia (1)
- Dimers (1)
- Dionaea-muscipula ellis (1)
- Dioncophyllaceae (1)
- Dioncophyllaceae leaves (1)
- Dioscorea (1)
- Dipeptidyl-peptidase IV inhibitors (1)
- Diplopia Internuclear ophthalmoplegia (INO) (1)
- Dirac points (1)
- Direct care workers (1)
- Directed Flight (1)
- Disaster response (1)
- Discovery (1)
- Discrete-to-continuum limits (1)
- Disease gene prioritization (1)
- Disease genetics (1)
- Disease network (1)
- Disease prevalence (1)
- Disease progression (1)
- Disease severity (1)
- Disease-modifying therapies (1)
- Disorders (1)
- Distal biceps tendon repair (1)
- Distal outflow trac (1)
- Distinct (1)
- Distress (1)
- Distributed Control (1)
- Diversity (1)
- Division (1)
- Dixon (1)
- Diät (1)
- Dmrt1bY (1)
- Dociostaurus maroccanus (1)
- Doctor (1)
- Domain-specific approach (1)
- Dongting Lake (1)
- Donor lymphocytes (1)
- Donor−acceptor dyads (1)
- Dopaminergic PAM cluster neurons (1)
- Dorsolateral prefrontal cortex (1)
- Dorylinae (1)
- Dose reduction (1)
- Dosimetry (1)
- Double hemorrhage model (1)
- Double sensitization (1)
- Double-Beta Decay (1)
- Double-blind (1)
- Down-regulation (1)
- Doxorubicin (1)
- Draize eye test (1)
- Drinfel’d twists (1)
- Drosha (1)
- Drosophila Antennal Lobe (1)
- Drosophila melanogaster motoneuron (1)
- Drosophila model (1)
- Drosophilia (1)
- Drought (1)
- Drug Therapy, Combination (1)
- Drug allergy (1)
- Drug delivery (1)
- Drug discovery (1)
- Drug metabolism (1)
- Drug reaction (1)
- Drug-free remission (1)
- Dsg2 (1)
- Dual 3'seq (1)
- Dual-PAM-100 (1)
- Duchenne dystrphy (1)
- Dufours gland (1)
- Dunce isoforms (1)
- Durchflusscytometrie (1)
- Dynamic Causal Modeling (1)
- Dynamic stopping (1)
- Dynamical Supersymmetry Breaking (1)
- Dyson orbitals (1)
- Dystonia (1)
- Dünndarm (1)
- E(+)E(-) collicions (1)
- E-H bond activation (1)
- E-cadherin (1)
- E. coli (1)
- E. coli Nissle 1917 (1)
- E. coli atp operon (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- E/T ratio (1)
- E/e’ (1)
- E1 (1)
- E2 conjugating enzyme (1)
- E3 14.7-kilodalton protein (1)
- E3 enzyme (1)
- E3 ligase (1)
- E3 ligating enzyme (1)
- E3 ubiquitin ligase (1)
- EAHP/SH bone marrow workshop (1)
- EANM (1)
- EANM dosage card (1)
- EAU guidelines (1)
- EBER in situ hybridization (1)
- EBF1 (1)
- EBM (1)
- EBRT (1)
- ECG (1)
- ECG-recording (1)
- ECM coating (1)
- ECM remodeling (1)
- ECMO (1)
- ECMO indication (1)
- ECORN-CF Projekt (1)
- ED2 (1)
- EDS (1)
- EDX spectra (1)
- EEA (1)
- EEG data (1)
- EEG frequency band analysis (1)
- EEG preprocessing (1)
- EEG processing (1)
- EEG/ERP (1)
- EEOS (1)
- EGF (1)
- EGF receptor (1)
- EGR1 (1)
- EHEC (1)
- EHS classification (1)
- EHT (1)
- EHT1864 (1)
- EIP on AHA (1)
- EJMA-D-19-00287 (1)
- EMMA (1)
- EMMPRIN (1)
- ENV (1)
- ENVISAT ASAR WSM (1)
- EO data (1)
- EORTC-BN20 (1)
- EORTC-QLQ-C15-PAL (1)
- EP Procedures (1)
- EPM (1)
- EPR (1)
- EQ-5D (1)
- EQ5D-5L (1)
- ER Ca2+ imaging (1)
- ER Ca2+ store (1)
- ER signaling (1)
- ER stress (1)
- ER-Stress (1)
- ERBB receptors (1)
- ERCC1-XPF (1)
- ERCC4 (1)
- ERG (1)
- ERI (1)
- ERK map kinease (1)
- ERK signaling (1)
- ERK signaling cascade (1)
- ERM proteins (1)
- ERP-BCI (1)
- ERPS (1)
- ERPs (1)
- ERPs (Event-Related Potentials) (1)
- ERT (1)
- ESAT‐6‐like secretion system (1)
- ESBL (1)
- ESC (1)
- ESCAlife (1)
- ESKAPE (1)
- ESM (1)
- ESPED (1)
- ESTARFM (1)
- ESTARFM framework (1)
- ETR (1)
- EU (1)
- EU member states (1)
- EU-RHAB registry (1)
- EULAR guidelines (1)
- EUROASPIRE survey (1)
- EU‐RHAB Registry (1)
- EVER1 (1)
- EVER2 (1)
- EVI (1)
- EVT (1)
- EVs (1)
- EWAS (1)
- EZH1 (1)
- EZH2 differentiation trichostatin (1)
- Early posterior negativity (1)
- Eating disorder (1)
- Eccentricities (1)
- Ecological Networks (1)
- Ecological momentary assessment (1)
- Ecological networks (1)
- Ecologically important traits (1)
- Ecosystem ecology (1)
- Ecosystem services (1)
- Ectopic bone formation (1)
- Edema (1)
- Edema formation (1)
- Edmund Husserl (1)
- Effective dose (1)
- Effectors in plant pathology (1)
- Efflux transport (1)
- Egfr (1)
- Ehlers-Danlos syndrome (1)
- Eigenvectors (1)
- Einfluss (1)
- El Escorial (1)
- El Niño (1)
- Elbow (1)
- Elbow joint (1)
- Elderly patients (1)
- Elective cesarean-section (1)
- Electric Field (1)
- Electrical breakdown (1)
- Electrical impedance tomography (1)
- Electrochemistry (1)
- Electroencephalography (1)
- Electromagnetic signals (1)
- Electron (1)
- Electron Microscopy (1)
- Electron demand in ditosylates (1)
- Electron transfer (1)
- Electrophiles (1)
- Electrophysiology (1)
- Electroweak Measurements (1)
- Electroweak Phase-Transition (1)
- Elektronisches Publizieren (1)
- Elissen-Palm flux (1)
- Elite Rowers (1)
- Ellenbogengelenk (1)
- Embolism resistance (1)
- Embryo (1)
- Embryonic induction (1)
- Embryonic stem cell (1)
- Embryos (1)
- Emergence (1)
- Emery-Dreifuss muscular dystrophy (1)
- Emission (1)
- Emodin (1)
- Emotion (1)
- Emotional behavior (1)
- Emotional expression (1)
- Emotional labor (1)
- Emotionality (1)
- Emotionsregulation (1)
- EndoVAC and small bowel (1)
- Endogenous genotoxicity (1)
- Endogenous opioids (1)
- Endoplasmic-Reticulum Stress (1)
- Endothelial growth-factor (1)
- Endothelzelle (1)
- Energies (1)
- Energy depletion (1)
- Energy transfer (1)
- England (1)
- English version (1)
- Enhancer (1)
- Enhancer elements (1)
- Enoxaparin (1)
- Enrichment analysis (1)
- Enrique Gaspar y Rimbau (1)
- Enteric nervous system (1)
- Enteric neuropathies (1)
- Enterica serovar typhimurium (1)
- Enterococcus faecalis (1)
- Enterococcus faecium (1)
- Enterovirus (1)
- Entomology (1)
- Entwicklung (1)
- Environmental enrichment (1)
- Environmental impact (1)
- Environmental isolate (1)
- Envisat (1)
- Enzyme Regulation (1)
- Enzyme immunoassay (1)
- Enzyme kinetics (1)
- Enzyme metabolism (1)
- Enzyme regulation (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- Enzyme‐Linked Immunosorbent Assay (1)
- EpCAM (1)
- Epicardium-derived cells (1)
- Epichloë spp. (1)
- Epidemiological study (1)
- Epidermal growth-factor (1)
- Epidermaler Wachstumsfaktor-Rezeptor (1)
- Epidermis (1)
- Epidural Analgesia (1)
- Epigenesis (1)
- Epigenetic (1)
- Epigenetic regulation (1)
- Epigenetics (1)
- Epilepsy (1)
- Episkin (1)
- Epitaxy (1)
- Eplerenone (1)
- Epoxide hydrolase (1)
- Epstein-Barr virus (1)
- Epstein-Barr virus-induced gene 2 (1)
- Epstein-Barr-virus (1)
- Equipment (1)
- Erbendorf (1)
- Erigone atra (1)
- Eriodictyon californicum (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escberichia coli (1)
- Escherichia coli AlkA (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Escherichia coli-Hfq (1)
- Escherichia coli-derived recombinant human bone morphogenetic protein-2 (1)
- Escherichia-coli K-12 (1)
- Ester (1)
- Estivation (1)
- Estrone (1)
- Ethanol (1)
- Ethionine (1)
- Ethiopia (1)
- Eukaryoten (1)
- Eukaryotic cell (1)
- Eulen <Schmetterlinge> (1)
- Euler system (1)
- Euler–Bernoulli damped beam (1)
- Eulophidae (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- European Innovation Partnership on Active and Healthy Ageing (1)
- European Property Law (1)
- European Society (1)
- European Society for Immunodeficiencies (ESID) (1)
- European Spanish (1)
- European countries (1)
- European experience (1)
- European experts (1)
- European foulbrood (1)
- European group (1)
- European orchard bee (Osmia cornuta) (1)
- Evans syndrome (1)
- Event (1)
- Event builder (1)
- Events GW150914 (1)
- Evoked potentials (1)
- Evolutionary developmental biology (1)
- Evolutionary emergence (1)
- Exacerbation (1)
- Examensklausur (1)
- Examination (1)
- Excision (1)
- Excited states (1)
- Exciton-polariton condensate (1)
- Excitons (1)
- Exercise (1)
- Exercise intervention (1)
- Exons (1)
- Exosome (1)
- Exotic mesons (1)
- Exotics (1)
- Expected MOS (1)
- Expected QoE (1)
- Experimental brain trauma (1)
- Experimental intracerebral hemorrhage (1)
- Experimental stroke (1)
- Experimental study (1)
- Expert chess players (1)
- Explorative analyses (1)
- Exposure therapy (1)
- Expresses genes (1)
- Expression of mood states (1)
- Extended field irradiation (1)
- Extensions of Higgs sector (1)
- External exposure assessment (1)
- Extra-anatomical (1)
- Extracellular domain (1)
- Extracellular matrix (1)
- Extracellular volume (1)
- Extracorporeal Membrane Oxygenation (1)
- Extracorporeal membrane oxygenation (1)
- Extramedullary disease (1)
- Extraocular eye muscles (1)
- Extreme flows (1)
- Exziton (1)
- Eye Movement Modeling Examples (1)
- Eye Movements/physiology (1)
- Eye development (1)
- Eye gaze (1)
- Eyjafjallajökull 2010 (1)
- E−X bond activation (1)
- F-18-FDG PET (1)
- F-18-FDG PET/CT (1)
- F-19 MRI (1)
- F1 (1)
- FADD (1)
- FADS (1)
- FAIR (1)
- FAM104A (1)
- FAM104B (1)
- FANCA (1)
- FANCD2 (1)
- FANCM (1)
- FANCP (1)
- FAP (1)
- FAPI PET/CT (1)
- FARS1 (1)
- FAS (1)
- FBXW7 (1)
- FCS (1)
- FDG-PET (1)
- FDG-PET/MRI (1)
- FDM (1)
- FE (1)
- FFPE (1)
- FGF (1)
- FGF/FGFR signalling (1)
- FGF21 (1)
- FGFR signaling (1)
- FGFR-inhibitors (1)
- FIB-SEM (1)
- FINCA (1)
- FISH-CLEM (1)
- FL spectroscopy (1)
- FLIMbee (1)
- FLJ14775 (1)
- FLJ20434 (1)
- FLS2 receptor (1)
- FLT-PET (1)
- FMR1 (1)
- FMR2 (1)
- FNIRS (1)
- FOLFIRI (1)
- FOLFOX (1)
- FOSMN (1)
- FP-CIT SPECT (1)
- FPG protein (1)
- FRET (1)
- FRET sensors (1)
- FRG (1)
- FRG calculations (1)
- FRN (1)
- FT-IR spectroscopy (1)
- FTY720 (1)
- FTY720-P (1)
- FV45 (1)
- FWGE (1)
- FXII (1)
- FXIIa inhibitor rHA-Infestin (1)
- FXR1 (1)
- FXR2 (1)
- Fabaceae (1)
- Fabry Disease (FD) (1)
- Fabry cardiomyopathy (1)
- Fabry patient (1)
- Faces and scenes (1)
- Facial Nerve Transection (1)
- Facial expression (1)
- Facial nerve palsy (1)
- Factor gene PRPF31 (1)
- Factor messenger-RNA (1)
- Factor sigma(B) (1)
- Factor-alpha (1)
- Fagus orientalis (1)
- Fak regulation (1)
- Faktor (1)
- False Vacuum (1)
- False positive reactions (1)
- Familial Alzheimers-disease (1)
- Familial Beckwith-Wiedemann syndrome (1)
- Family (1)
- Family Investigation of Nephropathy and Diabetes (1)
- Fanconi Anemia (1)
- Fanconi anaemia (1)
- Fanconi anemia (1)
- Fanconi-Anämie (1)
- Fanconi-anemia subtype (1)
- FasL (1)
- Fascia transversalis (1)
- Fatigue (1)
- Fats (1)
- Fatty acids (1)
- Fbw7 (1)
- Fc-receptor (1)
- FcγR receptor (1)
- FeS proteins (1)
- Fear (1)
- Fear conditioning (1)
- Fehleridentifikation (1)
- Female patients (1)
- Feminisation (1)
- Femoral vein (1)
- Femtosecond Mid-Infrared Study (1)
- Fermi liquid (1)
- Fernerkundung (1)
- Ferrite (1)
- Fetal brain development (1)
- Fettgehalt (1)
- Fettsucht (1)
- Fgf-signalling (1)
- Fibrin glue (1)
- Fibroblast Growth Factor (1)
- Fibroblast Growth Factor-21 (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Ficaria ambigua (1)
- Ficaria calthifolia (1)
- Ficaria verna (1)
- Field sting (1)
- Fiels-effect transistors (1)
- Fifth Dynasty (1)
- Filial piety/xiao (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- First G-APD Cherenkov Telescope (1)
- Fische (1)
- Fischer 344 rats (1)
- Fisher Z-score transformation (1)
- Fitbit Sense (1)
- Fks1 (1)
- Flagellum (1)
- Flash relaxation kinetics (1)
- Flavonoids (1)
- Flavor Violation (1)
- Flavour changing neutral currents (1)
- Flexor tendon repair (1)
- Flowering (1)
- Flowering plants (1)
- Flowers (1)
- Flt3L (1)
- Fludarabine (1)
- Fludarabine-treosulfan (FT) (1)
- FluidFM technology (1)
- Fluorescein angiography (1)
- Fluorescence Microscopy (1)
- Fluorescence and Crosslinking (1)
- Fluorescence in situ hybridization (1)
- Fluorescence microscopy (1)
- Fluorescence resonance energy transfer (1)
- Fluoreszenzresonanz-Energietransfer (1)
- Fluoro(perfluoroalkyl) phosphoranes (1)
- Fluorogenic RNA Aptamers (1)
- Fluorouracil (1)
- Flussufer (1)
- Foamy virus (1)
- Foc protein (1)
- Follicular lymphoma (1)
- Follow-up (1)
- Fontan’s Operation (1)
- Food Carvings Questionnaire (1)
- Food Cravings Questionnaires (1)
- Food craving (1)
- Foragers (1)
- Foraging behaviour (1)
- Forces (1)
- Forecasting (1)
- Forensische Anthropologie (1)
- Forensische Osteologie (1)
- Forests (1)
- FormCalc8 (1)
- Fortran code (1)
- Fourier-transform spectroscopy (1)
- Fourthcorner analysis (1)
- FoxO3 (1)
- FoxP3 Expression (1)
- FoxQ2 (1)
- Frabin/Fgd4 (1)
- Fractional cover analysis (1)
- Fragmentation (1)
- Fragmentierung (1)
- Frame-based (1)
- Frame-less (1)
- Framingham (1)
- Fraser syndrome (1)
- Fraxinus excelsior (1)
- Freeze-etching (1)
- Fremdsprachenlernen (1)
- Fremdsprachenunterricht (1)
- French-Canadian patients (1)
- Frequency (1)
- Frequency-response areas (1)
- Fresh Freeze Plasma (1)
- Friedreich’s ataxia (1)
- Frontal cortex (1)
- Fruits (1)
- Frustrated Lewis Pairs (1)
- Ftsz (1)
- Fulgurite (1)
- Full body ownership illusion (1)
- Function knowledge (1)
- Functional diversity (1)
- Functional magnetic resonance imaging (1)
- Functional modules (1)
- Functional nucleic acids (1)
- Functionalization (1)
- Fungal (1)
- Fungal cell-walls (1)
- Fungal host response (1)
- Fungal traits (1)
- Fungiplex Candida Auris (1)
- Fungus (1)
- Fusarium fujikuroi (1)
- Förster Resonance Energy Transfer (1)
- Förster resonance energy transfer (1)
- G Protein (1)
- G protein coupled receptor (GPCR) (1)
- G protein coupled receptors (1)
- G protein-coupled receptor (1)
- G-2 (1)
- G-protein coupled receptor (1)
- G-protein coupled receptors (1)
- G-protein-coupled receptor (1)
- G-protein-coupled receptors (1)
- G-quadruplex motifs (1)
- G3BP (1)
- GAAS (1)
- GABA(A) receptors (1)
- GABA-A receptor (1)
- GABA-receptor complex (1)
- GABAA (1)
- GABAB receptor agonists (1)
- GABA\(_A\) (1)
- GABA\(_{A}\) (1)
- GABA\(_{A}\) receptor (1)
- GABA\(_{A}\) receptors (1)
- GABA\(_{B}\) (1)
- GABAergic neurons (1)
- GABBR1 (1)
- GABP (1)
- GAD1 (1)
- GAG (1)
- GAMMA (1)
- GAN (1)
- GAP (1)
- GATA-3 (1)
- GA\(^2\)LEN (1)
- GBM (1)
- GBR (1)
- GBS (1)
- GC-Content (1)
- GCA (1)
- GCC (1)
- GCH1 (1)
- GDF-5 (1)
- GDNF (1)
- GDNF5 (1)
- GEDI (1)
- GFAP-astrocytopathies (1)
- GFP (1)
- GH response (1)
- GHQ-28 (1)
- GI (1)
- GI-101A tumor xenografts (1)
- GIS-analysis (1)
- GIST (1)
- GLA mutation (1)
- GLA protein UCMGP (1)
- GLDN variant (1)
- GLP-1 (1)
- GLUT1 (1)
- GLUT4 (1)
- GLUT5 (1)
- GLUTs (1)
- GLV-1 h153 (1)
- GM (1)
- GMP (1)
- GMPcGMP-dependent protein kinase I (1)
- GMSB model (1)
- GNA11 (1)
- GNAQ (1)
- GNSS/INS integrated navigation (1)
- GO1 (1)
- GOLD (1)
- GP41 cytoplasmic tail (1)
- GPCRs (1)
- GPI-anchor (1)
- GPR54 (1)
- GPS (1)
- GPS Reciever (1)
- GPS tracking (1)
- GPVI shedding (1)
- GPX4 (1)
- GRAID (1)
- GRAPPA (1)
- GRN (1)
- GRO alpha (1)
- GRP78 (1)
- GSH (1)
- GSK-3β (1)
- GSK3 (1)
- GSTP1 (1)
- GSV (1)
- GTL2 (1)
- GUT (1)
- GUT-directed hypnotherapy (1)
- GVL (1)
- GWAS meta-analysis (1)
- Ga-68 (1)
- GaAs (1)
- GaAsSb (1)
- GaSb/AlAsSb (1)
- GagPol fusion protein (1)
- Galactic Ridge (1)
- Galactic sources (1)
- Galactosidase-A gene (1)
- Galectin-1 (1)
- Gallium (1)
- Gamma-convergence (1)
- Gamma-ray bursts (1)
- Gamsberg (1)
- Ganglia (1)
- Ganglia (rat) (1)
- GapN (1)
- Garcinia biflavonoids (1)
- Garmin Fenix 6 Pro (1)
- Gaseous detectors (1)
- Gastric carcinogenesis (1)
- Gastroenteritis (1)
- Gastrointestinal (1)
- Gauge bosons (1)
- Gauge-dependent Quantity (1)
- Gaussia princeps luciferase (GpL) (1)
- Gaussia princeps luciferase fusion protein (1)
- Gaze behavior (1)
- Gaze perception (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Gecko (1)
- Gedächtnis (1)
- Gefäßpflanzen (1)
- Geitonogamy (1)
- Gelenkinstabilität (1)
- Gender (1)
- Gene Regulation (1)
- Gene Transfer (1)
- Gene duplication (1)
- Gene expression (1)
- Gene expression analysis (1)
- Gene expression profiling (1)
- Gene expression vectors (1)
- Gene mapping (1)
- Gene sets (1)
- Gene silencing (1)
- Gene therapy (1)
- Gene transfer (1)
- Gene-transfer (1)
- General anaesthesia (1)
- General-population (1)
- Generation (1)
- Generic questionnaire (1)
- Genetic (1)
- Genetic causes of cancer (1)
- Genetic instability (1)
- Genetics (1)
- Genitoanal region (1)
- Genom (1)
- Genom / Genkartierung / Genanalyse (1)
- Genome analysis (1)
- Genome assembly (1)
- Genome comparison (1)
- Genome evolution (1)
- Genome re-annotation (1)
- Genome wide analysis (1)
- Genome-wide association studies (1)
- Genomic profile (1)
- Genomics (1)
- Genomics data sets (1)
- Genotype (1)
- Genotype-phenotype association (1)
- Genotype–phenotype correlations (1)
- Gentransfer (1)
- Georgre Orwell (1)
- Geriatric care (1)
- Geriatrics (1)
- German PID-NET registry (1)
- German Research Foundation (1)
- German Stroke Registers Study Group (1)
- German healthcare system (1)
- German population (1)
- German translation (1)
- German/French/Italian (1)
- Germanium (1)
- Germanium telluride (1)
- Germination (1)
- Germinative cell (1)
- Germline (1)
- Germylenes (1)
- Gerontologie (1)
- Geruch (1)
- Geschlechtsbestimmung (1)
- Getz Ice Shelf (1)
- Gewebe (1)
- Ghana (1)
- Giant cell arteritis (GCA (1)
- GibS (1)
- Gibbs activation energy (1)
- Gifsy-1 (1)
- Gimbaled tracking (1)
- Gland (1)
- Gleason score (1)
- Gletscher (1)
- Glial fibrillary acidic protein (1)
- Glioblastom (1)
- Glioblastoma cell line (1)
- Glioblastoma multiforme (1)
- Glioblastomas (1)
- Glioma stem cells (1)
- GlobALS (1)
- Global Ecosystem Dynamics Investigation (1)
- Global Navigation Satellite System (GNSS) (1)
- Global Positioning System (GPS) (1)
- Globotriaosylceramide (1)
- Glomerular filtration (1)
- Glomerular-filtration-rate (1)
- Glucagon (1)
- Glucose metabolism (1)
- Glucose transport (1)
- Glucose uptake (1)
- Glucosetransportproteine (1)
- Glucosyltransferase (1)
- Gluon (1)
- Gluon Fusion (1)
- Glut1DS (1)
- Glutamate-induced excitotoxicity (1)
- Glutamate-receptor (1)
- Glutamatergic synapses (1)
- Glutamic-acid decarboxylase anxiety (1)
- Glutathione Stransferase (1)
- GlyR receptors (1)
- GlyRs (1)
- Glycaemic control (1)
- Glycosyltransferase (1)
- Go/NoGo task (1)
- Goldbrasse (1)
- Golgi apparatus (1)
- Good Practices (1)
- Good-or-Better (GoB) (1)
- Google Earth (1)
- Google Earth Engine (GEE) (1)
- Government research funding (1)
- Gradient boosted trees (GBT) (1)
- Gradients (1)
- Graft versus Tumor (1)
- Graft-versus-host disease (1)
- Graft-versus-leukemia (1)
- Gram points (1)
- Gram’s law (1)
- Granular layer (1)
- Graph eigenvalues (1)
- Graph products (1)
- Graphene nanoribbons (1)
- Graphnullity (1)
- Graptolithoidea (1)
- Grasses (1)
- Graves disease (1)
- Grave’s disease (1)
- Gravitons (1)
- Graßmannians (1)
- Grebe dysplasia (1)
- Green's function (1)
- Greenland (1)
- Greenland ice sheet (1)
- Green’s functions (1)
- Grenzflächenaktiver Stoff (1)
- Grippe (1)
- Groin infection (1)
- Group dynamics (1)
- Growth-factor receptor (1)
- Growth; BMP-2 (1)
- Gruppo-italiano (1)
- Guanylyl cyclase-A (1)
- Guideline (1)
- Guillain-Barré syndrome (1)
- Guillain-Barré-Syndrom (1)
- Guinea pig model (1)
- Guinean rain forest (1)
- Guinier-Preston zones (1)
- Göttingen (1)
- Gα\(_{i1}\), Gα\(_{i2}\) and Gα\(_{i3}\) activation (1)
- H+-atpase (1)
- H-infinity (1)
- H2A histone family member X (H2AX) (1)
- H3K27me3 (1)
- H441 (1)
- H7N9 influenza virus (1)
- HA modifiedCNF membranes (1)
- HAND (1)
- HAQ (1)
- HB-EGF (1)
- HBO (1)
- HCMV infection (1)
- HCV (1)
- HCV cure (1)
- HCV genotype 2 (1)
- HCV genotype-2 (1)
- HCV infection (1)
- HCW (1)
- HD (1)
- HDAC (1)
- HDBSCAN (1)
- HE-3 diffusion MRI (1)
- HECT (1)
- HECT Ligase (1)
- HEK cells (1)
- HEMA (1)
- HER2 (1)
- HER2 conversion (1)
- HER2 targeted therapy (1)
- HER2-low (1)
- HERV-K (1)
- HES (1)
- HEV (1)
- HEY repressors (1)
- HFmrEF (1)
- HFrEF (1)
- HGPS (1)
- HHblits (1)
- HIGGS (1)
- HIIT (High intensity interval training) (1)
- HIP osteoarthritis (1)
- HIV diagnosis and management (1)
- HIV infection (1)
- HIV infections (1)
- HIV neurocognitive impairment (1)
- HIV-1 protease (1)
- HIV-1 subtype AG (1)
- HIV-1-infected patients (1)
- HIV-1-infected subjects (1)
- HIV-1; subtype C; proviral plasmid; viral replication; resistance assays; Vpu; CD317; CD4 (1)
- HIV-Infektion (1)
- HIV-associated candidiasis (1)
- HIV-infected patients (1)
- HKT1 (1)
- HLA (1)
- HLA antigens (1)
- HLA class II (1)
- HLA class ll (1)
- HLA peptidome (1)
- HLA-E matching (1)
- HLA-G gene (1)
- HMD (Head-Mounted Display) (1)
- HMDP hydroxymethylene diphosphonate (1)
- HMG-Proteine (1)
- HMGB1 (1)
- HNSC (1)
- HPLC-MS/MS method (1)
- HPLC/UPLC methods (1)
- HPLC–MS (1)
- HPc (1)
- HPβCD (1)
- HRAS (1)
- HRMS (1)
- HRQL (1)
- HRQOL (1)
- HRTEM (1)
- HRV (1)
- HSAB principle (1)
- HSTC outcome (1)
- HT-29 colon carcinoma cells (1)
- HT29 cells (1)
- HTLV-I (1)
- HTTP adaptive video streaming (1)
- HaCaT cells (1)
- Habitats (1)
- Hadron Collider (1)
- Hadron Hadron scattering (experiments) (1)
- Hadron-Hadron Scattering (1)
- Hadron-hadron interactions (1)
- Haematogenous (1)
- Haematology (1)
- Haemodialysis (1)
- Haemolysin (1)
- Haftung (1)
- Halbleiter (1)
- Halictidae (1)
- Hall effect (1)
- Halobacterium halobium (1)
- Haloferax volcanii (1)
- Halothane (1)
- Hamman's syndrome (1)
- Hans algorithm (1)
- Haploidentical (1)
- Harnwegsinfekt (1)
- Harold Garnet Callan (1)
- Hautflügler (1)
- Hautkrebs (1)
- Hautus test (1)
- Hazards (1)
- Head (1)
- Head and neck cancer (1)
- Head and neck cancers (1)
- Head-injury (1)
- Health (1)
- Health care service research (1)
- Health promotion (1)
- Health-determinants (1)
- Healthcare Cost (1)
- Healthcare Economics (1)
- Healthcare research (1)
- Hearing loss (1)
- Hearing-loss (1)
- Heart failure with preserved ejection fraction (1)
- Heart failure with reduced ejection fraction (1)
- Heart rate (1)
- Heart rate variability (1)
- Heat Hyperalgesia (1)
- Heat Wave Magnitude Index (HWMI) (1)
- Heavy-Particles (1)
- Hecke L-functions (1)
- Hecke eigenforms (1)
- Hegyi competition index (1)
- Hela Cells (1)
- Helicobacterpylori (1)
- Hemagglutination inhibition (1)
- Hematopoietic Stem (1)
- Hematopoietic cell transplant (1)
- Hematopoietic stem cell transplantation (1)
- Heme-regulated inhibitor (1)
- Hemipelvectomy (1)
- Hemodialysis-patients (1)
- Hemodynamic depression (1)
- Hemoglobin A1C (1)
- Hemolysin excretion (1)
- Hemorrhage (1)
- Hemospermia (1)
- Heparan-sulfate (1)
- Heparin (1)
- Hepatitis B Virus (1)
- Hepatitis B virus (1)
- Hepatitis B virus reactivation (1)
- Hepatitis C (1)
- Hepatitis C infection (1)
- Hepatitis E (1)
- Herbivory (1)
- Hereditary breast cancer (1)
- Herodotus (1)
- Herpes (1)
- Herpes simplex encephalitis (1)
- Herpes simplex virus (1)
- Herzthoraxchirurgie (1)
- Hesse (1)
- Heterocyclen (1)
- Heterocyclische Verbindungen (1)
- Heteroptera (1)
- Heubacillus (1)
- HeuristicsMiner algorithm (1)
- Hexadehydro-Diels-Alder (1)
- Hexahydro-difenidol (1)
- Hexahydro-difenidol analogues (1)
- Hexahydro-procyclidine (1)
- Hexbutinol (1)
- Hexocyclium/sila-hexocyclium derivatives (1)
- Hg1-xCdxTe (1)
- HgTe (1)
- HiGHmed (1)
- Hibernation (1)
- Hickman catheter (1)
- Hierarchy problem (1)
- Higgs Boson (1)
- Higgs Mass (1)
- Higgs boson decays (1)
- Higgs boson mass (1)
- Higgs boson signal (1)
- Higgs-boson (1)
- Higgy-Boson (1)
- High efficiency (1)
- High fat diet (1)
- High grade glioma (1)
- High mobility group (1)
- High performance (1)
- High-Energies (1)
- High-Frequency Ventilation (1)
- High-dose chemotherapy (1)
- High-energy jets (1)
- High-fat diet (1)
- High-jump photographs (1)
- High-performance liquid chromatography (HPLC) (1)
- High-resolution (1)
- High-spontaneous rate (1)
- High-throughput data (1)
- High-throughput screening (1)
- Higher rates (1)
- Highlights Lecture (1)
- Hill's powers (1)
- Himalaya Karakoram (1)
- Hindbrain (1)
- Hip joint (1)
- Hippocampus (1)
- Hirnhautentzündung (1)
- Hirschsprung disease liability (1)
- Histologic grade (1)
- Histone deacetylase (1)
- Histone deacetylase inhibition (1)
- Histone gamma H2AX (1)
- Hittitology (1)
- Hodgkin-lymphoma (1)
- Hoechst 33258 dye (1)
- Hoechst 33342 (1)
- Hoffa (1)
- Holliday junction reolvass (1)
- Holocene (1)
- Holography and condensed matter physics (AdS/CMT) (1)
- Holozän (1)
- Home monitoring (1)
- Homebox gene (1)
- Homeostatic plasticity (1)
- Homoarginine (1)
- Homology (1)
- Homoptera aphididae (1)
- Homotopy Continuation Method (1)
- Honey bee (1)
- Honey bees (1)
- Honey-bees (1)
- Honeybee (1)
- Hordeum vulgare (1)
- Horizontal transfer (1)
- Hormesis (1)
- Horowitz Quotient (1)
- Hospital emergency plan (1)
- Hospital water system (1)
- Hospitalisation (1)
- Host adaptation (1)
- Host cells (1)
- Host-pathogen interactions (1)
- Hotel (1)
- Htr1a (1)
- Htr2a (1)
- Htr2c (1)
- Hubbard model (1)
- Hubbard-model (1)
- Hueter interval (1)
- Human (1)
- Human CDH13 (1)
- Human Knee (1)
- Human Medial Meniscus (1)
- Human Muse Cells (1)
- Human Physiome (1)
- Human Resource Management (1)
- Human Sodium/Iodide symporter (1)
- Human and murine cancer cells (1)
- Human atrial stromal cells (1)
- Human endogenous retrovirus (1)
- Human entorhinal area (1)
- Human foamy virus bel-l transactivator; Expression in insect cells (1)
- Human genome (1)
- Human immunodefiency virus (1)
- Human lung-cancer (1)
- Human platelets (1)
- Human prefrontal cortex (1)
- Human-immunodeficiency-virus (1)
- Hunsrueck (1)
- Huntington's disease . Human cerebral cortex (1)
- Hurst Exponent (1)
- Hurwitz zeta function (1)
- Hybridisierung <Biologie> (1)
- Hybridoma (1)
- Hydraulic conductivity (1)
- Hydraulic plasticity (1)
- Hydroarylation (1)
- Hydrogen-deuterium (1)
- Hydrogen-peroxide (1)
- Hydroxymethyluracil (1)
- Hymenoptera venom (1)
- Hyperalgesia (1)
- Hypercortisolism (1)
- Hyperfine coupling constants (1)
- Hyperkalaemia (1)
- Hyperkalemia (1)
- Hyperolius viridiflavus (1)
- Hyperosmotic Stress (1)
- Hypersensitivity (1)
- Hypertonic (1)
- Hypertonic saline 7.5-percent (1)
- Hypertrophic cardiomyopathy (1)
- Hypertrophic pyloric-stenosis (1)
- Hypertrophy (1)
- Hypnales (1)
- Hypopharyngeal glands (1)
- Hypophosphatasia (1)
- Hypothetical particle physics models (1)
- Hypoxia (1)
- Hyrcanian forest (1)
- Hyrtios (1)
- Hämolysin (1)
- I-lactate (1)
- IA (1)
- IABP (1)
- IACS (1)
- IARS2 (1)
- IBA-1 (1)
- ICD (1)
- ICD-10 (1)
- ICD-CRT (1)
- ICD-coding of CKD (1)
- ICEP (1)
- ICF (1)
- ICF2 (1)
- ICL (1)
- ICM (1)
- ICM cells (1)
- ICP27 (1)
- ICP4 (1)
- ICRS (1)
- ICSI (1)
- ICT (1)
- ICU staff (1)
- ICU treatment (1)
- IDH (1)
- IDH1/2 (1)
- IDO-1 (1)
- IDSA (1)
- IENFD (1)
- IFN (1)
- IFN-gamma (1)
- IFN-γ ELISpot (1)
- IFNG (1)
- IGF-I (1)
- IGF1 (1)
- IGF2-H19 (1)
- IGFBP2 (1)
- II citrullinemia (1)
- II type-2 receptor (1)
- II-VI semiconductor (1)
- III adenylyl cyclases (1)
- III secretion (1)
- III secretion system (1)
- III–V quantum dot (1)
- III–V semiconductor devices (1)
- IL-1 beta (1)
- IL-1 blockade (1)
- IL-10 expression (1)
- IL-12 family (1)
- IL-12 production (1)
- IL-12B (1)
- IL-12p40 (1)
- IL-15 (1)
- IL-17A-inhibition (1)
- IL-1ß (1)
- IL-22 binding protein isoform (1)
- IL-3 (1)
- IL-4 antagonists (1)
- IL-4-receptor (1)
- IL-5 (1)
- IL-7 (1)
- IL12B (1)
- IL1RA (1)
- IL2 branching (1)
- IL22RA2 (1)
- IL28B (1)
- IL28B polymorphisms (1)
- IL6 (1)
- IL‐10 (1)
- IL‐1β (1)
- IMA2.1 (1)
- IMAZA (1)
- IMD (1)
- IMR-90 (1)
- IMSI (1)
- IMpACT (1)
- INR rebound (1)
- INS/LIDAR integrated navigation (1)
- IP3 (1)
- IPND criteria (1)
- IRF4 (1)
- IS education (1)
- ISBI (1)
- ISS (1)
- IT in Business (1)
- IT security (1)
- IVF-methods (1)
- IVIg (1)
- Ibrutinib (1)
- Ibuprofen (1)
- IcaR (1)
- Icecube (1)
- Icosanoid (1)
- IctP (1)
- Identifizierung (1)
- Ifn-gamma (1)
- IgD (1)
- IgE sensitazion (1)
- IgG glycosylation (1)
- IgG substitution therapy (1)
- IgG4 (1)
- IgM (1)
- Ighmbp2 (1)
- Ileal Crohns-disease (1)
- Ileal conduit (1)
- Ileum-Conduit (1)
- Ileum; Atrium (1)
- Illumina Human Exome Bead Chip (1)
- Image Aesthetic Assessment (1)
- Image interpretation (1)
- Image processing (1)
- ImageJ (1)
- ImageJ plugin (1)
- Images (1)
- Imaging (1)
- Imaging Air Cherenkov Telescope (1)
- Imaging pitfalls (1)
- Imd pathway (1)
- Imidates (1)
- Imidoyl halides (1)
- Immediate-type (1)
- Immune receptor signaling (1)
- Immune system (1)
- Immune tolerance (1)
- Immune-System (1)
- Immune-related adverse event (1)
- Immunization (1)
- Immunoadsorption (1)
- Immunoapheresis (1)
- Immunocompromised patient (1)
- Immunodeficiency (1)
- Immunogenicity (1)
- Immunoglobulin E (1)
- Immunohistochemistry (1)
- Immunological Self-Tolerance (1)
- Immunology (1)
- Immunopanning (1)
- Immunoprecipitation (1)
- Immunosenescence (1)
- Immunostimulatory adjuvant (1)
- Immunstimulation (1)
- Impact-Faktor (1)
- Impaired vision (1)
- Impella (1)
- Implicit and explicit reward learning (1)
- Improved survival (1)
- Impulsivity (1)
- In Situ Nick-End Labeling (1)
- In vitro contracture test (1)
- In vitro models (1)
- In vitro skin irritation testing (1)
- In vitro toxicity testing (1)
- In vivo (1)
- In vivo imaging (1)
- In vivo studies (1)
- In-Vivo (1)
- In-vivo dia lysis (1)
- InSAR height (1)
- Inactivation (1)
- Inbreeding depression (1)
- Inc (1)
- IncRNA (1)
- Incidence (1)
- Inclusion (1)
- Inclusion Rate (1)
- Incomplete contracts (1)
- Incontinentia pigmenti (1)
- IncuCyte\(^®\)S3 (1)
- India (1)
- Indian muntjac (1)
- Indirect and direct contributions to A<sub>iso</sub> (1)
- Indirekte Abwehr (1)
- Induced Pluripotent Stem Cells (1)
- Induced senescence (1)
- Inducible Clindamycin Resistance (1)
- Indus-Ganges-Brahmaputra-Meghna (1)
- Infarct Zone (1)
- Infection (1)
- Infection control (1)
- Infectious Diseases (1)
- Infectious complications (1)
- Inferior Vena Cava (1)
- Inferior colliculus (1)
- Inferior vena cava (1)
- Inflammatio (1)
- Inflammatory bowel disease (1)
- Inflammatory diseases (1)
- Inflammatory pain (1)
- Infliximab (1)
- Influence of excitation classes (1)
- Influenza (1)
- Influenza vaccination (1)
- Influenzae type B (1)
- Information (1)
- Information Integration Theory (1)
- Inhalation (1)
- Inhibition (1)
- Inhibitory glycine receptor (1)
- Injuries (1)
- Inner hair cell (1)
- Innervation (1)
- Inoculum production (1)
- Insect flight (1)
- Insect hosts (1)
- Insect pests (1)
- Insect symbiois (1)
- Insekt (1)
- Insensitivity (1)
- Instability (1)
- Instructors (1)
- Insulating thin films (1)
- Insulator surfaces (1)
- Insulin Degrading Enzyme (1)
- Insulin therapy (1)
- Insulinlike Growth Factor (1)
- Integrase (1)
- Integrated network analysis (1)
- Intellectual disability (1)
- IntelliCage (1)
- Intelligent Virtual Agents (1)
- Intelligent mobile system (1)
- Intensity (1)
- Inter-observer variability (1)
- InteractionSuitcase (1)
- Interactive Tree Of Life (iTOL) (1)
- Interactive Ventilatory Support (1)
- Interband cascade lasers (1)
- Interference microscopy (1)
- Interferon beta (1)
- Interferon-alpha (1)
- Interieukin-1ß (1)
- Interleukin (1)
- Interleukin 2 (1)
- Interleukin 4 (1)
- Interleukin 4 (human) (1)
- Interleukin 7 (1)
- Interleukin IL-6 (1)
- Interleukin-1 (1)
- Interleukin-10 (1)
- Interleukin-18 (1)
- Interleukin-2 (1)
- Interleukin-4 (IL-4) (1)
- Interleukin-5 (1)
- Interleukin-6-Deficient mice (1)
- Intermediate filaments (1)
- Internal transcription start site (1)
- International Physical Activity Questionnaire (1)
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (1)
- Internet (1)
- Internet Behaviour (1)
- Internet of Things devices (1)
- Intestinal Intraepithelial Lymphocy (1)
- Intestinal pseudoobstruction (1)
- Intracellular domain (1)
- Intractable nausea and vomiting (1)
- Intravascular coagulation (1)
- Intravital imaging (1)
- Intrinsic charm (1)
- Invasion genes (1)
- Invasive Aspergillosis (1)
- Invasive fungal-infections (1)
- Inzisionale Hernie (1)
- Inzisionalhernie (1)
- IoT-driven processes (1)
- Ionizing radiation (1)
- Iowa Gambling Task (1)
- Ipilimumab (1)
- Ips typographus (1)
- Ire1 (1)
- Iron Oxide Nanoparticle (1)
- Iron-oxide (1)
- Iron-uptake (1)
- IronChip Evaluation Package (1)
- Irradiation (1)
- Irritable bowel syndrome (1)
- Ischemia (1)
- Ischemia/reperfusion (1)
- Ischemic stroke (1)
- Isheru (1)
- Islam (1)
- Islets of Langerhans (rat) (1)
- Isoenzym (1)
- Isomorphe Nukleobasen-Analoga (1)
- IsrK (1)
- J-aggregate behavior (1)
- J-aggregates (1)
- JA/JA-Ile transport protein JAT1 (1)
- JAK inhibitor (1)
- JAK2 (1)
- JAQ1 (1)
- JCV (1)
- JES (1)
- JIA (1)
- JOL reactivity (1)
- JQ1 (1)
- JR11 (1)
- JUN (1)
- Jacobian matrix (1)
- Jahn–Teller effect (1)
- Jak kinases (1)
- Janus fibers (1)
- Janus kinase (1)
- Japanese population (1)
- Jasmonate perception (1)
- Jasmonic acid (1)
- Java 3D (1)
- Jaynes-Cummings ladder (1)
- Jet physics (1)
- Jmjd6 (1)
- Johnstons organ (1)
- Joint capsule (1)
- Joint ownership (1)
- Joint pain (1)
- Josephson effect (1)
- Joubert syndrome (1)
- Journal of Nuclear Cardiology (1)
- Judaism (1)
- Jugend (1)
- Julia line (1)
- Jurkat T cells (1)
- Jurkat cells (1)
- Juvenile biventricular cardiomyopathy (1)
- Juvenile idiopathic arthritis (1)
- K + -channels (1)
- K band ranging (KBR) (1)
- K* µ+μ− (1)
- K+ channel (1)
- K+ channels (1)
- K-PG radiation (1)
- K-RAS (1)
- K-region (1)
- K279a (1)
- K2P channels (1)
- K2–K model (1)
- KAT/HAT (1)
- KATP channel (1)
- KCNK5 (1)
- KDELR2 (1)
- KEA (1)
- KFZA (1)
- KIF (1)
- KIF11 (1)
- KISS1 receptor (1)
- KISS1-54 (1)
- KM3NeT (1)
- KOOS (1)
- KRAS (1)
- KRAS biomarker signatures (1)
- KWIC (1)
- K\(_{2P}\)5.1 (1)
- Kaiser test (1)
- Kaliumkanal (1)
- Kappa-B activation (1)
- Kappa-B pathway (1)
- Karyotyp (1)
- Karyotype; chromosome banding; Desertellio elongatus; Crustacea; Isopoda; Oniscidea (1)
- Katayama fever (1)
- Keller–Segel model (1)
- Keras (1)
- Kerinokeratosis papulosa (1)
- Kerneldensity estimation (1)
- Ketogene Kost (1)
- Keuchhusten (1)
- KhpB protein (1)
- Kidney (perfused (1)
- Kidney cancer (1)
- Kidneys (1)
- Killer cell immunoglobulin-like receptors (1)
- Kinase inhibitor (1)
- Kinase pathway (1)
- Kindergarten (1)
- Kinetochore (1)
- Kinetochores (1)
- Kinetoplastea (1)
- Kinetoplastida (1)
- Kirchhoff's law (1)
- Klebsiella pneumoniae (1)
- Klima (1)
- Klotho-related molecules (1)
- Knee (1)
- Knieschmerzen (1)
- Knock-out mice (1)
- Knotless tendon repair (1)
- Koenigs function (1)
- Kohlberg (1)
- Kohlenhydrate (1)
- Kongress (1)
- Kono-S anastomosis (1)
- Konservierung (1)
- Krebskranker (1)
- Kristallographie (1)
- Kristallstruktur (1)
- Krylow matrix (1)
- Krüppel-like factor (1)
- Kunduz River Basin (1)
- L cells (1)
- L-3,4-Dihydroxyphenylalanine-induced dyskinesia (1)
- L-DOPA (1)
- L-Lactate Dehydrogenase (1)
- L. reuteri (1)
- L5178Y cells (1)
- LAALO3/SRTIO3 interfaces (1)
- LAD (1)
- LAMN (1)
- LASP2 (1)
- LATE DEATHS (1)
- LC-ESI/MS/MS (1)
- LC3 lipidation (1)
- LCCS11 (1)
- LCNEC (1)
- LCP (1)
- LCST (1)
- LC–HRESIMS (1)
- LC–MS/MS (1)
- LD, light:dark (1)
- LDA (1)
- LDL cholesterol (1)
- LED (1)
- LEOSS (1)
- LESA (1)
- LFA-1 (1)
- LGMDR5 (1)
- LHS (1)
- LI-rTMS (1)
- LIF (1)
- LIMP-2 (1)
- LIN-5 (1)
- LINC complexes (1)
- LINE-1 retrotransposition (1)
- LINGO-1 (1)
- LITAF (1)
- LMNA (1)
- LMNA mutations (1)
- LMX (1)
- LNCaP (1)
- LND (1)
- LNE (1)
- LOGIC study (1)
- LPHN3 (1)
- LRIG1 (1)
- LRP6 (1)
- LS-MIDA (1)
- LSD1 (1)
- LSVT-big therapy (1)
- LTB4 receptor (1)
- LTD (1)
- LTR retrotransposons (1)
- LULCC (1)
- LUMEN (1)
- LV dilatation (1)
- LV mass (1)
- LVNC (1)
- Labial glands (1)
- Labour Analgesia (1)
- Labour Pain (1)
- Lacking neurofilaments (1)
- Lactated ringers solution (1)
- Lag time (1)
- LamB (1)
- Lamarckian genetic algorithms (1)
- Lambda5-Germanate (1)
- Lamto Reserve (1)
- Land Change Modeler (1)
- Land Surface Temperature (1)
- Land Surface Temperature (LST) (1)
- Land Use/Land Cover (1)
- Land plants (1)
- Land-use change (1)
- Landau Gauge (1)
- Landau level (1)
- Landmarken (1)
- Landsat 8 (1)
- Landsat archive (1)
- Landsat-8 (1)
- Landscape ecology (1)
- Landschaft (1)
- Landwirtschaft (1)
- Langerhans cell (1)
- Langlebigkeit (1)
- Language comprehension (1)
- Lantana camara (1)
- Lao PDR (1)
- Laparoscopy (1)
- Laplace approximation (1)
- Laplace transform (1)
- Large T antigen (1)
- Large detector systems for particle and astroparticle physics (1)
- Large loop excision of the transformation zone (LLETZ) (1)
- Large multicenter ADHD (1)
- Large vessel vasculitides (LVV) (1)
- Larval development (1)
- Laser Doppler vibrometer (1)
- Late mortality (1)
- Late-effects (1)
- Latency (1)
- Lateral suboccipital craniectomy (1)
- Lateralitity (1)
- Laterality (1)
- Latimeria menadoensis (1)
- Latrophilin (1)
- Leaderless transcript (1)
- Leaf cutting ants (1)
- Learner Autonomy (1)
- Learning and memory (1)
- Learning/physiology (1)
- Leaves (1)
- Lebensalter (1)
- Lebensqualität (1)
- Lebenszyklus (1)
- Lectins (1)
- Legionella (1)
- Legionella ssp. (1)
- Legionellae (1)
- Legume crops (1)
- Legumes (1)
- LeishBASEedit (1)
- Leishmania major (1)
- Leistenhernie (1)
- Leonhard cIassification (1)
- Leonhard classification (1)
- Leptin (1)
- Lepton (1)
- Leptonic (1)
- Leptons (1)
- Lerch zeta function (1)
- Lernerautonomie (1)
- Lernkurve (1)
- Lese- und Schreibfähigkeit (1)
- Lese-Rechtschreibstörung (1)
- Lesefähigkeit (1)
- Lesen (1)
- Lesions (1)
- Leukemia Inhibitory Factor (1)
- Leukocyte/endothelium interaction (1)
- Level (1)
- Lewis acid (1)
- Lewis acid/base adducts (1)
- Lewis adducts (1)
- Lewy-like pathology (1)
- Li-Fraumeni syndrome (1)
- Lie group actions (1)
- Lie groups (1)
- Lie n-algebroids (1)
- Lieberoser Heide (1)
- Life expectancy (1)
- Lifetime spectroscopy (1)
- Ligamentum capitis femoris (1)
- Ligand <Biochemie> (1)
- Ligand effects (1)
- Light (1)
- Light Supersymmetric Particle (1)
- Light stimulation (1)
- Light-emitting diodes (1)
- Limb development (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Limb salvage (1)
- Limestone (1)
- Limit (1)
- Linagliptin (1)
- Linea alba (1)
- Lines (1)
- Lipid (1)
- Lipid metabolism (1)
- Lipom (1)
- Lipophilicity (1)
- Lipopolysaccharide (1)
- Liposomal amphotericin-B (1)
- Lipoxin (1)
- Lippert–Mataga plot (1)
- Liquid-crystalline (1)
- Listeria (1)
- Listeriolysin O (1)
- Lithium niobate (1)
- Live cells (1)
- Liver cirrhosis (1)
- Living cells (1)
- Llullaillaco Volcano (1)
- Ln-MOFs (1)
- LoRaWAN (1)
- Local governance (1)
- Local rings (1)
- Localized states (1)
- Location-based algorithms (1)
- Locked-in syndrome (1)
- Locomotion compensator (1)
- Locomotor activity (1)
- Locoregional recurrence (1)
- Locus (1)
- Locus coeruleus (1)
- Logged forests (1)
- Long COVID (1)
- Long bones (1)
- Long-range order (1)
- Long-term care (1)
- Long-term depression (1)
- Long-term follow-up (1)
- Longitudinal analysis (1)
- Longitudinally extensive transverse myelitis (1)
- Loop electrosurgical excision procedure (LEEP) (1)
- Lotka-Volterra models (1)
- Lov domain (1)
- Low risk alcohol use (1)
- Low-dose acyclovir (1)
- Low-fat diet (1)
- Lower Reference Value (1)
- Lower extremity reconstruction (1)
- LpxC inhibitors (1)
- Lu-177 (1)
- Luminescence (1)
- Lung (1)
- Lung Injury (1)
- Lung disease, (1)
- Lungenkrebs (1)
- Lutetium (1)
- Luxembourg (1)
- LyP (1)
- Lyapunov functions (1)
- Lycopersicon esculentum (1)
- Lymantria dispar (1)
- Lymph nodes (1)
- Lymph2Cx assay (1)
- Lymphocytes (1)
- Lymphoma (1)
- Lymphomas (1)
- Lynx lynx (1)
- Lysine (1)
- Lysine-specific methylase (1)
- Lysis (medicine) (1)
- Lyso-Gb3 (1)
- Lysosomal storage disease (1)
- M1/M2 macrophages (1)
- M14 carboxypeptidasses (1)
- M2 (1)
- M2 muscarinic receptors (1)
- M30 (1)
- M4 receptors (1)
- MACE (1)
- MACVIA (1)
- MAINZPouch (1)
- MALDI imaging (1)
- MAP kinase pathway (1)
- MAP1B (1)
- MAPK pathway (1)
- MAPK signaling (1)
- MAPKAPK2 (1)
- MARC effect (1)
- MAS (1)
- MASLD (1)
- MAX (1)
- MC expectation (1)
- MC program (1)
- MCC (1)
- MCL-1 (1)
- MCP1 (1)
- MCPyV (1)
- MCV-negative (1)
- MDL-28170 (1)
- MDR (1)
- MDS (1)
- MDSCs (1)
- MED-EL cochlear implant (1)
- MEDAS (1)
- MEK/ERK-signaling (1)
- MEMS IMU (1)
- MEN1 (1)
- MET receptor (1)
- METTL8 (1)
- MFM (1)
- MGL (1)
- MGMT (1)
- MGMT promoter methylation (1)
- MHC I (1)
- MHC II (1)
- MHC Klasse II (1)
- MHC class I chain-related protein (1)
- MHC molecules (1)
- MI-2/NURD complex (1)
- MIBG scintigraphy (1)
- MIC ligands (1)
- MIND estimator (1)
- MIP-1β (1)
- MIR-155 (1)
- MITE (1)
- MITF (1)
- MITF-low (1)
- MK801 (1)
- MLC tracking (1)
- MLLE domain (1)
- MMN (1)
- MMP (1)
- MMP-1 (1)
- MMP9 (1)
- MMQ cells (1)
- MNV type 3 (1)
- MOC fibers (1)
- MOD13Q1 (1)
- MODIS image (1)
- MODIS time-series (1)
- MOG-IgG (1)
- MOLLI (1)
- MOPC315.BM (1)
- MOR202 (1)
- MORN-repeat (1)
- MPACT (1)
- MPK12 (1)
- MPO (1)
- MPS (1)
- MR (1)
- MR angiography (1)
- MR guidance (1)
- MR neurography (1)
- MRI reporter (1)
- MRI spectroscopy (1)
- MRONJ (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MS-18 (1)
- MSC 11M35 (1)
- MSC: 14M15 (1)
- MSC: 49M37 (1)
- MSC: 53C22 (1)
- MSC: 53C35 (1)
- MSC: 65K05 (1)
- MSC: 90C30 (1)
- MSC: 90C40 (1)
- MSCI (1)
- MSCT (1)
- MSIS (1)
- MSSM (1)
- MSSS (1)
- MTB (1)
- MTCH2 (1)
- MTH1 (1)
- MTL30 (1)
- MTOR (1)
- MTX (1)
- MU-M (1)
- MUD (1)
- MUST-Score (1)
- MV receptor (1)
- MV transcription (1)
- MVT (1)
- MYB (1)
- MYCNv (1)
- Macaque monkey (1)
- Macrophage Migration Inhibitory Factor (MIF) (1)
- Macrophages (1)
- Mactel 2 (1)
- Maculinea butterfly (1)
- Mad Men (1)
- Madagascar (1)
- Magnesium (1)
- Magnetfeld (1)
- Magnetic resonance imaging(MRI) (1)
- Magnetic-resonance (1)
- Magnetic-resonance microscopy (1)
- Magnetresonanztomografie (1)
- Main-group chemistry (1)
- Maintenance (1)
- Maintenance treatment (1)
- Mais (1)
- Majeed (1)
- Majeed-Syndrome (1)
- Major abdominal surgery (1)
- Major depression (1)
- Major splice donor (1)
- Majorana fermions (1)
- Makrophage (1)
- Malaise trap (1)
- Malaria (1)
- Malaya (1)
- Male (1)
- Male breast cancer (1)
- Male intromittent organ (1)
- Malignancies (1)
- Malignant effusion (1)
- Malignant neoplasms (1)
- Malvaviscus arboreus (1)
- Mamestra brassicae (1)
- MammaJian mutagenicity test (1)
- Mammakarzinom (1)
- Mammalian genomes (1)
- Mammalian target (1)
- Management (1)
- Mandibular condyle (1)
- Mandibular continuity defects (1)
- Manganese (1)
- Manganese Carbonyl ligands (1)
- Mania (1)
- Manifestation (1)
- Mann-Kendall test (1)
- Mansoni infection (1)
- Mantle cell lymphoma (1)
- Marcus inverted region (1)
- Marfan syndrome (1)
- Markarian 501 (1)
- Markov chains (1)
- Marrakech (1)
- Marrow stromal cells (1)
- Martensit (1)
- Mass Spectrum (1)
- Mass critical care (1)
- Mass-spectrometry (1)
- Mast cells (1)
- Masticatory mucosa (1)
- Mastocytosis (1)
- Mastoid process (1)
- Materials chemistry (1)
- Materials science (1)
- Mato Grosso (1)
- Matrix (1)
- Matrix metalloproteinases (1)
- Matter (1)
- Maxwell demon (1)
- Mbt (1)
- McDonald criteria (1)
- McN-A-343 analogs (1)
- Mcl-1 (1)
- MeDALL (1)
- Measurement error correlation (1)
- Measurement invariance (1)
- Measuring masses (1)
- Meat (1)
- Mechanical strain (1)
- Mechanism of action (1)
- Mechanistic model (1)
- Medaka - Genetransfer - Transient expression - DNA fate - Fish developmental biology (1)
- Medaka fish (1)
- Media (1)
- Mediated Inflammatory Hyperalgesia (1)
- Medicago truncatula (1)
- Medical education (1)
- Medical history (1)
- Medical implants (1)
- Medical journals (1)
- Medical overuse (1)
- Medical research (1)
- Medical student (1)
- Medical students (1)
- Medicalization (1)
- Mediterranean environment (1)
- Medulloblastoma (1)
- Medullärer Schilddrüsenkrebs (1)
- Meeresschwämme (1)
- Megalobrama amblycephala (1)
- Megaponera analis (1)
- Mehrskalenmodell (1)
- Meige syndrome (1)
- Meiosis (1)
- Meisenheimer complex (1)
- Mekong-Delta (1)
- Melanocortin 4 receptor (MC4R) (1)
- Melanocyte stimulating hormones MSH (1)
- Melanoma B16 (1)
- Melanoma-cells (1)
- Melatonin (1)
- Meliponini (1)
- Mellitus (1)
- Melophorus-bagoti (1)
- Membranes (1)
- Memory (1)
- Memory B cells (1)
- Memory capacity (1)
- Memory dysfunction (1)
- Men (1)
- Mena/VASP (1)
- Meniere’s disease (1)
- Meningioma (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Mental arithmetic (1)
- Mental health therapies (1)
- Merkel cell carcinoma (MCC) (1)
- Merkel cell density (1)
- Merlin (1)
- Merocyanine (1)
- Merogone experiments (1)
- Mesenchymal stem cell (1)
- Mesenchymal transition (1)
- Mesh Augmentation (1)
- Mesoarchaean (1)
- Mesocestoides corti (1)
- Mesoskopisches System (1)
- Messenger RNA (1)
- Messenger Ribonucleoprotein Particles (1)
- Messenger-RNA (1)
- Messenger-RNAs (1)
- Messenger-RNS (1)
- Metaanalysis (1)
- Metabolic profiles (1)
- Metabolism saturation (1)
- Metabolismus (1)
- Metacestode (1)
- Metalloproteinasen (1)
- Metalloradicals (1)
- Metanephrine (1)
- Metapleural gland (1)
- Metarhizium anisopliae (1)
- Metastases (1)
- Metastatic melanoma (1)
- Meta‑analysis (1)
- Methanosarcina mazei (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Methoctramine (1)
- Methodological quality (1)
- Methylome (1)
- Mexican coffee plantations (1)
- Mexico City (1)
- Mexico [North America] (1)
- Mfn2 KO mice (1)
- MgAl LDH (1)
- MiMIC (1)
- MicroRNAs (1)
- Microarray analysis (1)
- Microarray data (1)
- Microbiology and Infectious Disease (1)
- Microcavity (1)
- Microcavity devices (1)
- Microenvironment (1)
- Microinjection (1)
- Micromonospora (1)
- Micronucleus formation (1)
- Micronucleus test (1)
- Microorganisms (1)
- Mid-infrared photoluminescence (1)
- Middle cerebral-artery (1)
- Midline (1)
- Midollo-Osseo (1)
- Mig1 (1)
- Migration (1)
- Migräne (1)
- Mikroarray (1)
- Mikrobiologie (1)
- Military shooting (1)
- Millisecond-timescale (1)
- Milnesium tardigradum (1)
- Mindfulness (1)
- Mini Unmanned Aerial Vehicle (1)
- Minimal Surface Tension (1)
- Minimal change disease (1)
- Minimal supersymmetric model (1)
- Minimalinvasiv (1)
- Minimalinvasive Leistenhernienversorgung (1)
- Minimally invasive surgery (1)
- Minischwein (1)
- Minor histocompatibility antigen mismatch transplantation (1)
- Minor subunits (1)
- Mip inhibitor (1)
- MircoRNA (1)
- Missense mutation (1)
- Missing Energy (1)
- MitoQ (1)
- Mitochondrial Matrix Protein (1)
- Mitomycin C (1)
- Mitosis (1)
- Mitotane (1)
- MitraClip (1)
- Mitsunobu (1)
- Mitteleuropa (1)
- Miyoshi myopathy (1)
- Mobile Sensor Network (1)
- Mobile application engineering (1)
- Mobile augmented reality (1)
- Mobile augmented reality game (1)
- Mobile genetic element (1)
- Model specification (1)
- Modell (1)
- Modified Nucleotides in tRNAs (1)
- Modifizierte Sugarbaker-Technik (1)
- Molecular Biophysics (1)
- Molecular Channel Transport (1)
- Molecular Imaging (1)
- Molecular beam epitaxy (1)
- Molecular biophysics (1)
- Molecular imaging (1)
- Molecular mechanism (1)
- Molecular pathogenesis (1)
- Molecular systematics (1)
- Molecular-dynamics (1)
- Molecular-genetics (1)
- Molecular-weight heparin (1)
- Molecularly targeted therapy (1)
- Molekulare Infektionsbiologie (1)
- Molekularpathologie (1)
- Molekularpharmakologie (1)
- Molekül (1)
- Molnupiravir (1)
- Molnupiravir-Induced RNA Mutagenesis Mechanism (1)
- Monoamine Oxidase/genetics (1)
- Monoclonal antibody (1)
- Monocytes and macrophages (1)
- Monopolar depression (1)
- Monte Carlo methods (1)
- Monte Carlo simulation (1)
- Monte-Carlo-Simulation (1)
- Mood disorders (1)
- Moose (1)
- Morbidity (1)
- Morbus Fabry (1)
- Morocco (1)
- Motion (1)
- Motion detection (1)
- Motivation (1)
- Motoneuron disease (1)
- Motor behaviour (1)
- Motor cortex (1)
- Motor nerve biopsy (1)
- Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors (1)
- Motor plasticity (1)
- Mott–Schottky analysis (1)
- Mouse models (1)
- Movement (1)
- Movement behavior (1)
- Mozambique (1)
- Mt. Kinabalu (1)
- Mucin (1)
- Mucopolysaccharidosis IIIa (1)
- Mucor (1)
- Mucorales (1)
- Mud (1)
- Multibranched structures (1)
- Multicenter randomized-trial (1)
- Multidetector computed tomography (1)
- Multimorbidity (1)
- Multiparameter predictor (1)
- Multiple (1)
- Multiple Sklerose (1)
- Multiple Traits (1)
- Multiple drug resistance (1)
- Multiple-Scattering (1)
- Multiple-Sclerosis (1)
- Multiplex PCR (1)
- Multipolar mitosis (1)
- Mund-Kiefer-Gesichts-Chirurgie (1)
- Munigua (1)
- Muon spectrometers (1)
- Mus spretus (1)
- Muscarinic M1 receptors (1)
- Muscarinic M1 receptors; Muscarinic M2 receptors (1)
- Muscarinic M3 receptor subtypes (1)
- Muscarinic M3selective antagonists (1)
- Muscarinic antagonist (1)
- Muscarinic receptor agonists (1)
- Muscarinic receptor antagonists (M 3-selective) (1)
- Muscarinic receptor antagonists (selective) (1)
- Muscarinic receptor subtype (1)
- Muscarinic receptor subtypes; Muscarinic rcceptor agonists (M 1-selective) (1)
- Muscarinie M2 receptors (1)
- Muscidifurax (1)
- Muscle function (1)
- Muscle power (1)
- Musearinic M4 receptors (1)
- Musearlnie M1 (1)
- Musearlnie aeetyleholine receptor agonists (1)
- Musearlnie aeetyleholine receptor antagonists (1)
- Musearlnie receptor subtypes (1)
- Mutagenicity (1)
- Mutagenicity assay (1)
- Mutagens (1)
- Mutant (1)
- Mutation assay (1)
- Mutation screening (1)
- Mwanza (1)
- Myanmar (1)
- Myb-MuvB (1)
- Myc (1)
- Myc Transcription (1)
- Mycobacterium avium (1)
- Mycobacterium caprae (1)
- Mycobacterium marinum (1)
- Mycobacterium tuberculosis complex (1)
- Mycoplasma (1)
- Myelin oligodendrocyte glycoprotein (MOG) antibodies (1)
- Myelitis (1)
- Myeloma cells (1)
- Myelomas (1)
- Myocardial fibrosis (1)
- Myocardial infarction (1)
- Myocardial perfusion (1)
- Myocardial-Infarction (1)
- Myocardial-perfusion SPECT (1)
- Myofibroblast differentiation (1)
- Myokarditis (1)
- Myrmecophytes (1)
- Myrmecophytism ; Malaysia ; trophobionts ; colony foundation ; Cladomyrma (1)
- Myrmica ant non-equilibrium dynamics (1)
- Müller cells (1)
- N-Acetyl-leukotriene E4 (1)
- N-CAM (1)
- N-Heterocyclic Carbene Adducts (1)
- N-Heterocyclic Carbenes (1)
- N-Heterocyclic carbenes (1)
- N-Myc down regulated gene 1 (1)
- N-functionalization (1)
- N-glycans (1)
- N-heterocyclic olefins (1)
- N-methyl-N-nitrosourea (1)
- N-methylpyridinium pyrene (1)
- N-oleoyl serinol (1)
- N-terminal HSP90 inhibitors (1)
- N-terminal domain (1)
- N100 (1)
- N1E 115 cells (1)
- N400 (1)
- NA (1)
- NA+/I-symporter (1)
- NA/I symporter (1)
- NAD (1)
- NAD(P)H-dehydrogenase (1)
- NAD(P)H-plastoquinone-oxidoreductase (1)
- NADH-dehydrogenase (1)
- NADPH (1)
- NADPH oxidase (1)
- NADPH oxidase 2 (NOX2) (1)
- NADPH oxidase inhibitors (1)
- NADPH oxidases (NOX) (1)
- NAKO (1)
- NAP-2 (1)
- NAS (1)
- NBAS (1)
- NCAM1 (1)
- NCH93 (1)
- NCI-60 (1)
- NCI-H295R (1)
- ND10 complex (1)
- NDH-H (1)
- NDH-I (1)
- NDH-J (1)
- NDH-K (1)
- NDI-H (1)
- NDVI thresholds (1)
- NEAT1 (1)
- NEC (1)
- NEIL2 (1)
- NETs (1)
- NEXAFS spectroscopy (1)
- NF-\(\kappa\)B (1)
- NF-\(\kappa\)B pathway (1)
- NF-κB/NFAT reporter cells (1)
- NF2-related schwannomatosis (NF2) (1)
- NFE2L2 (1)
- NFKB (1)
- NFkB-relatedgenes (1)
- NFkappaB (1)
- NFκB-activation (1)
- NHC Complexes (1)
- NHCs (1)
- NHLRC2 (1)
- NHX1 (1)
- NH\(_{3}\) (1)
- NI(111) (1)
- NIHSS (1)
- NIPAL4 (1)
- NIR OLED (1)
- NIRS (1)
- NK cell (1)
- NK cell deficiency (1)
- NK-DC cross-talk (1)
- NK-cells (1)
- NKG2D (1)
- NKG2D ligands (1)
- NLO QCD (1)
- NLPHL (1)
- NMD (1)
- NMDA receptor subunits NR2A and NR2B (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMJ–neuromuscular junction (1)
- NMO-IGG (1)
- NMO-IgG (1)
- NMR fingerprint (1)
- NMR relaxation (1)
- NMR-Tomographie (1)
- NMR-spectroscopy (1)
- NNLO (1)
- NO (1)
- NOP10 (1)
- NP-hard (1)
- NP-hardness (1)
- NPC1 gene (1)
- NPC2 gene (1)
- NPSI (1)
- NPSR1 (1)
- NPU (1)
- NPWT (1)
- NR3C1 (1)
- NRAS mutation (1)
- NRG1 (1)
- NS1608 (1)
- NSAIDs (1)
- NSG animals (1)
- NSG mice (1)
- NSG-SGM3 (1)
- NSG-UC (1)
- NT-proBNP (1)
- NTCDA (1)
- NTP-binding-properties (1)
- NT‐proBNP (1)
- NVLT (1)
- NVP-BGT226 (1)
- NaCl transport (1)
- NaV1.8 (1)
- NaV1.9 (1)
- Na\(_V\)1.8 (1)
- Nail unit (1)
- Naive T cells (1)
- Namibia (1)
- Nampt (1)
- Nanda-Hamner (1)
- NanoFEEP (1)
- Nanog protein (1)
- Nanos (1)
- Naphthylisoindolinone alkaloids (1)
- Nasal Carriage (1)
- Nash bargaining problem (1)
- Nash equilibria (1)
- Nash equilibrium (1)
- Nasonia (1)
- Nasonia courtship (1)
- Natalizumab (1)
- National Science Foundation (1)
- Natural product hybrids (1)
- Natural-history data (1)
- Ndrg1 (1)
- Neanderthal (1)
- Necrosis (1)
- Necrosis-factor-Alpha (1)
- Necrotizing enterocolitis (1)
- Nectin‐2 (1)
- Negative geotaxis (1)
- Neisseria (1)
- Nekrose (1)
- Nematode Caenorhabditis-elegans (1)
- Neoblast (1)
- Neolithic (1)
- Neolithic agriculture (1)
- Neolithic period (1)
- Neomycin Resistance (1)
- Neostriatum (1)
- Nephroblastoma (1)
- Neprilysin inhibition (1)
- Nerve fibers (1)
- Nerve growth factor (1)
- Nerve growth-factorcopy (1)
- Nervous system (1)
- Nesplora Aquarium (1)
- Nestin (1)
- Nesting resources (1)
- Netarsudil (1)
- Netherlands (1)
- Netrin (1)
- Network (1)
- Neugeborenes (1)
- Neural Differentiation (1)
- Neural basis (1)
- Neural circuits (1)
- Neural crest cells (1)
- Neural precursor cells (1)
- Neuralgie (1)
- Neuritis (1)
- Neuro-blastoma (1)
- Neuroblastoma (1)
- Neuroendocrine (1)
- Neuroendocrine Tumor (1)
- Neurofilament (1)
- Neurogenic inflammation (1)
- Neurogenie inflammation (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuromuscular junctions (1)
- Neuromyelitis optica (NMO) (1)
- Neuromyelitis optica antibodies (NMO-IgG) (1)
- Neuronal plasticity (1)
- Neuronal survival (1)
- Neuronales Netz (1)
- Neurone number (1)
- Neuropeptide (1)
- Neuropeptides (1)
- Neuroscience (1)
- Neurosciences (1)
- Neurotropathic Factor (1)
- Neurotrophin (1)
- Neutrino (1)
- Neutrino Detectors and Telescopes (experiments) (1)
- Neutrino Mass (1)
- Neutrino data (1)
- Neutrino detectors (1)
- Neutrino emission (1)
- Neutrino mass mixing (1)
- Neutrino telescope (1)
- Neutrophil (1)
- Neutrophils (1)
- New Species (1)
- New mexico (1)
- Newton methods (1)
- NfL (1)
- Nicandra (1)
- Nicardipine (1)
- Nickel ComplexCyclic (1)
- Nickel Complexes (1)
- Niedere Wirbeltiere (1)
- Niemann–Pick disease type C (1)
- Niere (1)
- Nierenfunktionsstörung (1)
- Niger <Ost> (1)
- Nile Delta (1)
- Nile Delta (Egypt) (1)
- Nile delta (1)
- Nile flow (1)
- Nissl stain (1)
- Nitric oxide (NO) (1)
- Nitric-oxide (1)
- Nitrogen metabolism (1)
- Nitrosation (1)
- Nitrosierung (1)
- Nivolumab (1)
- Njassasee (1)
- Nodo-parandopathy (1)
- Nodule (1)
- Nogo-A (1)
- Noise stimulation (1)
- Non-penetrating glaucoma surgery (1)
- Non-phototrophic bacteria (1)
- Non-reactive Measurement (1)
- Non-rigid image registration (1)
- Non-simultaneous bilateral distal biceps tendon rupture (1)
- Non-steroidal anti-inflammatory drug (1)
- Nonlinear Dynamics (1)
- Nonpathogenic Escherichia-coli (1)
- Nonverbal communications (1)
- Non‐ischaemic cardiogenic shock (1)
- Norbert Groeben (1)
- Normal Distribution (1)
- Normal breast (1)
- Normal tissue tolerance (1)
- Normetanephrine (1)
- North American (1)
- Northeastern Costa Rica (1)
- Northern Bald Ibis (1)
- Northern Xinjiang (1)
- Notch1 (1)
- Nothotaxa (1)
- Novel PI3K (1)
- Novobiocin (1)
- Npy (1)
- Npyr1 (1)
- Npyr2 (1)
- NuMA (1)
- Nuclear (1)
- Nuclear RDNA (1)
- Nuclear envelope (1)
- Nuclear expression (1)
- Nuclear pore complex (1)
- Nuclear pores (1)
- Nucleic Acids (1)
- Nucleobase Analogue (1)
- Nucleocytoplasmic exchange (1)
- Nucleocytoplasmic transport (1)
- Nucleolus-DNA (1)
- Nucleus (1)
- Nucleus accumbens (1)
- Nurses (1)
- Nursing homes (1)
- N‐Heterocyclic Carbenes (1)
- O6-alkylguanine-DNA alkyltransferase (1)
- OAT1 (1)
- OAT3 (1)
- OBF-1 OCA-B (1)
- OCB (1)
- OCSVM (1)
- OCT angiography (1)
- OCT-1-deficient mice (1)
- ODE (1)
- OECD guideline (1)
- OEG chains (1)
- OGG1 (1)
- OHIP-49 (1)
- OHIP-G14 (1)
- OHRQoL (1)
- OK cells (1)
- OLED (1)
- OLEDs (1)
- OLFM4 (1)
- ONJ (1)
- OPS201 (1)
- OPT (1)
- OPUS (1)
- OSC (1)
- OSCC (1)
- OSI (1)
- OSM (1)
- OXPHOS (1)
- OXTR (1)
- Obesity history (1)
- Object recognition (1)
- Observational study (1)
- Obturator bypass (1)
- Ockham (1)
- Oct4 (1)
- Octavalen (1)
- Oculomotor Muscles/physiology (1)
- Oesling (1)
- Ofatumumab (1)
- Oil (1)
- Oilseed rape (1)
- Oldenburg burnout inventory (1)
- Olefin Complexes (1)
- Olfr1393 (1)
- Olig2 (1)
- Oligoclonal bands (1)
- Oligofructoside (1)
- Omp85 (1)
- Oncogene (1)
- Oncolysis (1)
- Oncolytic action (1)
- Oncolytic vaccinia virus (1)
- Oncolytic virotherapy (1)
- Oncostatin-M-Receptor (1)
- OncotypeDX\(^{®}\) (1)
- One Health (1)
- One-loop Effective Potential (1)
- One-photon (1)
- Onset hypertrophic cardiomyopathy (1)
- Ontogeny (1)
- Oogenesis (1)
- Open source reconstructed epidermis (1)
- Open-source tool (1)
- Openfield test (1)
- Opioid receptor (1)
- OprO (1)
- OprP (1)
- OpsA (1)
- Opsins (1)
- Optical Activity (1)
- Optical Flow (1)
- Optical Music Recognition (1)
- Optical Spectroscopy (1)
- Optical coherence tomography (1)
- Optical control (1)
- Optical properties (1)
- Optogenetics (1)
- Orai2 (1)
- Oral anticoagulation (1)
- Oral antidiabetic drugs (1)
- Oral squamous cell carcinoma (1)
- Oralchirurgie (1)
- Oralsekret (1)
- Ordination methods (1)
- Organ motion (1)
- Organelles (1)
- Organoazides (1)
- Organoids (1)
- Orobanche crenata (1)
- Orthogonal field attenuation gel electrophoresis (1)
- Orthopädische Chirurgie (1)
- Oryza sativa (1)
- Oscillation (1)
- Oshana (1)
- Osmia (1)
- Osmia bicornis (1)
- Osmoregulation (1)
- Osmunda regalis (1)
- Osseointegration (1)
- Ostasien (1)
- Osteoarthrosis (1)
- Osteogeneration (1)
- Osteogenic precursor cells (1)
- Osteology (1)
- Osteomyelitis of the humerus (1)
- Osteopontin (1)
- Osteoporosis (1)
- Otolaryngolgy (1)
- Outcome (1)
- Outcomes (1)
- Outer membrane proteins (1)
- Outlier detection (1)
- Ovarian (1)
- Overdiagnosis (1)
- Overeating (1)
- Own-name (1)
- Oxford knee score (1)
- Oxide synthase gene (1)
- OxyR (1)
- Oxygen radical (1)
- Oxygen uptake (1)
- Oxyphencyclimine (1)
- O–I 1 fluorescence rise (1)
- P(P) over-bar collisions (1)
- P(P)over-bar collicions (1)
- P-cresyl sulfate (1)
- P-fimbriae (1)
- P-glycoprotein expression (1)
- P-gp (1)
- P-gp inhibitors (1)
- P. aeruginosa (1)
- P. falciparum (1)
- P100 (1)
- P14ARF (1)
- P15(INK4B) (1)
- P21 (1)
- P300 speller (1)
- P300 topography (1)
- P300-Speller (1)
- P515 (1)
- P67(PHOX) (1)
- P75 Neurotrophin receptor (1)
- P97 (1)
- PA-flexed view (1)
- PABC1 (1)
- PABP (1)
- PABPs (1)
- PAF-acether (1)
- PAG (1)
- PAH formation (1)
- PAI-1 (1)
- PAK4 (1)
- PALS (1)
- PAM2 (1)
- PAM2w (1)
- PAPA syndrome (1)
- PAR (1)
- PAR-CLIP (1)
- PARM (1)
- PARROT (1)
- PB-PB Collisions (1)
- PBEF (1)
- PBI cyclophane (1)
- PBM (1)
- PBPK/PBTK model (1)
- PC-1 blockade (1)
- PCDHGC3 (1)
- PCI (1)
- PCI-32765 (1)
- PCL retention (1)
- PCLS (1)
- PCR analysis (1)
- PCR diagnostics (1)
- PCa (1)
- PDE2 (1)
- PDE4-I (1)
- PDE4-inhibitor roflumilast (1)
- PDE4d (1)
- PDF set (1)
- PDGF (1)
- PDH (1)
- PD‐L1 (1)
- PEComa (1)
- PEGylation (1)
- PER-TIM complex (1)
- PEST (1)
- PET imaging (1)
- PET-1 (1)
- PET/MR systems (1)
- PETRI-seq (1)
- PF-05231023 (1)
- PF4 (1)
- PFA in ethanol (1)
- PFS25 (1)
- PGAS (1)
- PHQ-9 (1)
- PI stacking (1)
- PI-3-kinase (1)
- PI3K isoforms (1)
- PI3K/Akt/mTOR (1)
- PIA/ica (1)
- PICD (1)
- PID prevalence (1)
- PIK3CA mutations (1)
- PIK3R1 (1)
- PKB/Akt phosphorylation (1)
- PKC (1)
- PKCζ, (1)
- PKM2 (1)
- PKS I (1)
- PKS II (1)
- PLAG1 rearrangement (1)
- PLEKHG5 (1)
- PML nuclear-bodies (1)
- PMMA bone cement (1)
- PMNs (1)
- PMR (1)
- PNA (peptide nucleic acid) (1)
- PO (1)
- POEM (1)
- POLO-chart (1)
- POLSCORE (1)
- POTRA domain (1)
- POU6F2-AS2 (1)
- POZ domain (1)
- PP Collicions (1)
- PP Collisions (1)
- PP collisions (1)
- PP2A (1)
- PPAR-gamme (1)
- PPGPP (1)
- PPIase (1)
- PRAME (1)
- PRO (1)
- PROM’s (1)
- PRPF31 (1)
- PSA response (1)
- PSI-blast (1)
- PSMA PET/CT (1)
- PSMA-617 (1)
- PSMA-PET (1)
- PSMA-TV (1)
- PSMA‐617 (1)
- PSMC2 (1)
- PSP (1)
- PTA (1)
- PTCDA (1)
- PU.1 (1)
- PUFA (1)
- PUMP (1)
- PWV (1)
- PYY3-36 (1)
- Pacific Ocean (1)
- Paenibacillus (1)
- Paenibacterin (1)
- Paeonia (1)
- Pain questionnaire (1)
- Pain threshold ; Smoking ; Nicotine ; Acute tolerance ; Deprivation ; Psychophysiologicat measures (1)
- Pain-related evoked potentials (1)
- Pair Prodution (1)
- Pair-Production (1)
- Paleopedology (1)
- Palladium-catalyzed silaboration (1)
- Palliativmedizin (1)
- Palmoplantar keratoderma (1)
- Pamir (1)
- Pan1 (1)
- Pancreatic islet (1)
- Panic Disorder/genetics (1)
- Panic Disorder/therapy (1)
- Paprosky (1)
- Paradoxical heat sensation (1)
- Paraganglioma (1)
- Parallel fiber synapses (1)
- Parametric down-conversion (1)
- Parasite (1)
- Parasite development (1)
- Parastomale Hernie (1)
- Parataxonomy (1)
- Parent Piano-Stool Complex (1)
- Parent-of-origin (1)
- Parent–Child Interaction Therapy (PCIT) (1)
- Parietal cortex (1)
- Parkinsons diesease (1)
- Parkinsons-disease (1)
- Parkionson's disease (1)
- Partially parallel acquisitions (1)
- Particle accelerators (1)
- Particle dark matter (1)
- Particle physics (1)
- Particle production (1)
- Particle properties (1)
- Particle tracking detectors (Gaseous detectors) (1)
- Particle-acceleration (1)
- Particles (1)
- Partnership (1)
- Parton Ditributions (1)
- Parvovirus (1)
- Path-integraton (1)
- Pathogenesis (1)
- Pathogenicity (1)
- Pathologic neovascularization (1)
- Pathology (1)
- Patient Blood Management (PBM) (1)
- Patient Controlled Analgesia (1)
- Patient Satisfaction (1)
- Patient education (1)
- Patient-centered care (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Patron distributions (1)
- Pattern classification (1)
- Pauli procedure (1)
- Pauli-Verfahren (1)
- Pavlovian-to-instrumental transfer (1)
- Pearson correlation coefficient (1)
- Pediatric (1)
- Pediatric malignancy (1)
- Pedicled perforator flap (1)
- Pelvic tumors (1)
- Pelvisio® (1)
- Pentastomiasis (1)
- Pentixafor (1)
- Peptidase inhibitor 16 (PI16) (1)
- Peptide receptor radionuclide therapy (1)
- Peptide-leukotrienes (1)
- Peptidoglycan recognition (1)
- Perception (1)
- Performance (1)
- Perfusion (1)
- Perinatal Asphyxia (1)
- Period (1)
- Peripheral Inflammation (1)
- Peripheral blood lymphocytes (1)
- Peripheral nervous system (1)
- Perovskite (1)
- Personality (1)
- Personalized medicine (1)
- Perturbative QCD (1)
- Perugia-Kärpfling (1)
- Peter Singer (1)
- Petropedetidae (1)
- Peyer's patch (1)
- Peyer's patches (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pfam domain (1)
- Pflanzen (1)
- Pflanzeninhaltsstoff (1)
- Pfs230 (1)
- Phacocanaloplasty (1)
- Phacotrabeculectomy (1)
- Phaeophyceae (1)
- Pharmacokinetics (1)
- Pharmacological management (1)
- Phase II trial (1)
- Phase II trials (1)
- Phase- (1)
- Phasenumwandlung (1)
- Phedimus middendorffianus, var. diffusus (1)
- Phedimus spurius subsp. oppositifolius (1)
- PhenoCam (1)
- Phenolic acids (1)
- Phenols (1)
- Pheromone (1)
- Phoenix dactylifera (1)
- Phonological awareness (1)
- Phosphatidylinositol metabolism (1)
- Phosphodiesterase (1)
- Photic (1)
- Photoactivated localization microscopy (1)
- Photoaffinity labelling (1)
- Photocatalysis (1)
- Photoelektron (1)
- Photoelektronenspektroskopie (1)
- Photon detectors for UV, visible and IR photons (vacuum) (1)
- Photon migration (1)
- Photons (1)
- Photosystem I (1)
- Phrynobatrachus amphibia (1)
- Phylogenetics (1)
- Phylogenie (1)
- Physalis (1)
- Physical Activity (1)
- Physical Sciences (1)
- Physical fitness (1)
- Physical impairment (1)
- Physical sciences (1)
- Physics and instrumentation (1)
- Physiological functions (1)
- Physiologically based kinetic models (1)
- Picea mariana (1)
- Pigmentarchitectonics (1)
- Pilot studies (1)
- Pilus (1)
- Pilzbefall (1)
- Pinus sylvestris L. (1)
- Pirenzepine (1)
- Pitfall (1)
- Pithed rat (1)
- Pitrakinra (1)
- Pityriasis lichenoides (1)
- PknB (1)
- Placebo-controlled trial (1)
- Planetary Health (1)
- Planetary Health Education (1)
- Plant growth promotion (1)
- Plant root endophyte (1)
- Plant signalling (1)
- Plant utricularia-gibba (1)
- Plant-herbivore interactions (1)
- Plant-insect interactions (1)
- Plantation forests (1)
- Plasma (1)
- Plasma extravasation (1)
- Plasmid (1)
- Plastid DNA (1)
- Plataspidae (1)
- Platelet-derived growthfactor (1)
- Platform economy (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Pleistocene (1)
- Pleistozän (1)
- Plumbylenes (1)
- Pluripotency (1)
- Plus (1)
- Plus Plus (1)
- Pneumococcal vaccination (1)
- Pneumococci (1)
- Pneumocystis-carinii-pneumonia (1)
- Pnictogen reduction (1)
- Po (1)
- Podocarpus National Park (1)
- Poecilia (Teleostei: Poeciliidae) (1)
- Poecilia reticulata (1)
- Poeciliid fish (1)
- Pointing error (1)
- Pointmutation (1)
- Poisson algebras (1)
- Poisson surface reconstruction (1)
- Pol II (1)
- Polanyi (1)
- Polarimetric Synthetic Aperture Radar (PolSAR) (1)
- Polarity index (1)
- Polistine wasps (1)
- Politik (1)
- Pollination (1)
- Pollinators (1)
- Poly(A) binding protein (1)
- Polyadenylation (1)
- Polyadenylierung (1)
- Polycistronic mRNA (1)
- Polygonum cuspidatum (1)
- Polylactide-co-glycolide (1)
- Polymer-drug interaction (1)
- Polymerase chain raction (1)
- Polymers (1)
- Polymorphisms (1)
- Polyoma-Virus (1)
- Polyphasic fluorescence rise (1)
- Polyphenols (1)
- Polyspermy (1)
- Pompe disease (1)
- Pom‐PAD‐Dara (1)
- Pontryagin maximum principle (1)
- Poor-prognosis (1)
- Poplars (1)
- PorB (1)
- Porcine eye (1)
- Porifera (1)
- Porphyrin arrays (1)
- Port (1)
- Portland cement (1)
- Positioning (1)
- Positive-Pressure Respiration (1)
- Positron Emission Tomography (1)
- Positron annihilation spectroscopy (1)
- Positron-Emission Tomography (1)
- Positron-emission-tomography (1)
- Positronenemissionstomografie (1)
- Post-traumatic stress disorder (1)
- Posteriore Komponentenseparation (1)
- Postmarketing Experience (1)
- Postoperative complications (1)
- Potential-energy curves (1)
- Potentials (1)
- Pou2af1 (1)
- Practice (1)
- Practitioner's guide (1)
- Precipitation gradient (1)
- Preclinical evaluation (1)
- Predict fluid responsiveness (1)
- Prediction (1)
- Predictions (1)
- Predictive toxicology (1)
- Predictive value of tests (1)
- Predictors (1)
- Prednisolon (1)
- Predominant polarity (1)
- Pregnancy (1)
- Premna (1)
- Preserved Ejection Fraction (1)
- Preterm birth (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Prfa-mediated virulence (1)
- Primary care (1)
- Primary cell lines (1)
- Primary endosymbiont (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (1348)
- Physikalisches Institut (372)
- Institut für Psychologie (358)
- Medizinische Klinik und Poliklinik II (352)
- Neurologische Klinik und Poliklinik (350)
- Medizinische Klinik und Poliklinik I (332)
- Institut für Molekulare Infektionsbiologie (300)
- Institut für Anorganische Chemie (252)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (250)
- Institut für Organische Chemie (237)
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (11)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (7)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (5)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Johns Hopkins University School of Medicine (4)
- Zentraleinheit Klinische Massenspektrometrie (4)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (2)
- Interdisciplinary Center for Clinical Research (2)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) (2)
ResearcherID
- D-1221-2009 (1)
Jet mass and substructure of inclusive jets in √s=7 TeV pp collisions with the ATLAS experiment
(2012)
Recent studies have highlighted the potential of jet substructure techniques to identify the hadronic decays of boosted heavy particles. These studies all rely upon the assumption that the internal substructure of jets generated by QCD radiation is well understood. In this article, this assumption is tested on an inclusive sample of jets recorded with the ATLAS detector in 2010, which corresponds to 35 pb\(^{−1}\) of pp collisions delivered by the LHC at √s=7TeV. In a subsample of events with single pp collisions, measurements corrected for detector efficiency and resolution are presented with full systematic uncertainties. Jet invariant mass, k\(_t\) splitting scales and N-subjettiness variables are presented for anti-k\(_t\) R = 1.0 jets and Cambridge-Aachen R = 1.2 jets. Jet invariant-mass spectra for Cambridge-Aachen R = 1.2 jets after a splitting and filtering procedure are also presented. Leading-order parton-shower Monte Carlo predictions for these variables are found to be broadly in agreement with data. The dependence of mean jet mass on additional pp interactions is also explored.
Narrow resonances decaying into WW, WZ or ZZ boson pairs are searched for in 36.7 fb(-1) of proton-proton collision data at a centre-of-mass energy of root s = 13 TeV recorded with the ATLAS detector at the Large Hadron Collider in 2015 and 2016. The diboson system is reconstructed using pairs of large-radius jets with high transverse momentum and tagged as compatible with the hadronic decay of high-momentum Wor Zbosons, using jet mass and substructure properties. The search is sensitive to diboson resonances with masses in the range 1.2-5.0 TeV. No significant excess is observed in any signal region. Exclusion limits are set at the 95% confidence level on the production cross section times branching ratio to dibosons for a range of theories beyond the Standard Model. Model-dependent lower limits on the mass of new gauge bosons are set, with the highest limit set at 3.5 TeV in the context of mass-degenerate resonances that couple predominantly to bosons. (c) 2017 The Author(s). Published by Elsevier B.V.
The production of a top quark in association with a Z boson is investigated. The proton-proton collision data collected by the ATLAS experiment at the LHC in 2015 and 2016 at a centre-of-mass energy of root s = 13 TeV are used, corresponding to an integrated luminosity of 36.1 fb(-1). Events containing three identified leptons (electrons and/or muons) and two jets, one of which is identified as a b-quark jet are selected. The major backgrounds are diboson, tt($)over-bar and Z + jets production. A neural network is used to improve the background rejection and extract the signal. The resulting significance is 4.2 sigma in the data and the expected significance is 5.4 sigma. The measured cross-section for tZq production is 600 +/- 170(stat.)+/- 140(syst.)fb. (C) 2018 The Author(s). Published by Elsevier B.V.
A search for heavy resonances decaying into a Higgs boson (H) and a new particle (X) is reported, utilizing 36.1 fb(-1) of proton-proton collision data at root s = 13 TeV collected during 2015 and 2016 with the ATLAS detector at the CERN Large Hadron Collider. The particle Xis assumed to decay to a pair of light quarks, and the fully hadronic final state XH -> q (q) over bar 'b (b) over bar is analysed. The search considers the regime of high XH resonance masses, where the X and H bosons are both highly Lorentz-boosted and are each reconstructed using a single jet with large radius parameter. A two-dimensional phase space of XH mass versus X mass is scanned for evidence of a signal, over a range of XH resonance mass values between 1 TeV and 4 TeV, and for X particles with masses from 50 GeV to 1000 GeV. All search results are consistent with the expectations for the background due to Standard Model processes, and 95% CL upper limits are set, as a function of XH and X masses, on the production cross-section of the XH -> q (q) over bar 'b (b) over bar resonance. (c) 2018 The Author(s). Published by Elsevier B.V.
A search for an invisibly decaying Higgs boson or dark matter candidates produced in association with a leptonically decaying Z boson in proton-proton collisions at root s = 13 TeV is presented. This search uses 36.1 fb(-1) of data collected by the ATLAS experiment at the Large Hadron Collider. No significant deviation from the expectation of the Standard Model backgrounds is observed. Assuming the Standard Model ZH production cross-section, an observed (expected) upper limit of 67% (39%) at the 95% confidence level is set on the branching ratio of invisible decays of the Higgs boson with mass m(H) = 125 GeV. The corresponding limits on the production cross-section of the ZH process with the invisible Higgs boson decays are also presented. Furthermore, exclusion limits on the dark matter candidate and mediator masses are reported in the framework of simplified dark matter models. (c) 2017 The Author(s). Published by Elsevier B.V.
A search is conducted for new resonances decaying into a W or Z boson and a 125 GeV Higgs boson in the nu(nu) over barb (b) over bar, l(+/-)nu b (b) over bar, and l(+)l(-)b (b) over bar final states, where l(+/-) = e(+/-) or mu(+/-), in pp collisions at root s = 13 TeV. The data used correspond to a total integrated luminosity of 36.1 fb(-1) collected with the ATLAS detector at the Large Hadron Collider during the 2015 and 2016 data-taking periods. The search is conducted by examining the reconstructed invariant or transverse mass distributions of Wh and Zh candidates for evidence of a localised excess in the mass range of 220 GeV up to 5 TeV. No significant excess is observed and the results are interpreted in terms of constraints on the production cross-section times branching fraction of heavy W' and Z' resonances in heavy-vector-triplet models and the CP-odd scalar boson A in two-Higgs-doublet models. Upper limits are placed at the 95% confidence level and range between 9.0 x 10(-4) pb and 7.3 x 10(-1) pb depending on the model and mass of the resonance.
Results from a search for supersymmetry in events with four or more charged leptons (electrons, muons and taus) are presented. The analysis uses a data sample corresponding to 36.1 fb(-1) of proton-proton collisions delivered by the Large Hadron Collider at root s = 13 TeV and recorded by the ATLAS detector. Four-lepton signal regions with up to two hadronically decaying taus are designed to target a range of supersymmetric scenarios that can be either enriched in or depleted of events involving the production and decay of a Z boson. Data yields are consistent with Standard Model expectations and results are used to set upper limits on the event yields from processes beyond the Standard Model. Exclusion limits are set at the 95% confidence level in simplified models of general gauge mediated supersymmetry, where Higgsino masses are excluded up to 295 GeV. In R-parity-violating simplified models with decays of the lightest supersymmetric particle to charged leptons, lower limits of 1.46, 1.06, and 2.25 TeV are placed on wino, slepton and gluino masses, respectively.
A detailed study of multiparticle azimuthal correlations is presented using pp data at root s = 5.02 and 13 TeV, and p+Pb data at root s(NN) = 5.02 TeV, recorded with the ATLAS detector at the CERN Large Hadron Collider. The azimuthal correlations are probed using four-particle cumulants c(n){4} and flow coefficients v(n){4} = (-c(n){4})(1/4) for n = 2 and 3, with the goal of extracting long-range multiparticle azimuthal correlation signals and suppressing the short-range correlations. The values of c(n){4} are obtained as a function of the average number of charged particles per event, < N-ch >, using the recently proposed two-subevent and three-subevent cumulant methods, and compared with results obtained with the standard cumulant method. The standard method is found to be strongly biased by short-range correlations, which originate mostly from jetswith a positive contribution to c(n){4}. The threesubevent method, on the other hand, is found to be least sensitive to short-range correlations. The three-subevent method gives a negative c(2){4}, and therefore a well-defined v(2){4}, nearly independent of < N-ch >, which implies that the long-range multiparticle azimuthal correlations persist to events with low multiplicity. Furthermore, v(2){4} is found to be smaller than the v(2){2} measured using the two-particle correlation method, as expected for long-range collective behavior. Finally, the measured values of v(2){4} and v(2){2} are used to estimate the number of sources relevant for the initial eccentricity in the collision geometry. The results based on the subevent cumulant technique provide direct evidence, in small collision systems, for a long-range collectivity involving many particles distributed across a broad rapidity interval.
This paper presents a measurement of the W boson production cross section and the W+/W- cross-section ratio, both in association with jets, in proton-proton collisions at root s = 8 TeV with the ATLAS experiment at the Large Hadron Collider. The measurement is performed in final states containing one electron and missing transverse momentum using data corresponding to an integrated luminosity of 20.2 fb(-1). Differential cross sections for events with at least one or two jets are presented for a range of observables, including jet transverse momenta and rapidities, the scalar sum of transverse momenta of the visible particles and the missing transverse momentum in the event, and the transverse momentum of the W boson. For a subset of the observables, the differential cross sections of positively and negatively charged W bosons are measured separately. In the cross-section ratio of W+/W- the dominant systematic uncertainties cancel out, improving the measurement precision by up to a factor of nine. The observables and ratios selected for this paper provide valuable input for the up quark, down quark, and gluon parton distribution functions of the proton.
Measurements of differential cross-sections of top-quark pair production in fiducial phase-spaces are presented as a function of top-quark and \(t\overline{t}\) system kinematic observables in proton-proton collisions at a centre-of-mass energy of \(\sqrt{s}\) = 13 TeV. The data set corresponds to an integrated luminosity of 3.2 fb\(^{−1}\), recorded in 2015 with the ATLAS detector at the CERN Large Hadron Collider. Events with exactly one electron or muon and at least two jets in the final state are used for the measurement. Two separate selections are applied that each focus on different top-quark momentum regions, referred to as resolved and boosted topologies of the \(t\overline{t}\) final state. The measured spectra are corrected for detector effects and are compared to several Monte Carlo simulations by means of calculated \(χ^2\) and \(p\)-values.
A search is presented for narrow diboson resonances decaying to WW or WZ in the final state where one W boson decays leptonically (to an electron or a muon plus a neutrino) and the other W/Z boson decays hadronically. The analysis is performed using an integrated luminosity of 20.3 fb\(^{−1}\) of pp collisions at \(\sqrt {s}\) = 8 TeV collected by the ATLAS detector at the large hadron collider. No evidence for resonant diboson production is observed, and resonance masses below 700 and 1490 GeV are excluded at 95 % confidence level for the spin-2 Randall–Sundrum bulk graviton G\(^{*}\) with coupling constant of 1.0 and the extended gauge model W′ boson respectively.
The mass of the top quark is measured in a data set corresponding to 4.6 fb\(^{-1}\) of proton–proton collisions with centre-of-mass energy \(\sqrt {s}\)=7 TeV collected by the ATLAS detector at the LHC. Events consistent with hadronic decays of top–antitop quark pairs with at least six jets in the final state are selected. The substantial background from multijet production is modelled with data-driven methods that utilise the number of identified b-quark jets and the transverse momentum of the sixth leading jet, which have minimal correlation. The top-quark mass is obtained from template fits to the ratio of three-jet to dijet mass. The three-jet mass is calculated from the three jets produced in a top-quark decay. Using these three jets the dijet mass is obtained from the two jets produced in the W boson decay. The top-quark mass obtained from this fit is thus less sensitive to the uncertainty in the energy measurement of the jets. A binned likelihood fit yields a top-quark mass of m\(_{t}\)= 175.1 ± 1.4 (stat.) ± 1.2 (syst.) GeV.
A search for the supersymmetric partners of quarks and gluons (squarks and gluinos) in final states containing hadronic jets and missing transverse momentum, but no electrons or muons, is presented. The data used in this search were recorded in 2015 and 2016 by the ATLAS experiment in root s = 13 TeV proton-proton collisions at the Large Hadron Collider, corresponding to an integrated luminosity of 36.1 fb(-1). The results are interpreted in the context of various models where squarks and gluinos are pair produced and the neutralino is the lightest supersymmetric particle. An exclusion limit at the 95% confidence level on the mass of the gluino is set at 2.03 TeV for a simplified model incorporating only a gluino and the lightest neutralino, assuming the lightest neutralino is massless. For a simplified model involving the strong production of mass-degenerate first-and second-generation squarks, squark masses below 1.55 TeVare excluded if the lightest neutralino is massless. These limits substantially extend the region of supersymmetric parameter space previously excluded by searches with the ATLAS detector.
Measurements of ZZ production in the l(+)l(-)l'(+)l'(-) channel in proton-proton collisions at 13 TeV center-of-mass energy at the Large Hadron Collider are presented. The data correspond to 36.1 fb(-1) of collisions collected by the ATLAS experiment in 2015 and 2016. Here l and l ' stand for electrons or muons. Integrated and differential ZZ -> l(+)l(-)l'(+)l'(-) cross sections with Z -> l(+)l(-) candidate masses in the range of 66 GeV to 116 GeV are measured in a fiducial phase space corresponding to the detector acceptance and corrected for detector effects. The differential cross sections are presented in bins of twenty observables, including several that describe the jet activity. The integrated cross section is also extrapolated to a total phase space and to all standard model decays of Z bosons with mass between 66 GeV and 116 GeV, resulting in a value of 17.3 +/- 0.9 [+/- 0.6(start) +/- 0.5 (syst) +/- 0.6 (lumi)] pb. The measurements are found to be in good agreement with the standard model. A search for neutral triple gauge couplings is performed using the transverse momentum distribution of the leading Z boson candidate. No evidence for such couplings is found and exclusion limits are set on their parameters.
A search is presented for the direct pair production of the stop, the supersymmetric partner of the top quark, that decays through an R-parity-violating coupling to a final state with two leptons and two jets, at least one of which is identified as a b-jet. The data set corresponds to an integrated luminosity of 36.1 fb(-1) of proton-proton collisions at a center-of-mass energy of root s = 13 TeV, collected in 2015 and 2016 by the ATLAS detector at the LHC. No significant excess is observed over the Standard Model background, and exclusion limits are set on stop pair production at a 95% confidence level. Lower limits on the stop mass are set between 600 GeV and 1.5 TeV for branching ratios above 10% for decays to an electron or muon and a b-quark.
This Letter presents a search for new light resonances decaying to pairs of quarks and produced in association with a high-p(T) photon or jet. The dataset consists of proton-proton collisions with an integrated luminosity of 36.1 fb(-1) at a centre-of-mass energy of root s = 13 TeV recorded by the ATLAS detector at the Large Hadron Collider. Resonance candidates are identified as massive large-radius jets with substructure consistent with a particle decaying into a quark pair. The mass spectrum of the candidates is examined for local excesses above background. No evidence of a new resonance is observed in the data, which are used to exclude the production of a lepto-phobic axial-vector Z' boson. (C) 2018 The Author(s). Published by Elsevier B.V.
The dynamics of isolated-photon production in association with a jet in proton-proton collisions at a centre-of-mass energy of 13 TeV are studied with the ATLAS detector at the LHC using a dataset with an integrated luminosity of 3.2 fb(-1). Photons are required to have transverse energies above 125 GeV. Jets are identified using the anti-k(t) algorithm with radius parameter R = 0.4 and required to have transverse momenta above 100 GeV. Measurements of isolated-photon plus jet cross sections are presented as functions of the leading-photon transverse energy, the leading-jet transverse momentum, the azimuthal angular separation between the photon and the jet, the photon-jet invariant mass and the scattering angle in the photon-jet centre-of-mass system. Tree-level plus parton-shower predictions from SHERPA and PYTHIA as well as next-to-leading-order QCD predictions from JETPHOX and SHERPA are compared to the measurements. (C) 2018 The Author. Published by Elsevier B.V.
The production of exclusive gamma gamma -> mu(+)mu(-) events in proton-proton collisions at a centre-of-mass energy of 13 TeV is measured with the ATLAS detector at the LHC, using data corresponding to an integrated luminosity of 3.2 fb(-1). The measurement is performed for a dimuon invariant mass of 12 GeV < m(mu+mu-) < 70 GeV. The integrated cross-section is determined within a fiducial acceptance region of the ATLAS detector and differential cross-sections are measured as a function of the dimuon invariant mass. The results are compared to theoretical predictions both with and without corrections for absorptive effects. (c) 2017 The Author(s). Published by Elsevier B.V.
An angular analysis of the decay B-d(0) -> K*mu(+)mu(-) is presented, based on proton-proton collision data recorded by the ATLAS experiment at the LHC. The study is using 20.3 fb(-1) of integrated luminosity collected during 2012 at centre-of-mass energy of root s = 8TeV. Measurements of the K* longitudinal polarisation fraction and a set of angular parameters obtained for this decay are presented. The results are compatible with the Standard Model predictions.
Search for exclusive Higgs and Z boson decays to phi gamma and rho gamma with the ATLAS detector
(2018)
A search for the exclusive decays of the Higgs and Z bosons to a phi or rho meson and a photon is performed with a pp collision data sample corresponding to an integrated luminosity of up to 35.6 fb(-1) collected at root s = 13 TeV with the ATLAS detector at the CERN Large Hadron Collider. These decays have been suggested as a probe of the Higgs boson couplings to light quarks. No significant excess of events is observed above the background, as expected from the Standard Model. Upper limits at 95% confidence level were obtained on the branching fractions of the Higgs boson decays to phi gamma and rho gamma of 4.8 x 10(-4) and 8.8 x 10(-4), respectively. The corresponding 95% confidence level upper limits for the Z boson decays are 0.9 x 10(-6) and 25 x 10(-6) for phi gamma and rho gamma, respectively.
A search for long-lived, massive particles predicted by many theories beyond the Standard Model is presented. The search targets final states with large missing transverse momentum and at least one highmass displaced vertex with five or more tracks, and uses 32.8 fb(-1) of root s = 13 TeV pp collision data collected by the ATLAS detector at the LHC. The observed yield is consistent with the expected background. The results are used to extract 95% C.L. exclusion limits on the production of long-lived gluinos with masses up to 2.37 TeV and lifetimes of O(10(-2)) - O(10) ns in a simplified model inspired by split supersymmetry.
A search for supersymmetric partners of gluons and quarks is presented, involving signatures with jets and either two isolated leptons (electrons or muons) with the same electric charge, or at least three isolated leptons. A data sample of proton-proton collisions at root s = 13 TeV recorded with the ATLAS detector at the Large Hadron Collider between 2015 and 2018, corresponding to a total integrated luminosity of 139 fb(-1), is used for the search. No significant excess over the Standard Model expectation is observed. The results are interpreted in simplified supersymmetric models featuring both R-parity conservation and R-parity violation, raising the exclusion limits beyond those of previous ATLAS searches to 1600 GeV for gluino masses and 750 GeV for bottom and top squark masses in these scenarios.
Measurements of the W production cross sections in association with jets with the ATLAS detector
(2015)
This paper presents cross sections for the production of a W boson in association with jets, measured in proton–proton collisions at \(\sqrt {s}\) = 7 TeV with the ATLAS experiment at the large hadron collider. With an integrated luminosity of 4.6 fb\(^{−1}\), this data set allows for an exploration of a large kinematic range, including jet production up to a transverse momentum of 1 TeV and multiplicities up to seven associated jets. The production cross sections for W bosons are measured in both the electron and muon decay channels. Differential cross sections for many observables are also presented including measurements of the jet observables such as the rapidities and the transverse momenta as well as measurements of event observables such as the scalar sums of the transverse momenta of the jets. The measurements are compared to numerous QCD predictions including next-to-leading-order perturbative calculations, resummation calculations and Monte Carlo generators.
Measurements of the ZZ and WW final states in the mass range above the 2m\(_Z\) and 2m\(_W\) thresholds provide a unique opportunity to measure the off-shell coupling strength of the Higgs boson. This paper presents constraints on the off-shell Higgs boson event yields normalised to the Standard Model prediction (signal strength) in the ZZ→4ℓ, ZZ→2ℓ2ν and WW→eνμν final states. The result is based on pp collision data collected by the ATLAS experiment at the LHC, corresponding to an integrated luminosity of 20.3 fb\(^{-1}\) at a collision energy of \(\sqrt {s}\)=8 TeV. Using the CL\(_S\) method, the observed 95 % confidence level (CL) upper limit on the off-shell signal strength is in the range 5.1–8.6, with an expected range of 6.7–11.0. In each case the range is determined by varying the unknown gg→ZZ and gg→WW background K-factor from higher-order quantum chromodynamics corrections between half and twice the value of the known signal K-factor. Assuming the relevant Higgs boson couplings are independent of the energy scale of the Higgs boson production, a combination with the on-shell measurements yields an observed (expected) 95 % CL upper limit on Γ\(_H\)/Γ\(^{SM}_{H}\) in the range 4.5–7.5 (6.5–11.2) using the same variations of the background K-factor. Assuming that the unknown gg→VV background K-factor is equal to the signal K-factor, this translates into an observed (expected) 95 % CL upper limit on the Higgs boson total width of 22.7 (33.0) MeV.
High transverse momentum jets produced in pp collisions at a centre of mass energy of 7 TeV are used to measure the transverse energy–energy correlation function and its associated azimuthal asymmetry. The data were recorded with the ATLAS detector at the LHC in the year 2011 and correspond to an integrated luminosity of 158 pb\(^{-1}\). The selection criteria demand the average transverse momentum of the two leading jets in an event to be larger than 250 GeV. The data at detector level are well described by Monte Carlo event generators. They are unfolded to the particle level and compared with theoretical calculations at next-to-leading-order accuracy. The agreement between data and theory is good and provides a precision test of perturbative Quantum Chromodynamics at large momentum transfers. From this comparison, the strong coupling constant given at the Z boson mass is determined to be αs(m\(_{Z}\))=0.1173±0.0010 (exp.) \(^{+0.0065}_{−0.0026}\) (theo.).
Double-differential three-jet production cross-sections are measured in proton–proton collisions at a centre-of-mass energy of \(\sqrt {s}\) = 7 TeV using the ATLAS detector at the large hadron collider. The measurements are presented as a function of the three-jet mass (m\(_{jjj}\)), in bins of the sum of the absolute rapidity separations between the three leading jets (|Y\(^{*}\)|). Invariant masses extending up to 5 TeV are reached for 8 < |Y\(^{*}\)| < 10. These measurements use a sample of data recorded using the ATLAS detector in 2011, which corresponds to an integrated luminosity of 4.51 fb\(^{-1}\). Jets are identified using the anti-k\(_{t}\) algorithm with two different jet radius parameters, R = 0.4 and R = 0.6. The dominant uncertainty in these measurements comes from the jet energy scale. Next-to-leading-order QCD calculations corrected to account for non-perturbative effects are compared to the measurements. Good agreement is found between the data and the theoretical predictions based on most of the available sets of parton distribution functions, over the full kinematic range, covering almost seven orders of magnitude in the measured cross-section values.
The top quark mass was measured in the channels t\(\overline{t}\) → lepton+jets and t\(\overline{t}\) → dilepton (lepton = e,μ) based on ATLAS data recorded in 2011. The data were taken at the LHC with a proton–proton centre-of-mass energy of \(\sqrt {s}\) = 7 TeV and correspond to an integrated luminosity of 4.6 fb\(^{-1}\). The t\(\overline{t}\) → lepton+jets analysis uses a three-dimensional template technique which determines the top quark mass together with a global jet energy scale factor (JSF), and a relative b-to-light-jet energy scale factor(bJSF), where the terms b-jets and light-jets refer to jets originating from b-quarks and u, d, c, s-quarks or gluons, respectively. The analysis of the t\(\overline{t}\) → dilepton channel exploits a one-dimensional template method using the m\(_{lb}\) observable, defined as the average invariant mass of the two lepton+b-jet pairs in each event. The top quark
mass is measured to be 172.33±0.75(stat + JSF + bJSF)±1.02(syst) GeV, and 173.79 ± 0.54(stat) ± 1.30(syst) GeV in the t\(\overline{t}\) → lepton+jets and t\(\overline{t}\) → dilepton channels, respectively. The combination of the two results yields m\(_{top}\) =172.99 ± 0.48(stat) ± 0.78(syst) GeV, with a total uncertainty of 0.91 GeV.
Two searches for supersymmetric particles in final states containing a same-flavour opposite-sign lepton pair, jets and large missing transverse momentum are presented. The proton–proton collision data used in these searches were collected at a centre-of-mass energy \(\sqrt {s}\) = 8 TeV by the ATLAS detector at the Large Hadron Collider and corresponds to an integrated luminosity of 20.3 fb\(^{−1}\). Two leptonic production mechanisms are considered: decays of squarks and gluinos with Z bosons in the final state, resulting in a peak in the dilepton invariant mass distribution around the Z-boson mass; and decays of neutralinos (e.g. \(\tilde{χ}\)\(^{0}_{2}\) → ℓ\(^{+}\)ℓ\(^{−}\)\(\tilde{χ}\)\(^{0}_{1}\)), resulting in a kinematic endpoint in the dilepton invariant mass distribution. For the former, an excess of events above the expected Standard Model background is observed, with a significance of three standard deviations. In the latter case, the data are well-described by the expected Standard Model background. The results from each channel are interpreted in the context of several supersymmetric models involving the production of squarks and gluinos.
This paper presents a search for direct electroweak gaugino or gluino pair production with a chargino nearly mass-degenerate with a stable neutralino. It is based on an integrated luminosity of 36.1 fb(-1) of pp collisions at root s = 13 TeV collected by the ATLAS experiment at the LHC. The final state of interest is a disappearing track accompanied by at least one jet with high transverse momentum from initial-state radiation or by four jets from the gluino decay chain. The use of short track segments reconstructed from the innermost tracking layers significantly improves the sensitivity to short chargino lifetimes. The results are found to be consistent with Standard Model predictions. Exclusion limits are set at 95% confidence level on the mass of charginos and gluinos for different chargino lifetimes. For a pure wino with a lifetime of about 0.2 ns, chargino masses up to 460 GeV are excluded. For the strong production channel, gluino masses up to 1.65 TeV are excluded assuming a chargino mass of 460 GeV and lifetime of 0.2 ns.
The paper presents studies of Bose–Einstein Correlations (BEC) for pairs of like-sign charged particles measured in the kinematic range p\(_{T}\) > 100 MeV and |η| < 2.5 in proton collisions at centre-of-mass energies of 0.9 and 7 TeV with the ATLAS detector at the CERN Large Hadron Collider. The integrated luminosities are approximately 7 μb\(^{−1}\), 190 μb\(^{−1}\) and 12.4 nb\(^{−1}\) for 0.9 TeV, 7 TeV minimum-bias and 7 TeV high-multiplicity data samples, respectively. The multiplicity dependence of the BEC parameters characterizing the correlation strength and the correlation source size are investigated for charged-particle multiplicities of up to 240. A saturation effect in the multiplicity dependence of the correlation source size parameter is observed using the high-multiplicity 7 TeV data sample. The dependence of the BEC parameters on the average transverse momentum of the particle pair is also investigated.
A search for a new resonance decaying to a W or Z boson and a Higgs boson in the ℓℓ/ℓν/νν+b\(\overline{b}\) final states is performed using 20.3 fb\(^{−1}\) of pp collision data recorded at \(\sqrt {s}\) = 8 TeV with the ATLAS detector at the Large Hadron Collider. The search is conducted by examining the WH / ZH invariant mass distribution for a localized excess. No significant deviation from the Standard Model background prediction is observed. The results are interpreted in terms of constraints on the Minimal Walking Technicolor model and on a simplified approach based on a phenomenological Lagrangian of Heavy Vector Triplets.
An observation of the View the Λ\(^0_b\)→ψ(2S)Λ\(^0\) decay and a comparison of its branching fraction with that of the Λ\(^0_b\)→J/ψΛ\(^0\) decay has been made with the ATLAS detector in proton–proton collisions at \(\sqrt {s}\)=8 TeV at the LHC using an integrated luminosity of 20.6 fb\(^{-1}\). The J/ψJ/ψ and ψ(2S) mesons are reconstructed in their decays to a muon pair, while the Λ\(^0\)→pπ\(^-\) decay is exploited for the Λ\(^0\) baryon reconstruction. The Λ\(^0_b\) baryons are reconstructed with transverse momentum p\(_T\)>10 GeV pT>10 GeV and pseudorapidity |η|<2.1. The measured branching ratio of the Λ\(^0_b\)→ψ(2S)Λ\(^0\) and Λ\(^0_b\)→J/ψΛ\(^0\) decays is Γ(Λ\(^0_b\)→ψ(2S)Λ\(^0\))/Γ(Λ\(^0_b\)→J/ψΛ\(^0\))=0.501±0.033(stat)±0.019(syst), lower than the expectation from the covariant quark model.
A measurement of the calorimeter response to isolated charged hadrons in the ATLAS detector at the LHC is presented. This measurement is performed with 3.2 nb\(^{−1}\) of proton–proton collision data at \(\sqrt{s}\) = 7 TeV from 2010 and 0.1 nb\(^{−1}\) of data at \(\sqrt{s}\) = 8 TeV from 2012. A number of aspects of the calorimeter response to isolated hadrons are explored. After accounting for energy deposited by neutral particles, there is a 5% discrepancy in the modelling, using various sets of GEANT4 hadronic physics models, of the calorimeter response to isolated charged hadrons in the central calorimeter region. The description of the response to anti-protons at low momenta is found to be improved with respect to previous analyses. The electromagnetic and hadronic calorimeters are also examined separately, and the detector simulation is found to describe the response in the hadronic calorimeter well. The jet energy scale uncertainty and correlations in scale between jets of different momenta and pseudorapidity are derived based on these studies. The uncertainty is 2–5% for jets with transverse momenta above 2 TeV, where this method provides the jet energy scale uncertainty for ATLAS.
A search for the associated production of the Higgs boson with a top quark pair is performed in multilepton final states using 20.3 fb\(^{−1}\) of proton–proton collision data recorded by the ATLAS experiment at \(\sqrt {s}\)=8 TeV at the Large Hadron Collider. Five final states, targeting the decays H→WW\(^{*}\), ττ, and ZZ\(^{*}\), are examined for the presence of the Standard Model (SM) Higgs boson: two same-charge light leptons (e or μ) without a hadronically decaying τ lepton; three light leptons; two same-charge light leptons with a hadronically decaying τ lepton; four light leptons; and one light lepton and two hadronically decaying τ leptons. No significant excess of events is observed above the background expectation. The best fit for the t\(\overline{t}\)H production cross section, assuming a Higgs boson mass of 125 GeV, is 2.1\(^{+1.4}_{-1.2}\) times the SM expectation, and the observed (expected) upper limit at the 95% confidence level is 4.7 (2.4) times the SM rate. The p-value for compatibility with the background-only hypothesis is 1.8σ; the expectation in the presence of a Standard Model signal is 0.9σ.
This Letter reports a measurement of the exclusive γγ→ℓ\(^{+}\)ℓ\(^{−}\) (ℓ=e, μℓ=e, μ) cross-section in proton–proton collisions at a centre-of-mass energy of 7 TeV by the ATLAS experiment at the LHC, based on an integrated luminosity of 4.6 fb\(^{−1}\). For the electron or muon pairs satisfying exclusive selection criteria, a fit to the dilepton acoplanarity distribution is used to extract the fiducial cross-sections. The cross-section in the electron channel is determined to be \(^{excl.}_{γγ→e^{+}e^{-}}\)=0.428 ± 0.035 (stat.) ± 0.018 (syst.) pb for a phase–space region with invariant mass of the electron pairs greater than 24 GeV, in which both electrons have transverse momentum p\(_{T}\)>12 GeV and pseudorapidity |η|<2.4. For muon pairs with invariant mass greater than 20 GeV, muon transverse momentum p\(_{T}\)>10 GeV and pseudorapidity |η|<2.4, the cross-section is determined to be \(^{excl.}_{γγ→μ^{+}μ^{-}}\) =0.628 ± 0.032 (stat.) ± 0.021 (syst.) pb. When proton absorptive effects due to the finite size of the proton are taken into account in the theory calculation, the measured cross-sections are found to be consistent with the theory prediction.
The distribution and orientation of energy inside jets is predicted to be an experimental handle on colour connections between the hard-scatter quarks and gluons initiating the jets. This Letter presents a measurement of the distribution of one such variable, the jet pull angle. The pull angle is measured for jets produced in t\(\overline{t}\) events with one W boson decaying leptonically and the other decaying to jets using 20.3 fb\(^{−1}\) of data recorded with the ATLAS detector at a centre-of-mass energy of \(\sqrt {s}\)=8 TeV at the LHC. The jet pull angle distribution is corrected for detector resolution and acceptance effects and is compared to various models.
The results of a search for the direct pair production of top squarks, the supersymmetric partner of the top quark, in final states with one isolated electron or muon, several energetic jets, and missing transverse momentum are reported. The analysis also targets spin-0 mediator models, where the mediator decays into a pair of dark-matter particles and is produced in association with a pair of top quarks. The search uses data from proton-proton collisions delivered by the Large Hadron Collider in 2015 and 2016 at a centre-of-mass energy of root s = 13TeV and recorded by the ATLAS detector, corresponding to an integrated luminosity of 36 fb(-1). A wide range of signal scenarios with different mass-splittings between the top squark, the lightest neutralino and possible intermediate supersymmetric particles are considered, including cases where the W bosons or the top quarks produced in the decay chain are off-shell. No significant excess over the Standard Model prediction is observed. The null results are used to set exclusion limits at 95% confidence level in several supersymmetry benchmark models. For pair-produced top-squarks decaying into top quarks, top-squark masses up to 940 GeV are excluded. Stringent exclusion limits are also derived for all other considered top-squark decay scenarios. For the spin-0 mediator models, upper limits are set on the visible cross-section.
A search for supersymmetry involving the pair production of gluinos decaying via third-generation squarks into the lightest neutralino ((chi) over tilde (0)(1)) is reported. It uses LHC proton-proton collision data at a centre-of-mass energy root s = 13TeV with an integrated luminosity of 36.1 fb(-1) collected with the ATLAS detector in 2015 and 2016. The search is performed in events containing large missing transverse momentum and several energetic jets, at least three of which must be identified as originating from b-quarks. To increase the sensitivity, the sample is divided into subsamples based on the presence or absence of electrons or muons. No excess is found above the predicted background. For (chi) over tilde (0)(1) masses below approximately 300 GeV, gluino masses of less than 1.97 (1.92) TeV are excluded at 95% confidence level in simplified models involving the pair production of gluinos that decay via top (bottom) squarks. An interpretation of the limits in terms of the branching ratios of the gluinos into third-generation squarks is also provided. These results improve upon the exclusion limits obtained with the 3.2 fb(-1) of data collected in 2015.
This paper reports a search for triboson \({W^\pm}{W^\pm}{W^\mp}\) production in two decay channels (\({W^\pm}{W^\pm}{W^\mp}\) → \({ℓ^\pm}{νℓ^\pm}{νℓ^\mp}{ν}\) and \({W^\pm}{W^\pm}{W^\mp}\) → \({ℓ^\pm}{νℓ^\pm}{νjj}\) with \(ℓ=e,μ\)) in proton-proton collision data corresponding to an integrated luminosity of 20.3 fb\(^{−1}\) at a centre-of-mass energy of 8 TeV with the ATLAS detector at the Large Hadron Collider. Events with exactly three charged leptons, or two leptons with the same electric charge in association with two jets, are selected. The total number of events observed in data is consistent with the Standard Model (SM) predictions. The observed 95% confidence level upper limit on the SM \({W^\pm}{W^\pm}{W^\mp}\) production cross section is found to be 730 fb with an expected limit of 560 fb in the absence of SM \({W^\pm}{W^\pm}{W^\mp}\) production. Limits are also set on \(WWWW\) anomalous quartic gauge couplings.
This Letter presents the measurement of differential cross sections of isolated prompt photons produced in association with a b-jet or a c-jet. These final states provide sensitivity to the heavy-flavour content of the proton and aspects related to the modelling of heavy-flavour quarks in perturbative QCD. The measurement uses proton–proton collision data at a centre-of-mass energy of 8 TeV recorded by the ATLAS detector at the LHC in 2012 corresponding to an integrated luminosity of up to 20.2 fb−1 . The differential cross sections are measured for each jet flavour with respect to the transverse energy of the leading photon in two photon pseudorapidity regions: |η γ | < 1.37 and 1.56 < |η γ | < 2.37. The measurement covers photon transverse energies 25 < Eγ T < 400 GeV and 25 < Eγ T < 350 GeV respectively for the two |η γ | regions. For each jet flavour, the ratio of the cross sections in the two |η γ | regions is also measured. The measurement is corrected for detector effects and compared to leading-order and next- to-leading-order perturbative QCD calculations, based on various treatments and assumptions about the heavy-flavour content of the proton. Overall, the predictions agree well with the measurement, but some deviations are observed at high photon transverse energies. The total uncertainty in the measurement ranges between 13% and 66%, while the central γ + b measurement exhibits the smallest uncertainty, ranging from 13% to 27%, which is comparable to the precision of the theoretical predictions.
The momentum measurement capability of the ATLAS muon spectrometer relies fundamentally on the intrinsic single-hit spatial resolution of the monitored drift tube precision tracking chambers. Optimal resolution is achieved with a dedicated calibration program that addresses the specific operating conditions of the 354 000 high-pressure drift tubes in the spectrometer. The calibrations consist of a set of timing offsets and drift time to drift distance transfer relations, and result in chamber resolution functions. This paper describes novel algorithms to obtain precision calibrations from data collected by ATLAS in LHC Run 2 and from a gas monitoring chamber, deployed in a dedicated gas facility. The algorithm output consists of a pair of correction constants per chamber which are applied to baseline calibrations, and determined to be valid for the entire ATLAS Run 2. The final single-hit spatial resolution, averaged over 1172 monitored drift tube chambers, is 81.7 +/- 2.2 mu m.
A search for high-mass dielectron and dimuon resonances in the mass range of 250 GeV to 6TeV is presented. The data were recorded by the ATLAS experiment in proton-proton collisions at a centre-ofmass energy of root s = 13 TeV during Run 2 of the Large Hadron Collider and correspond to an integrated luminosity of 139 fb(-1). A functional form is fitted to the dilepton invariant-mass distribution to model the contribution from background processes, and a generic signal shape is used to determine the significance of observed deviations from this background estimate. No significant deviation is observed and upper limits are placed at the 95% confidence level on the fiducial cross-section times branching ratio for various resonance width hypotheses. The derived limits are shown to be applicable to spin-0, spin-1 and spin-2 signal hypotheses. For a set of benchmark models, the limits are converted into lower limits on the resonance mass and reach 4.5 TeV for the E-6-motivated Z(psi)' boson. Also presented are limits on Heavy Vector Triplet model couplings. (C) 2019 The Author. Published by Elsevier B.V.
A search for pair production of the supersymmetric partners of the Higgs boson (higgsinos (H) over tilde) in gaugemediated scenarios is reported. Each higgsino is assumed to decay to a Higgs boson and a gravitino. Two complementary analyses, targeting high- and low-mass signals, are performed to maximize sensitivity. The two analyses utilize LHC pp collision data at a center-of-mass energy root s = 13 TeV, the former with an integrated luminosity of 36.1 fb(-1) and the latter with 24.3 fb(-1), collected with the ATLAS detector in 2015 and 2016. The search is performed in events containing missing transverse momentum and several energetic jets, at least three of which must be identified as b-quark jets. No significant excess is found above the predicted background. Limits on the cross section are set as a function of the mass of the <(Hover tilde> in simplified models assuming production via mass-degenerate higgsinos decaying to a Higgs boson and a gravitino. Higgsinos with masses between 130 and 230 GeV and between 290 and 880 GeV are excluded at the 95% confidence level. Interpretations of the limits in terms of the branching ratio of the higgsino to a Z boson or a Higgs boson are also presented, and a 45% branching ratio to a Higgs boson is excluded for m(<(Hover tilde>) approximate to 400 GeV.
Many extensions of the Standard Model predict new resonances decaying to a Z, W, or Higgs boson and a photon. This paper presents a search for such resonances produced in pp collisions at root s = 13 TeV using a data set with an integrated luminosity of 36.1 fb(-1) collected by the ATLAS detector at the LHC. The Z/W/H bosons are identified through their decays to hadrons. The data are found to be consistent with the Standard Model expectation in the entire investigated mass range. Upper limits are set on the production cross section times branching fraction for resonance decays to Z.W + gamma in the mass range from 1.0 to 6.8 TeV and for the first time into H + gamma in the mass range from 1.0 to 3.0 TeV.
A search for direct pair production of top squarks in final states with two tau leptons, b-jets, and missing transverse momentum is presented. The analysis is based on proton-proton collision data at root s = 13 TeV corresponding to an integrated luminosity of 36.1 fb(-1) recorded with the ATLAS detector at the Large Hadron Collider in 2015 and 2016. Two exclusive channels with either two hadronically decaying tau leptons or one hadronically and one leptonically decaying tau lepton are considered. No significant deviation from the Standard Model predictions is observed in the data. The analysis results are interpreted in terms of model-independent limits and used to derive exclusion limits on the masses of the top squark (t) over tilde (1) and the tau slepton (tau) over tilde (1) in a simplified model of supersymmetry with a nearly massless gravitino. In this model, masses up to m((t) over tilde (1)) = 1.16 TeV and m ((tau) over tilde (1)) = 1.00 TeV are excluded at 95% confidence level.
This paper reports on a search for electroweak diboson (WW/WZ/ZZ) production in association with a high-mass dijet system, using data from proton-proton collisions at a center-of-mass energy of N root s = 13 TeV. The data, corresponding to an integrated luminosity of 35.5 fb(-1), were recorded with the ATLAS detector in 2015 and 2016 at the Large Hadron Collider. The search is performed in final states in which one boson decays leptonically, and the other boson decays hadronically. The hadronically decaying W/Z boson is reconstructed as either two small-radius jets or one large-radius jet using jet substructure techniques. The electroweak production of WW/WZ/ZZ in association with two jets is measured with an observed (expected) significance of 2.7 (2.5) standard deviations, and the fiducial cross section is measured to be 45.1 +/- 8.6(stat.)(-14.6)(+15.9)(syst.) fb.
A search for a heavy charged-boson resonance decaying into a charged lepton (electron or muon) and a neutrino is reported. A data sample of 139 fb(-1) of proton-proton collisions at root s = 13 TeV collected with the ATLAS detector at the LHC during 2015-2018 is used in the search. The observed transverse mass distribution computed from the lepton and missing transverse momenta is consistent with the distribution expected from the Standard Model, and upper limits on the cross section for pp -> W'-> lv are extracted (l = e or mu). These vary between 1.3 pb and 0.05 tb depending on the resonance mass in the range between 0.15 and 7.0 TeV at 95% confidence level for the electron and muon channels combined. Gauge bosons with a mass below 6.0 and 5.1 TeV are excluded in the electron and muon channels, respectively, in a model with a resonance that has couplings to fermions identical to those of the Standard Model W boson. Cross-section limits are also provided for resonances with several fixed Gamma/m values in the range between 1% and 15%. Model-independent limits are derived in single-bin signal regions defined by a varying minimum transverse mass threshold. The resulting visible cross-section upper limits range between 4.6 (15) ph and 22 (22) ab as the threshold increases from 130 (110) GeV to 5.1 (5.1) TeV in the electron (muon) channel.
This paper presents measurements of charged-particle distributions sensitive to the properties of the underlying event in events containing a Z boson decaying into a muon pair. The data were obtained using the ATLAS detector at the LHC in proton-proton collisions at a centre-of-mass energy of 13 TeV with an integrated luminosity of 3.2 fb(-1). Distributions of the charged-particle multiplicity and of the charged-particle transverse momentum are measured in regions of the azimuth defined relative to the Z boson direction. The measured distributions are compared with the predictions of various Monte Carlo generators which implement different underyling event models. The Monte Carlo model predictions qualitatively describe the data well, but with some significant discrepancies.
This paper presents measurements of the W+->mu+nu and W-->mu-nu cross-sections and the associated charge asymmetry as a function of the absolute pseudorapidity of the decay muon. The data were collected in proton-proton collisions at a centre-of-mass energy of 8 TeV with the ATLAS experiment at the LHC and correspond to a total integrated luminosity of 20.2fb(-1). The precision of the cross-section measurements varies between 0.8 and 1.5% as a function of the pseudorapidity, excluding the 1.9% uncertainty on the integrated luminosity. The charge asymmetry is measured with an uncertainty between 0.002 and 0.003. The results are compared with predictions based on next-to-next-to-leading-order calculations with various parton distribution functions and have the sensitivity to discriminate between them.
This Letter describes the observation of the light-by-light scattering process, gamma gamma -> gamma gamma, in Pb + Pb collisions at root S-NN = 5.02 TeV. The analysis is conducted using a data sample corresponding to an integrated luminosity of 1.73 nb(-1), collected in November 2018 by the ATLAS experiment at the LHC. Light-by-light scattering candidates are selected in events with two photons produced exclusively, each with transverse energy E-T(gamma) > 3 GeV and pseudorapidity vertical bar eta(gamma)vertical bar < 2.4, diphoton invariant mass above 6 GeV, and small diphoton transverse momentum and acoplanarity. After applying all selection criteria, 59 candidate events are observed for a background expectation of 12 +/- 3 events. The observed excess of events over the expected background has a significance of 8.2 standard deviations. The measured fiducial cross section is 78 +/- 13(stat) +/- 7(syst) +/- 3(lumi) nb.
This paper describes a study of techniques for identifying Higgs bosons at high transverse momenta decaying into bottom-quark pairs, H -> b (b) over bar, for proton-proton collision data collected by the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy root s = 13 TeV. These decays are reconstructed from calorimeter jets found with the anti-k(t) R = 1.0 jet algorithm. To tag Higgs bosons, a combination of requirements is used: b-tagging of R = 0.2 track-jets matched to the large-R calorimeter jet, and requirements on the jet mass and other jet substructure variables. The Higgs boson tagging efficiency and corresponding multijet and hadronic top-quark background rejections are evaluated using Monte Carlo simulation. Several benchmark tagging selections are defined for different signal efficiency targets. The modelling of the relevant input distributions used to tag Higgs bosons is studied in 36 fb(-1) of data collected in 2015 and 2016 using g -> b (b) over bar and Z(-> b (b) over bar)gamma event selections in data. Both processes are found to be well modelled within the statistical and systematic uncertainties.
The inclusive cross-section for jet production in association with a Z boson decaying into an electronpositron pair is measured as a function of the transverse momentum and the absolute rapidity of jets using 19.9 fb(-1) of root s = 8 TeV proton-proton collision data collected with the ATLAS detector at the Large Hadron Collider. The measured Z + jets cross-section is unfolded to the particle level. The cross-section is compared with state-of-the-art Standard Model calculations, including the next-to-leading-order and next-to-next-to-leading-order perturbative QCD calculations, corrected for non-perturbative and QED radiation effects. The results of the measurements cover final-state jets with transverse momenta up to 1 TeV, and show good agreement with fixed-order calculations.
Narrow resonances decaying into WW, WZ or ZZ boson pairs are searched for in 139 fb(-1) of proton-proton collision data at a centre-of-mass energy of root s = 13TeV recorded with the ATLAS detector at the Large Hadron Collider from 2015 to 2018. The diboson system is reconstructed using pairs of high transverse momentum, large-radius jets. These jets are built from a combination of calorimeter- and tracker-inputs compatible with the hadronic decay of a boosted W or Z boson, using jet mass and substructure properties. The search is performed for diboson resonances with masses greater than 1.3TeV. No significant deviations from the background expectations are observed. Exclusion limits at the 95% confidence level are set on the production cross-section times branching ratio into dibosons for resonances in a range of theories beyond the Standard Model, with the highest excluded mass of a new gauge boson at 3.8TeV in the context of mass-degenerate resonances that couple predominantly to gauge bosons.
In response to the 2013 Update of the European Strategy for Particle Physics (EPPSU), the Future Circular Collider (FCC) study was launched as a world-wide international collaboration hosted by CERN. The FCC study covered an energy-frontier hadron collider (FCC-hh), a highest-luminosity high-energy lepton collider (FCC-ee), the corresponding 100km tunnel infrastructure, as well as the physics opportunities of these two colliders, and a high-energy LHC, based on FCC-hh technology. This document constitutes the third volume of the FCC Conceptual Design Report, devoted to the hadron collider FCC-hh. It summarizes the FCC-hh physics discovery opportunities, presents the FCC-hh accelerator design, performance reach, and staged operation plan, discusses the underlying technologies, the civil engineering and technical infrastructure, and also sketches a possible implementation. Combining ingredients from the Large Hadron Collider (LHC), the high-luminosity LHC upgrade and adding novel technologies and approaches, the FCC-hh design aims at significantly extending the energy frontier to 100TeV. Its unprecedented centre of-mass collision energy will make the FCC-hh a unique instrument to explore physics beyond the Standard Model, offering great direct sensitivity to new physics and discoveries.
In response to the 2013 Update of the European Strategy for Particle Physics (EPPSU), the Future Circular Collider (FCC) study was launched as a world-wide international collaboration hosted by CERN. The FCC study covered an energy-frontier hadron collider (FCC-hh), a highest-luminosity high-energy lepton collider (FCC-ee), the corresponding 100 km tunnel infrastructure, as well as the physics opportunities of these two colliders, and a high-energy LHC, based on FCC-hh technology. This document constitutes the third volume of the FCC Conceptual Design Report, devoted to the hadron collider FCC-hh. It summarizes the FCC-hh physics discovery opportunities, presents the FCC-hh accelerator design, performance reach, and staged operation plan, discusses the underlying technologies, the civil engineering and technical infrastructure, and also sketches a possible implementation. Combining ingredients from the Large Hadron Collider (LHC), the high-luminosity LHC upgrade and adding novel technologies and approaches, the FCC-hh design aims at significantly extending the energy frontier to 100 TeV. Its unprecedented centre-of-mass collision energy will make the FCC-hh a unique instrument to explore physics beyond the Standard Model, offering great direct sensitivity to new physics and discoveries.
We review the physics opportunities of the Future Circular Collider, covering its e(+)e(-), pp, ep and heavy ion programmes. We describe the measurement capabilities of each FCC component, addressing the study of electroweak, Higgs and strong interactions, the top quark and flavour, as well as phenomena beyond the Standard Model. We highlight the synergy and complementarity of the different colliders, which will contribute to a uniquely coherent and ambitious research programme, providing an unmatchable combination of precision and sensitivity to new physics.
In response to the 2013 Update of the European Strategy for Particle Physics, the Future Circular Collider (FCC) study was launched, as an international collaboration hosted by CERN. This study covers a highest-luminosity high-energy lepton collider (FCC-ee) and an energy-frontier hadron collider (FCC-hh), which could, successively, be installed in the same 100 km tunnel. The scientific capabilities of the integrated FCC programme would serve the worldwide community throughout the 21st century. The FCC study also investigates an LHC energy upgrade, using FCC-hh technology. This document constitutes the second volume of the FCC Conceptual Design Report, devoted to the electron-positron collider FCC-ee. After summarizing the physics discovery opportunities, it presents the accelerator design, performance reach, a staged operation scenario, the underlying technologies, civil engineering, technical infrastructure, and an implementation plan. FCC-ee can be built with today's technology. Most of the FCC-ee infrastructure could be reused for FCC-hh. Combining concepts from past and present lepton colliders and adding a few novel elements, the FCC-ee design promises outstandingly high luminosity. This will make the FCC-ee a unique precision instrument to study the heaviest known particles (Z, W and H bosons and the top quark), offering great direct and indirect sensitivity to new physics.
A search for a heavy neutral Higgs boson, A, decaying into a Z boson and another heavy Higgs boson, H, is performed using a data sample corresponding to an integrated luminosity of 36.1 fb(-1) from proton-proton collisions at root s = 13 TeV recorded in 2015 and 2016 by the ATLAS detector at the Large Hadron Collider. The search considers the Z boson decaying to electrons or muons and the H boson into a pair of b-quarks. No evidence for the production of an A boson is found. Considering each production process separately, the 95% confidence-level upper limits on the pp -> A -> ZH production cross-section times the branching ratio H -> bb are in the range of 14-830 fb for the gluon-gluon fusion process and 26-570 fb for the b-associated process for the mass ranges 130-700 GeV of the H boson and 230-800 GeV of the A boson. The results are interpreted in the context of two-Higgs-doublet models. (C) 2018 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Funded by SCOAP(3).
The mass of the Higgs boson is measured in the H -> ZZ* -> 4l and in the H -> gamma gamma decay channels with 36.1 fb(-1) of proton-proton collision data from the Large Hadron Collider at a centre-of-mass energy of 13 TeV recorded by the ATLAS detector in 2015 and 2016. The measured value in the H -> ZZ* -> 4l channel is m(H)(ZZ*) = 124.79 +/- 0.37 GeV, while the measured value in the H -> gamma gamma channel is m(H)(gamma gamma) = 124.93 +/- 0.40 GeV. Combining these results with the ATLAS measurement based on 7 and 8 TeV proton-proton collision data yields a Higgs boson mass of m(H) = 124.97 +/- 0.24 GeV. (c) 2018 The Author. Published by Elsevier B.V.
This Letter presents a search for exotic decays of the Higgs boson to a pair of new (pseudo) scalar particles, H -> aa, where the a particle has a mass in the range 20-60 GeV, and where one of the a bosons decays into a pair of photons and the other to a pair of gluons. The search is performed in event samples enhanced in vector-boson fusion Higgs boson production by requiring two jets with large invariant mass in addition to the Higgs boson candidate decay products. The analysis is based on the full dataset of pp collisions at root s = 13 TeV recorded in 2015 and 2016 with the ATLAS detector at the CERN Large Hadron Collider, corresponding to an integrated luminosity of 36.7 fb(-1). The data are in agreement with the Standard Model predictions and an upper limit at the 95% confidence level is placed on the production cross section times the branching ratio for the decay H -> aa -> gamma gamma gg. This limit ranges from 3.1 pb to 9.0 pb depending on the mass of the a boson. (C) 2018 The Author. Published by Elsevier B.V.
A search for the standard model Higgs boson produced in association with a top-quark pair, t(t)overbarH, is presented. The analysis uses 36.1 fb(-1) of pp collision data at root s = 13 TeV collected with the ATLAS detector at the Large Hadron Collider in 2015 and 2016. The search targets the H -> b(b)overbar decay mode. The selected events contain either one or two electrons or muons from the top-quark decays, and are then categorized according to the number of jets and how likely these are to contain b-hadrons. Multivariate techniques are used to discriminate between signal and background events, the latter being dominated by ft + jets production. For a Higgs boson mass of 125 GeV, the ratio of the measured t(t)overbarH signal cross-section to the standard model expectation is found to be mu = 0.84(-0.61)(+0.64). A value of mu greater than 2.0 is excluded at 95% confidence level (C.L.) while the expected upper limit is mu < 1.2 in the absence of a t(t)overbarH signal.
A search for the associated production of the Higgs boson with a top quark pair (tt (b) over barH) is reported. The search is performed in multilepton final states using a data set corresponding to an integrated luminosity of 36.1 fb(-1) of proton-proton collision data recorded by the ATLAS experiment at a center-of-mass energy root s = 13 TeV at the Large Hadron Collider. Higgs boson decays to WW*, tau tau, and ZZ* are targeted. Seven final states, categorized by the number and flavor of charged-lepton candidates, are examined for the presence of the Standard Model Higgs boson with a mass of 125 GeVand a pair of top quarks. An excess of events over the expected background from Standard Model processes is found with an observed significance of 4.1 standard deviations, compared to an expectation of 2.8 standard deviations. The best fit for the (tt (b) over barH) production cross section is sot (tt (b) over barH) = 790(-210)(+230) fb, in agreement with the Standard Model prediction of 507(-50)(+35) fb. The combination of this result with other tt (b) over barH searches from the ATLAS experiment using the Higgs boson decay modes to b (b) over bar, gamma gamma and ZZ* -> 4l, has an observed significance of 4.2 standard deviations, compared to an expectation of 3.8 standard deviations. This provides evidence for the tt (b) over barH production mode.
A search is presented for photonic signatures, motivated by generalized models of gauge-mediated supersymmetry breaking. This search makes use of proton-proton collision data at root s = 13 TeV corresponding to an integrated luminosity of 36.1 fb(-1) recorded by the ATLAS detector at the LHC, and it explores models dominated by both strong and electroweak production of supersymmetric partner states. Experimental signatures incorporating an isolated photon and significant missing transverse momentum are explored. These signatures include events with an additional photon or additional jet activity not associated with any specific underlying quark flavor. No significant excess of events is observed above the Standard Model prediction, and 95% confidence-level upper limits of between 0.083 and 0.32 fb are set on the visible cross section of contributions from physics beyond the Standard Model. These results are interpreted in terms of lower limits on the masses of gluinos, squarks, and gauginos in the context of generalized models of gauge-mediated supersymmetry, which reach as high as 2.3 TeV for strongly produced and 1.3 TeV for weakly produced supersymmetric partner pairs.
Results of dedicated Monte Carlo simulations of beam-induced background (BIB) in the ATLAS experiment at the Large Hadron Collider (LHC) are presented and compared with data recorded in 2012. During normal physics operation this background arises mainly from scattering of the 4 TeV protons on residual gas in the beam pipe. Methods of reconstructing the BIB signals in the ATLAS detector, developed and implemented in the simulation chain based on the FLUKA Monte Carlo simulation package, are described. The interaction rates are determined from the residual gas pressure distribution in the LHC ring in order to set an absolute scale on the predicted rates of BIB so that they can be compared quantitatively with data. Through these comparisons the origins of the BIB leading to different observables in the ATLAS detectors are analysed. The level of agreement between simulation results and BIB measurements by ATLAS in 2012 demonstrates that a good understanding of the origin of BIB has been reached.
This paper reports searches for heavy resonances decaying into ZZ or ZW using data from proton-proton collisions at a centre-of-mass energy of root s - 13 TeV. The data, corresponding to an integrated luminosity of 36.1 fb(-1), were recorded with the ATLAS detector in 2015 and 2016 at the Large Hadron Collider. The searches are performed in final states in which one Z boson decays into either a pair of light charged leptons (electrons and muons) or a pair of neutrinos, and the associated W boson or the other Z boson decays hadronically. No evidence of the production of heavy resonances is observed. Upper bounds on the production cross sections of heavy resonances times their decay branching ratios to ZZ or ZW are derived in the mass range 300-5000 GeV within the context of Standard Model extensions with additional Higgs bosons, a heavy vector triplet or warped extra dimensions. Production through gluon-gluon fusion, Drell-Yan or vector-boson fusion are considered, depending on the assumed model.
A search for W'-boson production in the W' -> t (b) over bar -> q (q) over bar 'b (b) over bar decay channel is presented using 36.1 fb(-1) of 13 TeV proton-proton collision data collected by the ATLAS detector at the Large Hadron Collider in 2015 and 2016. The search is interpreted in terms of both a left-handed and a right-handed chiral W' boson within the mass range 1-5 TeV. Identification of the hadronically decaying top quark is performed using jet substructure tagging techniques based on a shower deconstruction algorithm. No significant deviation from the Standard Model prediction is observed and the results are expressed as upper limits on the W' -> t (b) over bar production cross-section times branching ratio as a function of the W'-boson mass. These limits exclude W' bosons with right-handed couplings with masses below 3.0 TeV and W' bosons with left-handed couplings with masses below 2.9 TeV, at the 95% confidence level. (C) 2018 The Author. Published by Elsevier B.V.
Results of a search for gluino pair production with subsequent R-parity-violating decays to quarks are presented. This search uses 36.1 fb(-1) of data collected by the ATLAS detector in proton-proton collisions with a centre-of-mass energy of root s = 13 TeV at the LHC. The analysis is performed using requirements on the number of jets and the number of jets tagged as containing a b-hadron as well as a topological observable formed by the scalar sum of masses of large-radius jets in the event. No significant excess above the expected Standard Model background is observed. Limits are set on the production of gluinos in models with the R-parity-violating decays of either the gluino itself (direct decay) or the neutralino produced in the R-parity-conserving gluino decay (cascade decay). In the gluino cascade decay model, gluino masses below 1850 GeV are excluded for 1000 GeV neutralino mass. For the gluino direct decay model, the 95% confidence level upper limit on the cross section times branching ratio varies between 0.80 fb at m((g) over tilde) = 900 GeV and 0.011 fb at m((g) over tilde) = 1800 GeV. (c) 2018 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license.
Background
Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surgery more feasible and might be more likely to eradicate micrometastatic disease than might the same chemotherapy given after surgery. We investigated the long-term benefits and risks of NACT and the influence of tumour characteristics on outcome with a collaborative meta-analysis of individual patient data from relevant randomised trials.
Methods
We obtained information about prerandomisation tumour characteristics, clinical tumour response, surgery, recurrence, and mortality for 4756 women in ten randomised trials in early breast cancer that began before 2005 and compared NACT with the same chemotherapy given postoperatively. Primary outcomes were tumour response, extent of local therapy, local and distant recurrence, breast cancer death, and overall mortality. Analyses by intention-to-treat used standard regression (for response and frequency of breast-conserving therapy) and log-rank methods (for recurrence and mortality).
Findings
Patients entered the trials from 1983 to 2002 and median follow-up was 9 years (IQR 5-14), with the last follow-up in 2013. Most chemotherapy was anthracycline based (3838 [81%] of 4756 women). More than two thirds (1349 [69%] of 1947) of women allocated NACT had a complete or partial clinical response. Patients allocated NACT had an increased frequency of breast-conserving therapy (1504 [65%] of 2320 treated with NACT vs 1135 [49%] of 2318 treated with adjuvant chemotherapy). NACT was associated with more frequent local recurrence than was adjuvant chemotherapy: the 15 year local recurrence was 21.4% for NACT versus 15.9% for adjuvant chemotherapy (5.5% increase [95% CI 2.4-8.6]; rate ratio 1.37 [95% CI 1.17-1.61]; p = 0.0001). No significant difference between NACT and adjuvant chemotherapy was noted for distant recurrence (15 year risk 38.2% for NACT vs 38.0% for adjuvant chemotherapy; rate ratio 1.02 [95% CI 0.92-1.14]; p = 0.66), breast cancer mortality (34.4% vs 33.7%; 1.06 [0.95-1.18]; p = 0.31), or death from any cause (40.9% vs 41.2%; 1.04 [0.94-1.15]; p = 0.45).
Interpretation
Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT. Strategies to mitigate the increased local recurrence after breast-conserving therapy in tumours downsized by NACT should be considered-eg, careful tumour localisation, detailed pathological assessment, and appropriate radiotherapy. Copyright (c) The Author(s). Published by Elsevier Ltd.
The ANTARES neutrino telescope has an energy threshold of a few tens of GeV. This allows to study the phenomenon of atmospheric muon neutrino disappearance due to neutrino oscillations. In a similar way, constraints on the 3+1 neutrino model, which foresees the existence of one sterile neutrino, can be inferred. Using data collected by the ANTARES neutrino telescope from 2007 to 2016, a new measurement of m 2 and (23) has been performed which is consistent with world best-fit values and constraints on the 3+1 neutrino model have been derived.
KM3NeT will be a network of deep-sea neutrino telescopes in the Mediterranean Sea. The KM3NeT/ARCA detector, to be installed at the Capo Passero site (Italy), is optimised for the detection of high-energy neutrinos of cosmic origin. Thanks to its geographical location on the Northern hemisphere, KM3NeT/ARCA can observe upgoing neutrinos from most of the Galactic Plane, including the Galactic Centre. Given its effective area and excellent pointing resolution, KM3NeT/ARCA will measure or significantly constrain the neutrino flux from potential astrophysical neutrino sources. At the same time, it will test flux predictions based on gamma-ray measurements and the assumption that the gamma-ray flux is of hadronic origin. Assuming this scenario, discovery potentials and sensitivities for a selected list of Galactic sources and to generic point sources with an E-2 spectrum are presented. These spectra are assumed to be time independent. The results indicate that an observation with 3 sigma significance is possible in about six years of operation for the most intense sources, such as Supernovae Remnants RX J1713.7-3946 and Vela Jr. If no signal will be found during this time, the fraction of the gamma-ray flux coming from hadronic processes can be constrained to be below 50% for these two objects. (C) 2019 The Authors. Published by Elsevier B.V.
The Hamamatsu R12199-023-inch photomultiplier tube is the photodetector chosen for the first phase of the KM3NeT neutrino telescope. About 7000 photomultipliers have been characterised for dark count rate, timing spread and spurious pulses. The quantum efficiency, the gain and the peak-to-valley ratio have also been measured for a sub-sample in order to determine parameter values needed as input to numerical simulations of the detector.
Astrophysical sources of gravitational waves, such as binary neutron star and black hole mergers or core-collapse supernovae, can drive relativistic outflows, giving rise to non-thermal high-energy emission. High-energy neutrinos are signatures of such outflows. The detection of gravitational waves and high-energy neutrinos from common sources could help establish the connection between the dynamics of the progenitor and the properties of the outflow. We searched for associated emission of gravitational waves and high-energy neutrinos from astrophysical transients with minimal assumptions using data from Advanced LIGO from its first observing run O1, and data from the Antares and IceCube neutrino observatories from the same time period. We focused on candidate events whose astrophysical origins could not be determined from a single messenger. We found no significant coincident candidate, which we used to constrain the rate density of astrophysical sources dependent on their gravitational-wave and neutrino emission processes.
A search for doubly charged Higgs bosons with pairs of prompt, isolated, highly energetic leptons with the same electric charge is presented. The search uses a proton-proton collision data sample at a centre-of-mass energy of 13 TeV corresponding to 36.1 fb(-1) of integrated luminosity recorded in 2015 and 2016 by the ATLAS detector at the LHC. This analysis focuses on the decays H-+/-+/- -> e(+/-)e(+/-), H-+/-+/- -> e(+/-)mu(+/-) and H-+/-+/- -> mu(+/-)mu(+/-), fitting the dilepton mass spectra in several exclusive signal regions. No significant evidence of a signal is observed and corresponding limits on the production cross-section and consequently a lower limit on m(H-+/-+/-) are derived at 95% confidence level. With l(+/-)l(+/-) = e(+/-)e(+/-)/mu(+/-)mu(+/-)/e(+/-)mu(+/-), the observed lower limit on the mass of a doubly charged Higgs boson only coupling to left-handed leptons varies from 770 to 870GeV (850GeV expected) for B(H-+/-+/- -> l(+/-)l(+/-)) = 100% and both the expected and observed mass limits are above 450GeV for B(H-+/-+/- -> l(+/-)l(+/-)) = 10% and any combination of partial branching ratios.
A search for the direct production of charginos and neutralinos in final states with at least two hadronically decaying tau leptons is presented. The analysis uses a dataset of pp collisions corresponding to an integrated luminosity of 36.1 fb, recorded with the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy of 13 TeV. No significant deviation from the expected Standard Model background is observed. Limits are derived in scenarios of pair production and of and production in simplified models where the neutralinos and charginos decay solely via intermediate left-handed staus and tau sneutrinos, and the mass of the state is set to be halfway between the masses of the and the (chi) over tilde (0.)(1) . Chargino masses up to 630 GeV are excluded at 95% confidence level in the scenario of direct production of for a massless (chi) over tilde (0.)(1). Common and masses up to 760 GeV are excluded in the case of production of and assuming a massless . Exclusion limits for additional benchmark scenarios with large and small mass-splitting between the and the are also studied by varying the mass between the masses of the and the (chi) over tilde (0.)(1)
Measurements of longitudinal flow correlations are presented for charged particles in the pseudorapidity range vertical bar eta vertical bar < 2.4 using 7 mu b(-1) and 470 mu b(-1) of Pb+Pb collisions at root s(NN) = 2.76 and 5.02 TeV, respectively, recorded by the ATLAS detector at the LHC. It is found that the correlation between the harmonic flow coefficients v(n) measured in two separated eta intervals does not factorise into the product of single-particle coefficients, and this breaking of factorisation, or flow decorrelation, increases linearly with the eta separation between the intervals. The flow decorrelation is stronger at 2.76 TeVthan at 5.02 TeV. Higher-order moments of the correlations are also measured, and the corresponding linear coefficients for the kth-moment of the v(n) are found to be proportional to k for v(3), but not for v(2). The decorrelation effect is separated into contributions from the magnitude of v(n) and the event-plane orientation, each as a function of eta. These two contributions are found to be comparable. The longitudinal flow correlations are also measured between v(n) of different order in n. The decorrelations of v(2) and v(3) are found to be independent of each other, while the decorrelations of v(4) and v(5) are found to be driven by the nonlinear contribution from v(2)(2) and v(2)v(3), respectively.
A search is performed for new phenomena in events having a photon with high transverse momentum and a jet collected in 36.7 fb(-1) of proton-proton collisions at a centre-of-mass energy of root s = 13 TeV recorded with the ATLAS detector at the Large Hadron Collider. The invariant mass distribution of the leading photon and jet is examined to look for the resonant production of new particles or the presence of new high-mass states beyond the Standard Model. No significant deviation from the background-only hypothesis is observed and cross-section limits for generic Gaussian-shaped resonances are extracted. Excited quarks hypothesized in quark compositeness models and high-mass states predicted in quantum black hole models with extra dimensions are also examined in the analysis. The observed data exclude, at 95% confidence level, the mass range below 5.3 TeV for excited quarks and 7.1 TeV (4.4 TeV) for quantum black holes in the Arkani-Hamed-Dimopoulos-Dvali (Randall-Sundrum) model with six (one) extra dimensions.
A search for heavy resonances decaying into a pair of Z bosons leading to l(+) l(-) l(+) l(-) and l(+) l(-) nu(nu) over bar final states, where l stands for either an electron or a muon, is presented. The search uses proton-proton collision data at a centre-of-mass energy of 13 TeV corresponding to an integrated luminosity of 36.1 fb(-1) collected with the ATLAS detector during 2015 and 2016 at the Large Hadron Collider. Different mass ranges for the hypothetical resonances are considered, depending on the final state and model. The different ranges span between 200 and 2000 GeV. The results are interpreted as upper limits on the production cross section of a spin-0 or spin-2 resonance. The upper limits for the spin-0 resonance are translated to exclusion contours in the context of Type-I and Type-II two-Higgs-doublet models, while those for the spin-2 resonance are used to constrain the Randall-Sundrum model with an extra dimension giving rise to spin-2 graviton excitations.
measurement of the rapidity and transverse momentum dependence of dijet azimuthal decorrelations is presented, using the quantity R-Delta phi. The quantity R-Delta phi specifies the fraction of the inclusive dijet events in which the azimuthal opening angle of the two jets with the highest transverse momenta is less than a given value of the parameter Delta phi(max). The quantity R-Delta phi is measured in proton-proton collisions at root s = 8 TeV as a function of the dijet rapidity interval, the event total scalar transverse momentum, and Delta phi(max). The measurement uses an event sample corresponding to an integrated luminosity of 20.2 fb(-1) collected with the ATLAS detector at the CERN Large Hadron Collider. Predictions of a perturbative QCD calculation at next-to-leading order in the strong coupling with corrections for nonperturbative effects are compared to the data. The theoretical predictions describe the data in the whole kinematic region. The data are used to determine the strong coupling alpha(S) and to study its running for momentum transfers from 260 GeV to above 1.6 TeV. Analysis that combines data at all momentum transfers results in alpha(S) (m(Z)) = 0.1127(- 0.0027) (+0.0063).
A search for neutral heavy resonances is performed in the WW -> e nu mu nu decay channel using pp collision data corresponding to an integrated luminosity of 36.1 fb(-1), collected at a centre-of-mass energy of 13 TeV by the ATLAS detector at the Large Hadron Collider. No evidence of such heavy resonances is found. In the search for production via the quark-antiquark annihilation or gluon-gluon fusion process, upper limits on sigma(X) x B(X -> WW) as a function of the resonance mass are obtained in the mass range between 200 GeV and up to 5 TeV for various benchmark models: a Higgs-like scalar in different width scenarios, a two-Higgs-doublet model, a heavy vector triplet model, and a warped extra dimensions model. In the vector-boson fusion process, constraints are also obtained on these resonances, as well as on a Higgs boson in the Georgi-Machacek model and a heavy tensor particle coupling only to gauge bosons.
The differential cross-section for the production of a W boson in association with a top quark is measured for several particle-level observables. The measurements are performed using 36.1 fb(-1) of pp collision data collected with the ATLAS detector at the LHC in 2015 and 2016. Differential cross-sections are measured in a fiducial phase space defined by the presence of two charged leptons and exactly one jet matched to a b-hadron, and are normalised with the fiducial cross-section. Results are found to be in good agreement with predictions from several Monte Carlo event generators.
A direct search for the standard model Higgs boson decaying to a pair of charm quarks is presented. Associated production of the Higgs and Z bosons, in the decay mode ZH -> l(+)l(-) cc is studied. A data set with an integrated luminosity of 36.1 fb(-1) of pp collisions at root s = 13TeV recorded by the ATLAS experiment at the LHC is used. The H -> cc signature is identified using charm-tagging algorithms. The observed (expected) upper limit on sigma(pp -> ZH) x B(H -> cc) is 2.7 (3.9(-2.1)(+2.1) ) pb at the 95% confidence level for a Higgs boson mass of 125 GeV, while the standard model value is 26 fb.
A search for new phenomena in final states containing an e(+)e(-) or m(+)m(-) pair, jets, and large missing transverse momentum is presented. This analysis makes use of proton-proton collision data with an integrated luminosity of 36.1 fb(-1), collected during 2015 and 2016 at a centre of-mass energy Os = 13 TeV with the ATLAS detector at the Large Hadron Collider. The search targets the pair production of supersymmetric coloured particles (squarks or gluinos) and their decays into final states containing an e(+)e(-) or m(+)m(-) pair and the lightest neutralino ((c) over tilde (0)(1)) via one of two next-to-lightest neutralino ((c) over tilde (0)(2)) decay mechanisms: (c) over tilde (0)(2) Z (c) over tilde (0)(1), where the Z boson decays leptonically leading to a peak in the dilepton invariant mass distribution around the Z boson mass; and (c) over tilde (0)(2) l(+)1(-) (c) over tilde (0)(1) with no intermediate l(+)l(-) resonance, yielding a kinematic endpoint in the dilepton invariant mass spectrum. The data are found to be consistent with the Standard Model expectation. Results are interpreted using simplified models, and exclude gluinos and squarks with masses as large as 1.85 and 1.3 TeV at 95% confidence level, respectively.
A measurement of J/psi and psi(2S) production is presented. It is based on a data sample from Pb+Pb collisions at root s(NN) = 5.02 TeV and pp collisions at root s = 5.02 TeV recorded by the ATLAS detector at the LHC in 2015, corresponding to an integrated luminosity of 0.42 nb(-1) and 25 pb(-1) in Pb+Pb and pp, respectively. The measurements of per-event yields, nuclear modification factors, and non-prompt fractions are performed in the dimuon decay channel for 9 < p(T)(mu mu) < 40 GeV in dimuon transverse momentum, and -2 < y(mu mu) < 2 in rapidity. Strong suppression is found in Pb+Pb collisions for both prompt and non-prompt J/psi, increasing with event centrality. The suppression of prompt psi(2S) is observed to be stronger than that of J/psi, while the suppression of non-prompt psi(2S) is equal to that of the non-prompt J/psi within uncertainties, consistent with the expectation that both arise from b-quarks propagating through the medium. Despite prompt and non-prompt J/psi arising from different mechanisms, the dependence of their nuclear modification factors on centrality is found to be quite similar.
A search for high-mass resonances decaying to tau nu using proton-proton collisions at root s = 13 TeV produced by the Large Hadron Collider is presented. Only tau-lepton decays with hadrons in the final state are considered. The data were recorded with the ATLAS detector and correspond to an integrated luminosity of 36.1 fb(-1). No statistically significant excess above the standard model expectation is observed; model-independent upper limits are set on the visible tau nu production cross section. Heavy W' bosons with masses less than 3.7 TeV in the sequential standard model and masses less than 2.2-3.8 TeV depending on the coupling in the nonuniversal Go(221) model are excluded at the 95% credibility level.
Search for a Structure in the B-s(0) π\(^{±}\) Invariant Mass Spectrum with the ATLAS Experiment
(2018)
A search for the narrow structure, X(5568), reported by the DO Collaboration in the decay sequence X -> B-s(0) pi +/-, B-s(0) -> J/psi phi, is presented. The analysis is based on a data sample recorded with the ATLAS detector at the LHC corresponding to 4.9 fb(-1) of pp collisions at 7 TeV and 19.5 fb(-1)at 8 TeV. No significant signal was found. Upper limits on the number of signal events, with properties corresponding to those reported by DO, and on the A production rate relative to B-s(0) mesons, rho x, were determined at 95% confidence level. The results are N(X) < 382 and rho x <0.015 for B-s(0) mesons with transverse momenta above 10 GeV and N(X) < 356 and rho(x) < 0.016 for transverse momenta above 15 GeV. Limits are also set for potential B-s(0) pi(+) resonances in the mass range 5550 to 5700 MeV.
Measurements are made of differential cross-sections of highly boosted pair-produced top quarks as a function of top-quark and t (t) over bar system kinematic observables using proton-proton collisions at a center-of-mass energy of root s = 13 TeV. The data set corresponds to an integrated luminosity of 36.1 fb(-1), recorded in 2015 and 2016 with the ATLAS detector at the CERN Large Hadron Collider. Events with two large-radius jets in the final state, one with transverse momentum p(T) > 500 GeV and a second with p(T) > 350 GeV, are used for the measurement. The top-quark candidates are separated from the multijet background using jet substructure information and association with a b-tagged jet. The measured spectra are corrected for detector effects to a particle-level fiducial phase space and a parton-level limited phase space, and are compared to several Monte Carlo simulations by means of calculated chi(2) values. The cross-section for t (t) over bar production in the fiducial phase-space region is 292 +/- 7(stat) +/- 71(syst) tb, to be compared to the theoretical prediction of 384 +/- 36 fb.
A search for supersymmetric partners of top quarks decaying as (t) over tilde (1) -> c (chi) over tilde (0)(1)and supersymmetric partners of charm quarks decaying as (c) over tilde (1) -> c (chi) over tilde (0)(1) where (chi) over tilde (0)(1) is the lightest neutralino, is presented. The search uses 36.1 fb(-1) pp collision data at a centre-of-mass energy of 13 TeV collected by the ATLAS experiment at the Large Hadron Collider and is performed in final states with jets identified as containing charm hadrons. Assuming a 100% branching ratio to c (chi) over tilde (0)(1), top and charm squarks with masses up to 850 GeV are excluded at 95% confidence level for a massless lightest neutralino. For m (t) over tilde (1,(c) over tilde1) - m((chi) over tilde 10)< 100 GeV, top and charm squark masses up to 500 GeV are excluded.
Properties of the Higgs boson are measured in the two-photon final state using 36.1 fb(-1) of proton-proton collision data recorded at root s = 13 TeV by the ATLAS experiment at the Large Hadron Collider. Cross-section measurements for the production of a Higgs boson through gluon-gluon fusion, vector-boson fusion, and in association with a vector boson or a top-quark pair are reported. The signal strength, defined as the ratio of the observed to the expected signal yield, is measured for each of these production processes as well as inclusively. The global signal strength measurement of 0.99 +/- 0.14 improves on the precision of the ATLAS measurement at root s = 7 and 8 TeV by a factor of two. Measurements of gluon-gluon fusion and vector-boson fusion productions yield signal strengths compatible with the Standard Model prediction. Measurements of simplified template cross sections, designed to quantify the different Higgs boson production processes in specific regions of phase space, are reported. The cross section for the production of the Higgs boson decaying to two isolated photons in a fiducial region closely matching the experimental selection of the photons is measured to be 55 +/- 10 fb, which is in good agreement with the Standard Model prediction of 64 +/- 2 fb. Furthermore, cross sections in fiducial regions enriched in Higgs boson production in vector-boson fusion or in association with large missing transverse momentum, leptons or top-quark pairs are reported. Differential and double-differential measurements are performed for several variables related to the diphoton kinematics as well as the kinematics and multiplicity of the jets produced in association with a Higgs boson. These differential cross sections are sensitive to higher order QCD corrections and properties of the Higgs boson, such as its spin and CP quantum numbers. No significant deviations from a wide array of Standard Model predictions are observed. Finally, the strength and tensor structure of the Higgs boson interactions are investigated using an effective Lagrangian, which introduces additional CP-even and CP-odd interactions. No significant new physics contributions are observed.
A search is conducted for new resonances decaying into a WW or WZ boson pair, where one W boson decays leptonically and the other W or Z boson decays hadronically. It is based on proton-proton collision data with an integrated luminosity of 36.1 fb(-1) collected with the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy of root s = 13 TeV in 2015 and 2016. The search is sensitive to diboson resonance production via vector-boson fusion as well as quark-antiquark annihilation and gluon-gluon fusion mechanisms. No significant excess of events is observed with respect to the Standard Model backgrounds. Several benchmark models are used to interpret the results. Limits on the production cross section are set for a new narrow scalar resonance, a new heavy vector-boson and a spin-2 Kaluza-Klein graviton.
Previous studies have shown that weighted angular moments derived from jet constituents encode the colour connections between partons that seed the jets. This paper presents measurements of two such distributions, the jet-pull angle and jet-pull magnitude, both of which are derived from the jet-pull angular moment. The measurement is performed in delivered by the Large Hadron Collider. The observables are measured for two dijet systems, corresponding to the colour-connected daughters of the Wboson and the two b-jets from the top-quark decays, which are not expected to be colour connected. To allow the comparison of the measured distributions to colour model predictions, the measured distributions are unfolded to particle level, after correcting for experimental effects introduced by the detector. While good agreement can be found for some combinations of predictions and observables, none of the predictions describes the data well across all observables.
Searches for dijet resonances with sub-TeV masses using the ATLAS detector at the Large Hadron Collider can be statistically limited by the bandwidth available to inclusive single-jet triggers, whose data-collection rates at low transverse momentum are much lower than the rate from standard model multijet production. This Letter describes a new search for dijet resonances where this limitation is overcome by recording only the event information calculated by the jet trigger algorithms, thereby allowing much higher event rates with reduced storage needs. The search targets low-mass dijet resonances in the range 450-1800 GeV. The analyzed data set has an integrated luminosity of up to 29.3 fb(-1) and was recorded at a center-of-mass energy of 13 TeV. No excesses are found; limits are set on Gaussian-shaped contributions to the dijet mass distribution from new particles and on a model of dark-matter particles with axial-vector couplings to quarks.
This paper presents a measurement of the polarisation of tau leptons produced in Z/gamma* -> tau tau decays which is performed with a dataset of proton-proton collisions at root s = 8 TeV, corresponding to an integrated luminosity of 20.2 fb(-1) recorded with the ATLAS detector at the LHC in 2012. The Z/gamma* -> tau tau decays are reconstructed from a hadronically decaying tau lepton with a single charged particle in the final state, accompanied by a tau lepton that decays leptonically. The tau polarisation is inferred from the relative fraction of energy carried by charged and neutral hadrons in the hadronic tau decays. The polarisation is measured in a fiducial region that corresponds to the kinematic region accessible to this analysis. The tau polarisation extracted over the full phase space within the Z/gamma* mass range of 66 < mZ/gamma* < 116GeVis found to be P-tau = -0.14 +/- 0.02(stat)+/- 0.04(syst). It is in agreement with the Standard Model prediction of Pt = -0.1517 +/- 0.0019, which is obtained from the ALP-GEN event generator interfaced with the PYTHIA 6 parton shower modelling and the TAUOLA tau decay library.
A measurement of off-shell Higgs boson production in the ZZ -> 4l and ZZ -> 2l2v decay channels, where stands for either an electron or a muon, is performed using data from proton-proton collisions at a centre-of-mass energy of root s = 13 TeV. The data were collected by the ATLAS experiment in 2015 and 2016 at the Large Hadron Collider, and they correspond to an integrated luminosity of 36.1 fb(-1). An observed (expected) upper limit on the off-shell Higgs signal strength, defined as the event yield normalised to the Standard Model prediction, of 3.8 (3.4) is obtained at 95% confidence level (CL). Assuming the ratio of the Higgs boson couplings to the Standard Model predictions is independent of the momentum transfer of the Higgs production mechanism considered in the analysis, a combination with the on-shell signal-strength measurements yields an observed (expected) 95% CL upper limit on the Higgs boson total width of 14.4 (15.2) MeV.
This paper presents a direct measurement of the decay width of the top quark using t (t) over bar events in the lepton+jets final state. The data sample was collected by the ATLAS detector at the LHC in proton-proton collisions at a centre-of-mass energy of 8 TeV and corresponds to an integrated luminosity of 20.2 fb(-1). The decay width of the top quark is measured using a template fit to distributions of kinematic observables associated with the hadronically and semileptonically decaying top quarks. The result, Gamma(t) = 1.76 +/- 0.33 (stat.) (+0.79)(-0.68) (syst.) GeV for a top-quark mass of 172.5 GeV, is consistent with the prediction of the Standard Model.
Long-term monitoring of the ANTARES optical module efficiencies using \(^{40}\)K decays in sea water
(2018)
Cherenkov light induced by radioactive decay products is one of the major sources of background light for deep-sea neutrino telescopes such as ANTARES. These decays are at the same time a powerful calibration source. Using data collected by the ANTARES neutrino telescope from mid 2008 to 2017, the time evolution of the photon detection efficiency of optical modules is studied. A modest loss of only 20% in 9 years is observed. The relative time calibration between adjacent modules is derived as well.
This Letter presents measurements of correlated production of nearby jets in Pb+Pb collisions at \(\sqrt S_{NN}\)=2.76 TeV using the ATLAS detector at the Large Hadron Collider. The measurement was performed using 0.14 nb\(^{-1}\) of data recorded in 2011. The production of correlated jet pairs was quantified using the rate, R\(_{ΔR}\), of “neighbouring” jets that accompany “test” jets within a given range of angular distance, ΔR , in the pseudorapidity–azimuthal angle plane. The jets were measured in the ATLAS calorimeter and were reconstructed using the anti-k\(_t\) algorithm with radius parameters d=0.2, 0.3, and 0.4. R\(_{ΔR}\) was measured in different Pb+Pb collision centrality bins, characterized by the total transverse energy measured in the forward calorimeters. A centrality dependence of R\(_{ΔR}\) is observed for all three jet radii with R\(_{ΔR}\) found to be lower in central collisions than in peripheral collisions. The ratios formed by the R\(_{ΔR}\) values in different centrality bins and the values in the 40–80% centrality bin are presented.
A search is presented for particles that decay producing a large jet multiplicity and invisible particles. The event selection applies a veto on the presence of isolated electrons or muons and additional requirements on the number of \(b\)-tagged jets and the scalar sum of masses of large-radius jets. Having explored the full ATLAS 2015-2016 dataset of LHC proton-proton collisions at \(\sqrt{s}\) = 13 TeV, which corresponds to 36.1 fb\(^{−1}\) of integrated luminosity, no evidence is found for physics beyond the Standard Model. The results are interpreted in the context of simplified models inspired by R-parity-conserving and R-parity-violating supersymmetry, where gluinos are pair-produced. More generic models within the phenomenological minimal supersymmetric Standard Model are also considered.
Inclusive and differential fiducial cross sections of Higgs boson production in proton-proton collisions are measured in the \(H\) → \({ZZ^*}\) → \(4{ℓ}\) decay channel. The proton-proton collision data were produced at the Large Hadron Collider at a centre-of-mass energy of 13 TeV and recorded by the ATLAS detector in 2015 and 2016, corresponding to an integrated luminosity of 36.1 fb\(^{−1}\). The inclusive fiducial cross section in the \(H\) → \({ZZ^*}\) → \(4{ℓ}\) decay channel is measured to be 3.62 ± 0.50(stat)\(^{+0.25}_{− 0.20}\) (sys) fb, in agreement with the Standard Model prediction of 2.91 ± 0.13 fb. The cross section is also extrapolated to the total phase space including all Standard Model Higgs boson decays. Several differential fiducial cross sections are measured for observables sensitive to the Higgs boson production and decay, including kinematic distributions of jets produced in association with the Higgs boson. Good agreement is found between data and Standard Model predictions. The results are used to put constraints on anomalous Higgs boson interactions with Standard Model particles, using the pseudo-observable extension to the kappa-framework.
This article presents a search for flavour-changing neutral currents in the decay of a top quark into an up-type (\({q = c, u}\)) quark and a Higgs boson, where the Higgs boson decays into two photons. The proton-proton collision data set analysed amounts to 36.1 fb\(^{−1}\) at \(\sqrt{s} = 13\) TeV collected by the ATLAS experiment at the LHC. Top quark pair events are searched for, where one top quark decays into \(qH\) and the other decays into \(bW\). Both the hadronic and leptonic decay modes of the \(W\) boson are used. No significant excess is observed and an upper limit is set on the \({t → cH}\) branching ratio of 2.2 × 10\(^{−3}\) at the 95% confidence level, while the expected limit in the absence of signal is 1.6 × 10\(^{−3}\). The corresponding limit on the \(tcH\) coupling is 0.090 at the 95% confidence level. The observed upper limit on the \({t → uH}\) branching ratio is 2.4 × 10\(^{−3}\).
A search for the supersymmetric partners of the Standard Model bottom and top quarks is presented. The search uses 36.1 fb\(^{−1}\) of \(pp\) collision data at \(\sqrt{s}\) = 13 TeV collected by the ATLAS experiment at the Large Hadron Collider. Direct production of pairs of bottom and top squarks (\(\overline{b}_1\) and \(\overline{t}_1\)) is searched for in final states with \(b\)-tagged jets and missing transverse momentum. Distinctive selections are defined with either no charged leptons (electrons or muons) in the final state, or one charged lepton. The zero-lepton selection targets models in which the \(\overline{b}_1\) is the lightest squark and decays via \(\overline{b}_1\) → \(b\overline{χ}^0_1\), where \(\overline{χ}^0_1\) is the lightest neutralino. The one-lepton final state targets models where bottom or top squarks are produced and can decay into multiple channels, \(\overline{b}_1\) → \(b\overline{χ}^0_1\) and \(\overline{b}_1\) → \(t\overline{χ}^±_1\), or \(\overline{t}_1\) → \(t\overline{χ}^0_1\) and \(\overline{t}_1\) → \(b\overline{χ}^±_1\), where \(\overline{χ}^±_1\) is the lightest chargino and the mass difference \(m_{\overline{χ}^±_1}\) − \(m_{\overline{χ}^0_1}\) is set to 1 GeV. No excess above the expected Standard Model background is observed. Exclusion limits at 95% confidence level on the mass of third-generation squarks are derived in various supersymmetry-inspired simplified models.